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Abstract
Abstract
Nitric oxide (NO) is a signalling molecule in the central nervous system and other 
tissues. NO synthesis and its immediate targets are well-characterised molecularly, 
but little is known about how the NO signal is terminated. Recent work has 
suggested the existence of a biological sink for NO in dispersed brain tissue. This 
study aimed to discover the kinetic properties of NO inactivation in brain and to 
elucidate the mechanism(s) underlying this process.
Measurements of cGMP accumulation in brain slices from cerebellum indicated that 
intact brain inactivates NO. When analysed using a model of NO diffusion and 
inactivation, the experimental data were consistent with the maximum rate of 
inactivation being fast (over 1 pM/s). It was inferred from the kinetics that biological 
inactivation of NO would predominantly affect NO signalling when several sources 
of NO are concurrently active.
The mechanism of NO consumption initially studied in dispersed brain tissue has 
since been shown to be the reaction of NO with lipid peroxyls, a process that may 
have relevance to pathophysiology. Pharmacological and other tests showed that 
the breakdown of NO by cerebellar slices was, however, independent of this 
mechanism. Further manipulations also eliminated other potential routes of NO 
metabolism (reaction with red blood cells or superoxide, or autoxidation) as 
underlying causes. Lipid peroxide-independent NO inactivation was also found in 
acute and cultured cerebellar cells. The reaction exhibited marked oxygen- 
dependence.
In dilute preparations, NO metabolism was largely lost on cell lysis, but was 
recoverable by addition of the electron donor NADPH. This activity resided in the 
membrane fraction following high speed centrifugation. Inactivation of NO in 
NADPH-treated lysates or membrane fractions, and in intact cells, was partially 
inhibited by cyanide. This evidence suggests the involvement of membrane-bound 
haem and flavoproteins. In concentrated tissue preparations and intact brain slices, 
however, an alternative process becomes dominant. Which of these mechanisms is 
most important physiologically requires further investigation. Their relative 
distributions with respect to the sites of NO release may be critical.
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Chapter 1: General Introduction
1.1 Identification of NO as a biological signalling molecule
Historically, NO has been considered a poisonous molecule, proving near 
fatal when inhaled by Sir Humphrey Davy in his research into inhalable 
anaesthetics and later killing one patient and injuring another when a stock of 
nitrous oxide (N2O) was contaminated with NO in 1966 (Clutton-Brock, 
1967). Its importance as an endogenous messenger has only become 
apparent relatively recently and came initially as somewhat of a surprise, 
given this association with toxic effects. Its meteoric rise from poison to 
physiological agent was recognised with the naming of NO as “molecule of 
the year” by the journal Science in 1992 and the award of the 1998 Nobel 
Prize for Physiology and Medicine to Robert Furchgott, Louis Ignarro and 
Ferid Murad for their contributions to the research leading to the discovery of 
the physiological functions of NO.
The importance of NO as a physiological messenger was revealed by a 
series of key experiments on the vascular system in the 1980s. These 
studies stemmed from a conundrum as to the mechanism behind the 
sympathetic vasodilatory response, allowing increased blood flow to the 
skeletal muscles and the classic “fight-or-flighf response. Historically, 
experiments on cat hind limb (Folkow et at., 1948) showed this response to 
be mediated through acetylcholine (ACh). Conversely, however, ACh 
stimulation of arteries isolated in an organ bath produced no response or 
even contraction of arterial smooth muscle. This contradiction was resolved 
by Furchgott’s finding that the endothelium was required for ACh to produce 
a relaxation (Furchgott & Zawadzki, 1980), via a diffusible substance that 
was termed endothelium derived relaxing factor (EDRF).
At this time it was known that when added in high concentrations, NO had a 
short half-life in aqueous solution (in the order of seconds), could produce 
elevated levels of the cyclic nucleotide cyclic guanosine monophosphate 
(cGMP) and could be scavenged by haemoglobin (Hb; Murad et a i , 1978). 
When the effect of EDRF was shown to be mediated by cGMP (Ignarro et al.,
17
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1986a) and be blocked by Hb (Martin eta l., 1985), in addition to its having a 
similarly short biological half-life (Rubanyi & Vanhoutte, 1986), the link 
between NO and EDRF was made. Two critical experiments in 1987 served 
to confirm that EDRF was indeed identical to NO. Not only did EDRF have 
the same vasodilatory effects as applied NO (Ignarro et al., 1987), but EDRF 
from endothelial cells was revealed through chemiluminescent analysis and 
the characteristic shift in the Soret peak of oxyhaemoglobin to be NO 
(Ignarro et al., 1987; Palmer et al., 1987). Subsequently it was found that 
NO is endogenously synthesised from L-arginine (Palmer et al., 1988).
The identification of EDRF as NO soon led to advances in the fields of 
neuroscience and cytotoxicity. It was known that glutamate increased cGMP 
levels in the brain, particularly in the cerebellum (Garthwaite & Balazs, 1981). 
Additionally, the cells in which cGMP accumulated were different from those 
in which glutamate receptors were stimulated, suggestive of the involvement 
of an intercellular messenger (Garthwaite & Garthwaite, 1987). When this 
intercellular messenger was demonstrated to share the same properties as 
EDRF/NO (e.g. ability to relax smooth muscle, Ca2+- and L-arginine- 
dependent release and inhibition by Hb; Garthwaite et al., 1989; Garthwaite 
et al., 1988), the role of NO as a physiological messenger in the brain was 
revealed. Similarly, NO was subsequently identified as one of the 
transmitters in the non-adrenergic, non-cholinergic (NANC) nerves of the 
autonomic peripheral nervous system, where, as following release from 
endothelial cells, it causes relaxation of smooth muscle (Sanders & Ward, 
1992). It was not long before synthetic machinery for NO was discovered, in 
the form of nitric oxide synthase (NOS) which was found to be highly 
expressed in brain (Bredt etal., 1990; Bredt & Snyder, 1990).
In the arena of inflammation and cytotoxicity, it had been known for some 
time that an imbalance existed between intake and excretion of nitrite (N0 2 -) 
and nitrate (NO3') in mammals (Green etal., 1981a; Green etal., 1981b) and 
that this imbalance was exacerbated following induction of inflammation in 
rats (Wagner et al., 1983). Macrophages were subsequently identified as the 
major contributor to these elevated NO27NO3' levels (Stuehr & Marietta,
18
Chapter 1: General Introduction
1985). The co-dependence on L-arginine of production of NO2/NO3' and the 
destruction of tumour cells by activated macrophages suggested a causative 
link between NCV/NCV and cytotoxicity (Hibbs, Jr. et al., 1987). Indeed, 
further studies revealed that in fact NO is synthesised from L-arginine by 
activated macrophages (and is subsequently oxidised to NO2/NO3) and it is 
this that underlies their cytotoxic properties (Hibbs, Jr. etal., 1988).
The NO-cGMP system is found throughout the body, its three major 
functions being those touched on above: relaxation of smooth muscle
leading to vasodilation, neural signalling and a role in the inflammatory 
response. It is the role of NO in the nervous system that has been of 
particular interest to me and as such will be considered in detail below.
1.2 The NO signalling pathway in brain
1.2.1 The NO signal
1.2.1.1 Nitric oxide synthases
Throughout the body, NO is synthesised by three major subtypes of nitric 
oxide synthase (NOS): the endothelial (eNOS), neuronal (nNOS) and 
inducible (iNOS) isoforms, all of which catalyse the reaction of the substrates 
L-arginine, NADPH and O2 to NO, L-citrulline and NADP+. All isoforms exist 
as a homodimer, each monomer containing a C-terminal reductase domain 
and an N-terminal oxygenase domain. The reductase oxidises NADPH to 
NADP+, donating electrons which are transferred via the bound flavins FAD 
and FMN to a haem moiety in the oxygenase domain (Fig. 1.1). Two 
oxygenation cycles are then performed, the first forming N-hydroxy-L- 
arginine (NHA) from L-arginine in a reaction which requires 
tetrahydrobiopterin (BH4) as a cofactor. In the second cycle, NHA is 
converted to NO. All isoforms of NOS require calmodulin (CaM) to be bound 
for transfer of electrons between the flavin and haem domains. In eNOS and
19
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nNOS, an “autoinhibitory loop” of 40-50 amino acids in the FMN-binding 
domain destabilises CaM binding at low Ca2+ concentrations, conferring a 
dependence on intracellular Ca2+ onto these isoforms (Alderton et al., 2001). 
In the brain, eNOS is expressed in blood vessels and iNOS can be 
expressed in glia and/or neurons following inflammatory stimulation, but 
nNOS is the only isoform physiologically expressed in neurons (Blackshaw et 
al., 2003).
NADPH CaM
ArginineOxygenase
BH4
— » / Fe /
Reductase Citmlline
NO
FAD
FMN
Fig. 1.1: Synthesis of NO from NOS (From (Alderton etal., 2001).
1.2.1.2 Modulation of nNOS
Its modulation can occur at several levels: feedback inhibition by NO can 
occur at the haem iron, where newly-formed NO competes with O2 for 
binding to the ferrous iron, then generating ferric iron and nitrate (Santolini et 
al., 2001). This competition between NO and 02for binding also increases 
the Km of nNOS for O2 (to 350 pM; Stuehr et al., 2004), such that nNOS 
activity is 02-dependent throughout the physiological range (Abu-Soud et al., 
1996). Phosphorylation of nNOS at Ser-847 by Ca2+/CaM-dependent protein 
kinases decreases its activity and thus acts as an alternative mechanism for 
negative feedback of NOS activity (Hayashi et al., 1999; Komeima et al., 
2000; Nakane et al., 1991). Two proteins have been identified which bind 
and may regulate nNOS. Protein inhibitor of NOS (PIN) and C-terminal PDZ 
ligand of NOS (CAPON) both bind to the extended PDZ domain of nNOS 
(Jaffrey et al., 1998; Jaffrey & Snyder, 1996). Their functions are unclear: 
PIN may inhibit nNOS activity (Jaffrey & Snyder, 1996) or contribute to 
axonal transport (Rodriguez-Crespo et al., 1998), while CAPON may inhibit
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PSD-95 association (post-synaptic density protein-95; Jaffrey et al., 1998) 
but also aid membrane association via synapsins (Jaffrey et al., 2002).
1.2.1.3 nNOS distribution
Potential sites for NO production have been revealed by 
immunohistochemical staining (Bredt et al., 1990; Burette et al., 2002; de 
Vente et al., 1998; Martinelli et al., 2002), in situ hybridization studies 
(Keilhoff et al., 1996), autoradiographic binding studies (Hara et al., 1996; 
Rao & Butterworth, 1996) and also the use of the NADPH-diaphorase 
staining technique (Keilhoff et al., 1996; Sajin et al., 1992; Southam & 
Garthwaite, 1993; Vincent & Kimura, 1992). This exploits the activity of the 
synthetic enzyme for NO, nitric oxide synthase (NOS), to reduce tetrazolium 
salts to visible formazans, in an NADPH-dependent fashion, enabling 
histochemical visualisation of sites of NOS activity. Most NADPH- 
diaphorase activity in fixed brain can be accounted for by NOS (Dawson et 
al., 1991).
These studies reveal that nNOS is present throughout the brain, though often 
in discrete neuronal populations that have few other phenotypic 
characteristics in common. In the cerebellum, for example, which has the 
highest NOS activity in the brain (Salter et al., 1995), it localises to the 
molecular and granule cell layers, but is predominantly absent from healthy 
Purkinje cells (Rodrigo et al., 2001). In the cerebral cortex, it is strongest in 
sub-populations of cells in the superficial layers and in the striatum it is found 
in medium aspiny cells. In the hippocampus, immunohistochemical studies 
initially found NOS to be located only in interneurons in the CA1 and CA3 
subfields, a finding at odds with the evidence linking NO to CA1 pyramidal 
cell synaptic plasticity and also contradicting some of the NADPH-diaphorase 
results. Recently, however, use of a weaker fixation protocol and electron 
microscopy in addition to light microscopy has revealed that NOS is indeed 
present in spines of a subset of CA1 pyramidal neurons (Burette et al., 
2002).
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This increased sensitivity of detection allows the sub-cellular loci of nNOS to 
be determined. Strongly labelled cells often demonstrate diffuse cytosolic 
labelling. Cells which are weakly labelled or unlabelled at the light 
microscope level can, when examined under the electron microscope, reveal 
nNOS which is localised specifically to membranes and post-synaptic 
densities but which was previously too weak and discretely distributed to be 
detected (Burette et al., 2002). This membrane localisation is due to the 
interaction of neuronal NOS with the post synaptic density protein, PSD-95. 
PSD-95 interacts through its second PDZ domain with an extended PDZ 
domain towards the N-terminal of nNOS (Brenman et al., 1996). Disruption 
of this interaction by deletion of the N-terminal of nNOS prevents membrane 
association without changing the catalytic activity of the enzyme. NMDA 
receptors also bind PSD-95 (Kornau et al., 1995) and both form a ternary 
complex with nNOS (Christopherson et al., 1999). This PSD-95 mediated 
localization of NMDA receptors with nNOS appears to be functionally 
significant as suppression of PSD-95 blocks the production of cGMP 
following NMDA application, but not following non-specific depolarisation 
(Sattler et al., 1999). Association of nNOS with the membrane and NMDA 
receptors thus enables synaptic activation of NO synthesis.
The splice variants nNOSp and y lack the PDZ domain that allows 
association of nNOS with the membrane and are therefore cytosolic. nNOSp 
at least is expressed at the protein level and is catalytically functional 
(Eliasson et al., 1997) so could generate NO in response to Ca2+ entry from 
other sources (e.g. voltage-gated Ca2+ channels). In support of this, 
immunohistochemical detection of L-citrulline, a by-product of NO synthesis, 
reveals basal NO production predominantly near both dendritic membranes 
and the endoplasmic reticulum, where Ca2+ can be released from 
intracellular stores (Martinelli etal., 2002).
nNOS protein expression is developmentally regulated in rat, though mRNA 
levels remain constant from E10, protein levels increase gradually, appearing 
earliest in the brainstem (E15) and only after birth in the hippocampus, 
cerebellum and olfactory bulb (P3) (Keilhoff et al., 1996). Human striatum
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also exhibits developmental regulation of NOS activity, as NADPH- 
diaphorase staining changes from a patchy striosomal foetal distribution, to a 
dense matrix stain in adult (Sajin et al., 1992). The pattern of nNOS 
expression can also be regulated by neuronal activity: in adult monkey, 
monocular deprivation results in decreased nNOS protein in the neuropil of 
layer IVc of the deprived ocular dominance column (Aoki et al., 1993).
1.2.1.4 NO
The pattern of nNOS activation will be instrumental in shaping the NO signal. 
Repeated activity of groups of neurons may be expected to generate a 
diffuse cloud of NO throughout the neuronal bundle, while sparse activity 
could lead to an NO signal being localised to individual neurons and 
synapses (Wood & Garthwaite, 1994). Direct measurement of the temporal 
and spatial NO profile would be valuable to determine which of these 
possibilities occurs in different situations. Unfortunately, however, adequate 
methods for achieving this are currently unavailable. Fluorescent indicators 
for NO, 4,5-diaminofluorescein (DAF-2) and its cell-permeable analogue 
DAF-2 AM, have been used experimentally (Brown et al., 1999; Kojima et al., 
1998), but the interpretation of fluorescence changes of these compounds is 
fraught with difficulty, due to synergy with Ca2+ and Mg2+ (Broillet et al.,
2001), and cross-reactivity with ascorbic acid (Zhang et al., 2002), 
catecholamines and glutathione (Nagata et al., 1999) and peroxynitrite 
(Roychowdhury et al., 2002). Electrochemical detection of NO is possible 
(Kimura et al., 1998; Shibuki & Kimura, 1997; Wakatsuki et al., 1998) but the 
electrodes do not have sufficient spatial or temporal resolution to record 
endogenous NO profiles accurately.
While the dynamics of NO signals are currently uncertain, the physiological 
concentrations of NO are likely to be in the low nanomolar range, rather than 
micromolar levels as previously thought. Previous studies using porphyrinic 
microsensors suggested that stimulation of NO production in endothelial cells 
with bradykinin produced around 1 pM NO (Malinski etal., 1993b) while after
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middle cerebral artery occlusion NO appeared to increase to 2 pM (Malinski 
et al., 1993a). Porphyrinic microsensors may however cross react with 
tyrosine (Stingele et al., 1998) or ascorbate (Lin et al., 1996), and it seems 
now that the previous measurements of endogenous NO levels were a 
substantial overestimation. Coating porphyrinic sensors with additional 
membranes to increase selectivity results in considerably lower 
measurements of NO produced in response to ischaemia (20 nM; (Lin et al., 
1996)) and NMDA (1 -  40 nM NO; Leonard et al., 2001; Lin et al., 1996; Liu 
et al., 1997; Wu et al., 2001b). Other designs of electrochemical sensors 
yield similar results. In cerebellar slices, for example, electrochemical 
detection showed the maximum NO concentration achieved following parallel 
fibre stimulation (20 Hz for 5 s) to be ~4 nM (Shibuki & Kimura, 1997). 
Physiologically relevant NO levels can be at least an order of magnitude 
lower as indicated by the finding that afferent fibre stimulation of cortical 
slices resulted in NO-dependent synaptic plasticity associated with a peak 
NO concentration in layer V of only 0.4 nM NO in layer V (Wakatsuki et al.,
1998). Additionally, NMDA-induced NO synthesis produces sub-maximal 
activation of the receptors for NO (NO(GC) receptors1; Griffiths and 
Garthwaite, 2001), the operating range of which is 0.5-10 nM NO at steady- 
state (Bellamy et al, 2002; Gibb et al, 2003). Signalling events can be 
induced by even lower concentrations of NO: the EC50 for protein 
phosphorylation in rat platelets is ~0.5 nM (Mo et al., 2004). Both 
measurement of NO itself and of NO(GC) receptor function, therefore, 
suggest that physiological NO signals are likely to be in the low nM range or 
below.
1 The protein which synthesises cGMP on binding of NO is traditionally referred to as soluble 
guanylyl cyclase (sGC). Considering that these proteins are now known to be bona fide NO 
receptors, having a ligand-binding site and transduction unit (Koesling et al., 2004), it is 
preferable to call them guanylyl cyclase-coupled NO receptors, or NO(GC) receptors.
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1.2.2 NO signal transduction
1.2.2.1 Cytochrome c Oxidase
A number of potential physiological targets have been proposed for NO. 
Cytochrome c oxidase (CcO) is inhibited by NO, with an IC50 in 
synaptosomes of between 60 and 120 nM at 30 pM O2 (Bellamy et al., 2002; 
Brown & Cooper, 1994). NO-mediated inhibition of CcO has been proposed 
to be a physiological mechanism by which cellular O2 consumption can be 
regulated (Brown, 1995a). Induction of iNOS in cultured astrocytes can 
produce sufficient NO to inhibit cellular respiration (Brown et al., 1995) and 
stimulation of eNOS with bradykinin inhibits the respiration of endothelial 
cells (Clementi et al., 1999). It remains to be seen whether physiological NO 
production from nNOS can have such effects however and thus whether NO 
physiologically regulates O2 consumption in the brain. If, as discussed 
above, the NO concentration does not increase above 10 nM, this is unlikely.
1.2.2.2 S-nitrosation of thiols
Another reported mechanism by which NO has been reported to exert a 
physiological effect is via S-nitrosation (often wrongly referred to as S- 
nitrosylation; Koppenol, 2002) of protein cysteine residues, forming RSNOs, 
and consequently functionally modifying the proteins (Hess et al., 2005). 
This process has been most extensively described in the reaction of NO with 
Hb, though neuronal proteins such as the NMDA receptor have also been 
reported to be modified by S-nitrosation (Jaffrey et al., 2001; Lipton et al., 
2002). The evidence for a role for S-nitrosation in physiological NO 
signalling is highly controversial, however. In the case of S-nitrosation of Hb, 
for example, NO is proposed to bind to deoxy-haem moieties (Gow et al.,
1999) before being transferred to the p-globin Cys-93, to form S-nitrosated 
Hb (SNO-Hb). NO is then suggested to be delivered to hypoxic tissue via a 
number of transnitrosation reactions, linked to the transition of haemoglobin 
from the R (oxy) to the T (deoxy) state (Gow & Stamler, 1998; Pawloski et 
al., 2001). This process would allow NO to act in an endocrine manner to
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promote vasodilation and increased blood flow to hypoxic regions. 
Experimental observations supporting the physiological role of S-nitrosation 
have, however, subsequently been found to be misleading: the mechanism 
requires NO to preferentially bind to deoxy-haem, which is only ~1 % of the 
total haem population, and as such must react around 100 times faster with 
deoxy- than oxy-haem, a prediction not bom out by the experimental data 
(Gladwin et al., 2003). Additionally, vasodilation suggestive of release of 
NO in conditions of hypoxia seems to actually be due to hypoxia itself 
(Gladwin etal., 2003); bolus delivery of small volumes of highly concentrated 
NO produces S-nitrosation reactions that do not occur following slower (more 
physiological) release of lower NO concentrations from a donor (Joshi et al.,
2002), and previously observed arterial/venous gradients of SNO-Hb cannot 
be reliably replicated and may simply be due to the methodology used to 
detect RSNOs (Giustarini et al., 2004). Perhaps more importantly, though, 
the formation of a RSNO species (e.g. SNO-Hb) cannot occur simply by 
reaction with NO and first requires the formation of an oxidised species of 
NO (e.g. NO+, N2O3) to proceed (Hogg, 2002). Explanation of such a 
fundamental procedure is clearly required to understand whether it can occur 
in physiological conditions, but has not been forthcoming. In neurons, the 
inhibition of NMDA receptors by S-nitrosation has been shown to be 
produced only when both NO and ultraviolet light are concurrently present, 
indicative of artefactual generation of a nitrosating species such as NO+ 
(Hopper et al., 2004). The evidence as yet points more towards similarly 
artefactual generation of the critical nitrosating species, for example by use 
of high NO concentrations or donors that may not generate authentic NO2.
2 The interpretation of results generated from several “NO donor” compounds is 
complicated in that other NO-derivatives than authentic NO can also be produced, 
depending on the environment of release. NO generation by organic nitrates depends on 
the presence of specific thiols (e.g. cysteine, but not glutathione), while SIN-1 (3-morpholino- 
sydnonimine) concomitantly releases NO and superoxide (02"), thus generating 
peroxynitrite (ONOO*). Sodium nitroprusside (SNP) and S-nitrosothiols such as S-nitroso-N- 
acetyl-DL-pencillamine (SNAP) and S-nitrosoglutathione (GSNO) can generate NO* and 
NO' in addition to NO and their decomposition is dependent on light, thiols and, in the case 
of S-nitrosothiols, transition metals. Use of the NONOate class of donors are preferable to 
the above, as authentic NO is generated and the kinetics of NO release are predictable, 
appearing to depend only on concentration and structure of the NONOate, pH and 
temperature (Feelisch, 1998). Even so, the only way to be confident of the level and kinetics 
of NO generated in a given system is by direct measurement of NO using a NO-sensitive 
electrode.
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As the physiological relevance of NO-mediated S-nitrosation of proteins is 
unclear, at best, it will not be further considered here.
1.2.2.3 NO-activated guanylyl cyclase
The only well-established physiological transduction pathway for NO is 
through NO(GC) receptors, though evidence that endogenously produced 
NO has biological effects that are independent of these receptors (Jacoby et 
al, 2001; Lev-Ram et al, 2002) indicates that other, as yet unidentified, 
targets also exist. The receptor exists as a heterodimer of a and p subunits. 
The a iP i and a2pl isoforms have been detected at the protein level 
(Russwurm et al, 2001) and show differential expression across the brain at 
the mRNA level (Gibb and Garthwaite, 2001). Signal transduction occurs on 
binding of NO to a prosthetic haem bound to the regulatory domain of the p 
subunit (Fig. 1.2). This results in formation of a temporary hexacoordinated 
ferrous haem complex and then a pentacoordinate nitrosyl ferrous haem, on 
breakage of the bond between Fe2+ and its axial ligand, the p subunit His- 
105. Cleavage of this bond produces a conformational change in the 
enzyme leading to a several hundred-fold increase in catalytic activity, 
probably by allowing access of guanosine triphosphate (GTP) to the catalytic 
site, resulting in the formation of cGMP from GTP (Hobbs, 1997; Koesling, 
1999; Lucas et al, 2000). Catalysis of GTP to cGMP also requires the 
presence of divalent cations, which are required as substrate co-factors to 
facilitate binding of GTP. Physiologically, this role is probably fulfilled by 
Mg2+. Binding of Ca2+, however, to two allosteric sites, results in inhibition of 
the enzyme (Kazerounian et al., 2002).
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NO
His105
GTP cGMP
Fig. 1.2: Binding of NO to GC leads to synthesis of cGMP from GTP.
Both isoforms share similar kinetic properties, with EC50 values for NO of 0.5 
- 2 nM under steady-state conditions in cells (Bellamy et al., 2002; Gibb et 
al., 2003; Griffiths et al., 2003). Previously, estimates for the EC50 of the 
NO(GC) receptor for NO were much higher (over 250 nM Russwurm et al., 
1998; Stone & Marietta, 1996), unlike the recent work which utilise 
experimental adaptations to hold the NO concentration constant. On 
stimulation by NO, the enzyme activity desensitises within a few seconds 
(Bellamy et al., 2000; Bellamy & Garthwaite, 2001b) in a process that 
appears to depend on the level of NO and cGMP (Bellamy & Garthwaite, 
2001b; Wykes et al., 2002). This rapid desensitisation is characteristic of the 
dynamic nature of cellular NO(GC) receptor activity, as is also evidenced by 
the fast activation (within 20 ms) and deactivation (half-time of 200 ms) on 
addition or removal of NO (Bellamy & Garthwaite, 2001b). When exposure to 
NO is prolonged (hours), NO(GC) receptor protein is reduced as a result of 
mRNA destabilisation (Kloss et al., 2003).
1.2.2.4 Localisation of the NO(GC) receptor
The relationship between the sites of synthesis and action of NO is revealing 
about the functioning of NO as an intercellular signalling molecule. NO(GC) 
receptors and cGMP are found in discrete neuronal sub-populations that are
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usually complementary to that of nNOS (de Vente et al, 1998; Southam and 
Garthwaite, 1993). In the striatum, for example, where NO(GC) receptor 
activity is highest (Matsuoka et al., 1992), while nNOS is found in the 
inhibitory aspiny cells (Vincent & Kimura, 1992), cGMP and NO(GC) 
receptors are located primarily in excitatory medium spiny neurons (Ariano et 
al., 1982), while in the cerebellum the NO(GC) receptor is found in Purkinje 
cells (Ariano et al., 1982), which are devoid of nNOS (Vincent & Kimura,
1992). This juxtaposition of source and target is yet more apparent at the 
synaptic level. In the hippocampus, for example, nNOS is present at the 
postsynaptic membrane and the NO receptors are found in apposing 
presynaptic terminals (Burette et al, 2002). The identity of the receptor 
isoform in this case is unknown but the a2 pl isoform, which is abundant in 
the hippocampus (Gibb and Garthwaite, 2001) can associate with 
membranes via PSD-95 and/or presynaptic proteins (Russwurm et al, 2001) 
while, in rat heart at least, the a iP i isoform can translocate to the membrane
in a Ca2+-dependent manner (Zabel et al, 2002).
The distribution of the sources and targets of NO, therefore, support its role 
as a trans-synaptic signalling molecule. It can be synthesised 
presynaptically in axon terminals, or postsynaptically in dendrites and spines, 
permitting signalling in either the anterograde or retrograde directions in 
different neural systems. In addition, there is evidence that neuronally- 
derived NO can also signal to astrocytes (Matyash et al., 2 0 0 1 ) and blood 
vessels (Yang & ladecola, 1998).
1.2.3 The cGMP signal
Immunohistochemistry for cGMP generally follows that of NO(GC) receptor 
(Ariano et al., 1982; Matsuoka et al., 1992; Southam & Garthwaite, 1993). 
Until recently, however, no cGMP had been visualised in cerebellar Purkinje 
cells, though evidence suggested a requirement for cGMP synthesis for 
parallel fibre-Purkinje cell long term depression (Lev-Ram et al., 1997) and
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despite the presence of the cyclase (Gibb & Garthwaite, 2001; Matsuoka et 
al., 1992). Real-time detection of cGMP using a fluorescent indicator 
constructed from a truncated form of cGMP-dependent protein kinase (cGK), 
has recently resolved this issue and shown a transient increase of cGMP in 
Purkinje cells upon stimulation of parallel fibres or application of NO donors 
(Honda et al., 2001). In addition, hydrolysis in Purkinje cells of a fluorescent 
analogue of cGMP was increased by NO, indicating that cGMP production 
was occurring and activating phosphodiesterase 5 (Hartell et al., 2001). As 
with detection of nNOS and NO synthesis, fine spatial and temporal 
resolution is required to accurately detect the detail of NO-cGMP signals.
The cGMP profile is shaped by the balance between its synthesis via 
NO(GC) receptor activation and its breakdown by phosphodiesterases 
(PDEs). PDE5 and 9 which are selective for cGMP over cyclic adenosine 
monophosphate (cAMP), and PDE1, 2, 3, 10, 11 and, to some extent PDE4 
(Bellamy & Garthwaite, 2001a), which all also hydrolyse cAMP, are 
potentially responsible for the breakdown of NO-evoked cGMP accumulation 
in the brain (Beavo, 1995; Fawcett et al., 2000; Soderling & Beavo, 2000). 
While the functional properties of NO(GC) receptors are similar between 
isoforms, those of the various PDEs are much more variable. Several contain 
modulatory binding sites for cGMP, termed GAF domains (Martinez et al., 
2002), the effects of which have been well-characterised in PDE2 and 5. 
Binding of cGMP increases the rate of cyclic nucleotide hydrolysis (Beavo,
1995) and, in the case of PDE5, also allows phosphorylation of the enzyme 
by cGMP-dependent protein kinase I (Thomas et al., 1990), which may 
contribute to the enhanced activity of PDE5 (Mullershausen et al., 2003).
With such functional heterogeneity, the type and level of PDE expression is 
critical in setting the profile of the cGMP signal in different subpopulations of 
cells. The rapid activation and desensitisation kinetics of NO(GC) receptors 
combined with low PDE activity produce a rapid rise of cGMP to a prolonged 
plateau in cerebellar astrocytes (Bellamy et al., 2000) while, in Purkinje cells, 
high PDE activity results in only a transient cGMP signal on NO stimulation 
(Honda et al., 2001; Shimizu-Albergine et al., 2003). An intermediate,
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triphasic, profile is seen in a population of striatal neurons (Wykes et al., 
2002). Presumably the diversity of cGMP responses impacts on the selection 
of downstream targets, but information on this issue is scant at present.
1.2.4 Targets for cGMP
1.2.4.1 cGMP-dependent protein kinases
cGKs are established receptors for cGMP and are sensitive to 
submicromolar concentrations (Hofmann et al., 2000). There are two major 
subtypes: cGKI exists in two cytosolic alternatively-spliced isoforms, cGK1 a 
and cGK1p. Conversely, cGKII is membrane-bound, due to N-terminal 
myristoylation. The expression of cGKI is restricted to Purkinje cells of the 
cerebellum, the hippocampus, and the dorsomedial thalamus (El Husseini et 
al., 1999), while cGKII is widely expressed in distinct cell populations across 
the brain, especially in the olfactory bulb, cerebral cortex and thalamus (de 
Vente et al., 2001).
Both cGKI and II are homodimers and share the same general structure: In 
the N-terminal domain are a dimerisation site characterised by a leucine 
zipper motif and several regulatory sites that allow autoinhibiton in the 
absence of cGMP, autophosphorylation and regulation of the affinity and co­
operation of cGMP binding. An adjacent regulatory domain contains one 
high- and one low-affinity binding site for cGMP, both of which must be 
occupied for full catalytic activity (Gamm et al., 1995). At the C-terminus is 
found the catalytic site, where Mg2+-ATP and the substrate bind and the y- 
phosphate group from ATP is transferred to the target protein. Despite their 
similarities, the two subtypes display distinct substrate specificities and 
sensitivity for cGMP, with cKI isoforms being 8 -fold more sensitive than 
cGKII (Gamm etal., 1995).
The physiological substrates for cGKIa/p and cGKII remain unclear. The 
best-characterised is the phosphatase inhibitor known as G-substrate, which
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is located primarily in cerebellar Purkinje cells (Endo et al., 1999) but is also 
present at low levels in cortex, hippocampus and the caudate (Detre et al., 
1984). G-substrate can inhibit both protein phosphatase 1c (PP1c) and 
protein phosphatase 2A (PP2A; (Endo et al., 1999; Hall et al., 1999). Both 
cGKI and II also undergo autophosphorylation which, in cGKI, increases 
cGMP binding (El Husseini et al., 1998; Lohmann et al., 1997). Inositol 
trisphosphate receptors (IP3  receptors) are phosphorylated by cGKI in 
cerebellum (Haug etal., 1999). Other candidate substrates include DARPP- 
32, a phosphatase inhibitor sharing homology with G-substrate (Tsou et al.,
1993), and several additional cGK-specific substrates which have been 
detected in brain, though not identified (Wang & Robinson, 1995). cGK 
activity has been implicated in numerous neurophysiological processes, 
including synaptic plasticity (Arancio et al., 2001; Feil et al., 2003; Kleppisch 
et al., 2003; Reyes-Harde et al., 1999; Wu et al., 1998) and membrane 
excitability (Centonze etal., 2001; Klyachko etal., 2001; Smith & Otis, 2003), 
but which, if any, of the above substrates is physiologically responsible for 
these functional changes has not yet been investigated.
1.2.4.2 Cyclic nucleotide-gated channels
Cyclic nucleotide-gated channels (CNGs) are very weakly voltage-sensitive, 
cationic channels, which are opened on binding of either cGMP or cAMP 
(Biel et al., 1998; Kaupp & Seifert, 2002; Lucas et al., 2000; Matulef & 
Zagotta, 2003; Zagotta & Siegelbaum, 1996). In the absence of extracellular 
Ca2+ they permeate Na+ and K+ but have a high affinity for Ca2+ such that 
physiological concentrations of extracellular Ca2+ (1-2 mM) block the pore to 
Na+ and K* and Ca2+ becomes the dominant permeant ion. Originally 
identified in rod and cone photoreceptors and olfactory receptor neurons 
(ORNs), CNGs are tetramers of a and p subunits. There are four a subunits: 
oh is primarily expressed and was identified in rods, 02  in cones and 03  and 
04  in ORNs. Two p subunits have currently been identified: Pia and Pib, two 
splice variants of the same gene product, primarily expressed in rods and
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ORNs respectively, and 03, which is predominantly found in cones. 0 4  was 
originally classified as a p subunit, and named P2, hence the current absence 
of a P2 subunit. Both a and p subunits have the same basic structure of six 
transmembrane domains (S1-S6), a pore forming loop between S5 and S6 , 
and a C-terminal cyclic nucleotide binding domain (CNBD). Only 01.3 
subunits form functional channels when expressed alone, however, though 
co-expression of p subunits is required to impart properties like those seen in 
the native channels, such as flickering between open and closed states. 
Indeed expression of a3, 0 4  and Pib are required to closely mimic the 
properties of the native ORN-type CNG (Bonigk et al., 1999). The major 
difference between the sub-types of CNG is their cyclic nucleotide sensitivity 
and selectivity. Rod and cone-type channels are highly selective for cGMP 
over cAMP but show relatively low sensitivity, with half-maximal activation 
occurring at 50 pM cGMP. Olfactory channels responds equally to either 
ligand and are more sensitive, being activated at low micromolar 
concentrations (Kaupp & Seifert, 2002).
The subunits comprising olfactory-type neurons are expressed in several 
brain regions, including the hippocampus, cerebellar Purkinje cells and 
cortex (Bradley et al., 1997; El Husseini et al., 1995; Kingston et al., 1999; 
Strijbos et al., 1999). Those of rod- and cone-type CNGs are traditionally 
thought to be limited to retinal cells (Bradley et al., 1997), but may be 
expressed more widely as mRNA of rod-type channels has been detected in 
hippocampus (Kingston et al., 1996). There is, therefore, scope for 
modulation of membrane potential and Ca2+-influx by NO/cGMP-mediated 
activation of CNGs, but direct physiological evidence for this is scarce. 
NO/cGMP modulation of transmitter release has been demonstrated in 
salamander and lizard retina (Savchenko etal., 1997) and NO(GC) receptor- 
sensitive depolarisation of the membrane potential has been observed in rat 
hippocampal pyramidal cells (Kuzmiski & MacVicar, 2001), though as this 
latter current was insensitive to inhibition of NOS, its physiological relevance 
to NO-mediated cGMP signalling is unclear. Further work is evidently 
required in order to clarify the precise role of CNGs as a target for the 
NO/cGMP signalling pathway.
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1.2.4.3 HCN channels
Hyperpolarisation-activated cyclic nucleotide-regulated non-selective cation 
(HCN) channels represent a potential, but unconfirmed, target for NO/cGMP 
signalling. Activation of HCN channels occurs on hyperpolarisation of the 
membrane and the activity is potentiated by cyclic nucleotide binding, leading 
to the slow onset of an inward non-selective cation current, (lh) and 
membrane depolarisation. Ih can act as a pacemaker current in some cell 
types (e.g. thalamocortical relay neurons), being activated by 
hyperpolarisation following an action potential and then depolarising the 
membrane towards the threshold for firing a subsequent action potential. It 
also helps regulate the resting membrane potential and the cable properties 
of dendrites, thus influencing dendritic integration and synaptic transmission 
(Huang & Hsu, 2003; Nolan etal., 2003; Robinson & Siegelbaum, 2003).
There are four HCN subunits (HCN1-4) which exhibit differential expression 
across the brain. HCN1 shows predominantly cortical expression, HCN2 is 
widespread throughout the brain and HCN3 and 4 are found subcortically 
(Franz et al., 2000; Notomi & Shigemoto, 2004; Santoro et al., 2000). The 
subunits share a basic structure: an N-terminal domain which is critical for 
subunit association (Proenza et al., 2002); six transmembrane domains (S1- 
6 ) of which S4 is a positively charged voltage sensor which moves inwards 
on hyperpolarisation to produce channel opening; a pore-spanning S5-S6 
linker region which determines ion selectivity and a C-terminal CNBD 
(Robinson & Siegelbaum, 2003). Binding of cAMP or cGMP to the CNBD 
removes tonic inhibition of the channel, shifting its activation to more 
depolarised potentials and increasing the amplitude of the current (Robinson 
& Siegelbaum, 2003). Homomeric expression of the different subunit types 
reveals substantial differences between subtypes in terms of kinetics of 
activation and gating and of cyclic nucleotide sensitivity (Robinson & 
Siegelbaum, 2003). HCN1 homotetramers show fast activation kinetics but 
low cyclic nucleotide sensitivity, HCN2 activates more slowly, due to greater 
tonic inhibition at the CNBD site, but has greater cyclic nucleotide sensitivity.
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HCN4 has the slowest activation kinetics and is also strongly regulated by 
cyclic nucleotides. Native channels are presumably heteromeric and their 
properties are best described by a combination of the properties of 
homomeric channels. For example, cortical layer V pyramidal neurons 
express HCN1 and 2 and the lh current in these neurons exhibits activation 
kinetics intermediate between those exhibited by HCN1 or 2  homomers 
(Santoro et al, 2000).
Regulation of HCN channels by cAMP has been described in several 
neuronal systems and has been implicated in a number of functions, from 
LTP to modulation of membrane conductance (Beaumont & Zucker, 2000; 
Cuttle et al., 2001; Huang & Hsu, 2003; Ingram & Williams, 1996). The 
channels can also be activated by cGMP (Zagotta et al., 2003) making them 
putative targets for NO-cGMP signalling, though direct evidence for this 
possibility is lacking. Exogenously-applied cGMP increases lh in nodose and 
trigeminal ganglion neurons (Ingram & Williams, 1996) and in the calyx of 
Held (Cuttle et al., 2001), while exogenous NO modulates lh in 
thalamocortical relay neurons in a manner that is mimicked by applied 8 -Br- 
cGMP (Pape & Mager, 1992), but a physiological link between NO synthesis 
and subsequent cGMP-mediated effects on lh remains elusive. Endogenous 
NO/cGMP-induced increases in membrane excitability and conductance 
have been observed that are suggestive of mediation by lh (Bains & 
Ferguson, 1997; Shaw et al., 1999) though this has not been directly 
examined. Further work is required to elucidate whether HCN channels can 
be considered general targets for the physiological NO/cGMP pathway.
1.2.4.4 cGMP-modulated PDEs
Several PDE isoforms (PDEs 2, 5, 6 , 10 and 11) have one or two modulatory 
binding sites for cGMP, termed GAF (A and B) domains (Martinez et al., 
2002; Soderling & Beavo, 2000) in addition to their catalytic cyclic nucleotide 
binding domains. The effects of cGMP-binding have been well-characterised
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in PDEs 2 and 5. Binding of cGMP to the GAF B domain of PDE2 
allosterically increases the rate of hydrolysis of both cAMP and cGMP 
(Beavo, 1995). In PDE5, binding of cGMP to the GAF A domain increases 
the rate of hydrolysis (Okada & Asakawa, 2002; Rybalkin et al., 2003) and 
also allows phosphorylation of the enzyme by cGMP-dependent protein 
kinase I (cGKI; Thomas et al., 1990), further enhancing the stimulatory effect 
of cGMP on the rate of hydrolysis (Mullershausen et al., 2001; 
Mullershausen et al., 2003). cGMP therefore can not only negatively 
regulate its own signalling, but can also increase the hydrolysis of cAMP, via 
PDE2, thus providing an opportunity for crosstalk between the two signalling 
cascades. In addition, cGMP has a high affinity for the catalytic site of 
PDE3, but is inefficiently hydrolysed, so effectively competitively inhibits the 
hydrolysis of cAMP by PDE3 (Beavo, 1995). Through these mechanisms, 
NO could cause increases or decreases in cAMP, with multiple potential 
consequences. For example, in cultured amacrine cells, a component of the 
NO-induced decrease in GABA-mediated currents, seems due to activation 
of PDE2 and increased hydrolysis of cAMP (Wexler et al., 1998).
The components of the NO-cGMP signalling pathway as they are currently 
understood are summarised in Fig. 1.3.
Presynaptic Cell CNG
channel•  glutamate HCN
channelGMP, PDE cGKI
cGMPGTP
NO
PSD-95
NMDAR
NOnNOS
Postsynaptic Cell
L-Arg NO
Fig. 1.3 : The NO-cGMP signalling pathway.
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1.3 Functions of NO-cGMP signalling in the brain
NO has been implicated in numerous physiological functions in the central 
nervous system (CNS). For example NO is involved in signalling in the 
visual system (Cudeiro & Rivadulla, 1999), central control of autonomic 
function (Paton etal., 2002), monoaminergicprojection systems (Kiss, 2000), 
neurotransmitter release (Prast & Philippu, 2001), behaviour (Nelson et al.,
1997), and Ca2+-signalling (Clementi & Meldolesi, 1997). In three particular 
areas, recent research has clarified the role of NO as a trans-synaptic 
messenger: development of the CNS and the acute and long-term 
modulation of neuronal function (see Fig. 1.4).
Development
Proiferation
Differentiation
Neurite outgrowth
+ Topographical 
organisation
Acute Membrane excitability 
Transmitter release
Long-term
Long-term potentiation
* Long-term depression
+ I lotorosynaptic spread 
of plasticity
Fig. 1.4: Functions of NO in the brain.
1.3.1 CNS Development
NO has been implicated in three chronologically distinct steps in the 
development of the CNS: inhibition of proliferation and promotion of 
differentiation, the directionality of neurite growth, and the refinement of 
topographical projections.
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In recent years, a number of studies have demonstrated the inhibitory role of 
NO in neuronal precursor proliferation, both in developing brain and in areas 
of ongoing neurogenesis in adult. Inhibition of endogenous NO production 
increases the number of proliferating cells as indicated by 
bromodeoxyuridine (BrdU) staining (Moreno-Lopez et al., 2004; Packer et al., 
2003; Park et al., 2003; Peunova et al., 2001) or expression of markers for 
proliferating cells, nestin and sox-2 (Cheng etal., 2003). The NO scavenger, 
Hb, produces the same effect, while application of exogenous NO decreases 
the number of proliferating cells (Cheng et al., 2003; Peunova ef al., 2001). 
nNOS is expressed in neurons adjacent to, but not within, areas of adult 
neurogenesis (Moreno-Lopez et al., 2000; Packer et al., 2003), and is 
induced by brain-derived neurotrophic factor, in post-mitotic neurons nearby 
proliferating cells in developing cortex (Cheng et al., 2003), suggesting that 
NO acts as an intercellular inhibitory signal to stop proliferation. Knockout 
mice for nNOS also show an increase in the number of proliferating cells, 
though the effect is somewhat less striking than that of broad-spectrum NOS 
inhibition (Packer et al., 2003), indicating that NO derived from both eNOS 
and nNOS may be responsible for the control of proliferation.
NO may also accelerate the differentiation of newly-formed neurons and so 
could act as a switch between proliferation and differentiation. Expression of 
neuronal phenotypic markers, as well as nNOS itself, was delayed by those 
treatments that promoted proliferation (NOS inhibition, Hb) and was 
increased by those that raised NO levels (Cheng etal., 2003; Moreno-Lopez 
et al., 2004). At this early stage of neuronal development, therefore, it 
seems that NO acts in a paracrine manner, being released from nearby 
differentiated neurons to stop neuronal precursors from proliferating and to 
induce a neuronal phenotype. The mechanism through which NO exerts 
these effects remains unclear. None of the above experiments tested the 
involvement of the NO(GC) receptor/cGMP pathway, but the low levels of 
NO(GC) receptor and cGMP detected immunohistochemically in neurons 
prior to differentiation may point to an alternative signalling process (Arnhold 
etal., 2 0 0 2 ).
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A number of studies have implicated NO in controlling the direction of neurite 
growth. The results of these studies appear contradictory, with some 
showing NO-induced collapse and retraction of growth cones (Ernst et al., 
2000; Gallo et al., 2002; He et al., 2002) and others finding NO/cGMP to be 
attractive and protective against growth cone collapse (Campbell et al., 2001; 
Schmidt et al., 2002; Steinbach et al., 2002; Xiang et al., 2002). Such 
opposing findings can be better understood when the concentrations of 
applied NO are considered. Those which showed collapse of growth cones 
used high micromolar to millimolar concentrations of NO donors which are 
likely to produce unphysiologically high NO levels and be damaging to cells. 
Those using lower donor concentrations or cGMP analogues, in general, 
demonstrate growth cone attraction and protection. For example, the 
semaphorin-3A-mediated attraction of apical dendrites of rat cortical 
pyramidal cells to the pial surface is dependent on NO(GC) receptors and 
cGK, while the repellent effect of semaphorin-3A on pyramidal axons is 
independent of this pathway (Polleux et al., 2000). Evidence therefore points 
to a role for NO/cGMP in directing neurites but the reliance on exogenously- 
applied NO and cGMP analogues means that the physiological relevance of 
the effects remain unclear. Only a study in PC12 cells has demonstrated 
that blockade of endogenous NO synthesis can block neurite outgrowth 
(Yamazaki et al, 2001). Further studies on primary neuronal cultures are 
required to help evaluate the importance on NO in this aspect of neuronal 
development.
The roles of NO in synaptic plasticity (see below) suggest that it is a 
plausible candidate for mediating the activity-dependent refinement of 
topographical projections that occurs after the laying down of a coarse map 
by chemical guidance cues. Nonetheless, NO appears to fulfil such a role 
only in a few specific areas. In the chick and the rat, elimination of ipsilateral 
retinotectal or retinocollicular projections is decreased following inhibition of 
NO synthesis (Campello-Costa et al., 2000; Wu et al., 2001a). eNOS/nNOS 
double knockout mice also show a more diffuse ipsilateral retinocollicular 
projection, which nevertheless becomes more refined with age (Wu et al., 
2000). In the ferret, the retinal representation in the dorsal lateral geniculate
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nucleus first becomes segregated into eye-specific columns, and then later 
sublamination occurs to order inputs from ON- and OFF-retinal ganglion 
cells. The latter of these processes is dependent on NO and NO(GC) 
receptor activity and is correlated temporally with the presence of high cGMP 
levels in the dorsal lateral geniculate nucleus (Leamey et al., 2001). The 
organisation of other sensory projections seems to be independent of NO 
and the lack of gross changes in neuroanatomy and behaviour following 
chronic in vivo NOS inhibition would indicate that NO is not necessary to 
form cortical neural maps during late development (Contestabile, 2000).
Early in development, therefore, NO functions as a paracrine messenger to 
determine the fate of neuronal precursors and newly formed cells. Later, 
when its role is that of a trans-synaptic messenger, its role in the formation of 
topographical organisation seems to be considerably more restricted. At 
these later stages, and into adulthood, there is, however, ample evidence to 
support a role for NO in modulating the information flow between neurons, as 
shall be considered below.
1.3.2 Acute neuronal modulation
NO can influence neuronal function in an acute manner by altering 
membrane excitability and neurotransmitter release. In different neuronal 
systems, NO can both increase and decrease excitability, or do nothing, the 
effect in each case presumably being determined by which (if any) target 
proteins for the NO/cGMP pathway are present.
Inhibition of neuronal activity by NO has been reported in a number of cell 
types: exogenous NO decreases a Na+ current in nodose ganglion neurons 
(Bielefeldt et al., 1999), while spinally-projecting paraventricular nucleus 
(PVN) neurons respond to exogenous NO or increased NO synthesis by 
enhanced gamma aminobutyric acid (GABA) release (Li et al., 2002). In this 
subpopulation, blockade of NO synthesis or scavenging of basal NO has no
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effect, indicating NO-mediated effects are stimulus-induced rather than tonic. 
PVN cells projecting to the rostral ventrolateral medulla (RVLM), however, 
are subject to tonic inhibition by NO and so respond to nNOS inhibition with 
an increase in discharge rate (Stern etal., 2003).
NO can disinhibit other cells by reducing GABAergic transmission. In the 
cerebellum, Golgi cells are subject to a tonic NO-dependent 
hyperpolarisation, possibly via BK channels, and this results in decreased 
release of GABA from these cells (Wall, 2003). In addition, NO tonically 
inhibits the GABAa current in granule cells (which receive GABAergic 
innervation from Golgi cells) by a cGK-dependent process (Robello et al., 
1996; Wall, 2003). The net effect of NO, therefore, is a decrease in 
GABAergic transmission and a subsequent disinhibition of downstream 
granule cell activity. NO-mediated disinhibition also occurs by a decrease in 
an outward current in ventrobasal and lateral geniculate thalamic nuclei 
(Shaw et al., 1999) and in a subpopulation of PVN cells, where it is partially 
mediated by cGMP activation of PDE2 and hence a decrease in cAMP and 
cAMP-dependent kinase (cAK) activation (Bains & Ferguson, 1997). 
NO/cGMP stimulation in the thalamic nuclei is associated in vivo with 
increased responses to sensory stimulation, indicating that NO enhances 
sensory transmission through the thalamus (Shaw et al., 1999).
NO may also have more direct excitatory effects on synaptic transmission, 
leading to a cGMP and cGK-dependent increase in glutamate release in 
RVLM neurons (Huang et al., 2003) which is partly mediated by a 
potentiation of Ca2+ entry through N-type channels. NO, cGMP and cGK 
also increase K+ efflux through BK channels at depolarised potentials, which 
in posterior pituitary terminals, counter-intuitively increases Ca2+-entry and 
neuropeptide release, by increasing the action potential 
afterhyperpolarisation and decreasing Na+ channel inactivation such that the 
action potential failure rate decreases (Klyachko etal., 2001).
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Further excitatory effects of NO are increased In3 in striatal cholinergic 
interneurons (Centonze et al., 2001), increased lh and hence decreased 
oscillatory activity in thalamocortical relay cells (Pape & Mager, 1992) and 
increased tonic firing in cerebellar Purkinje cells (Smith & Otis, 2003) and 
brainstem vagal motor neurons (Travagli & Gillis, 1994).
As there are many ways in which NO could modulate neuronal excitability, 
the response of a given neuron will necessarily depend on the target 
elements expressed there. While its effects on acute neuronal function are 
by no means ubiquitous, its actions on both presynaptic release and 
postsynaptic responses support its ability to act as a signalling molecule in 
both anterograde and retrograde directions, but its precise role must be 
understood on a regional, or even cell-specific, basis.
1.3.3 Long-term modulation of neuronal function
The process in which neurons undergo long-term potentiation (LTP) and 
long-term depression (LTD) of the strength of their synaptic connections has 
long been studied as a likely neurophysiological correlate of learning, 
memory and developmental plasticity. In classical LTP, the correlated firing 
of the pre- and postsynaptic cell results in the synapse being strengthened, 
such that subsequent presynaptic activity is able to exert a stronger influence 
on the firing of the postsynaptic neuron. The location of the physiological 
change that underlies such synaptic modification has been a matter of much 
debate, but it is now well-accepted that both postsynaptic and presynaptic 
changes can occur. It is an attractive hypothesis that there is a retrograde 
messenger which relays information about the postsynaptic activity to the 
presynaptic terminal in this situation. Due to its diffusibility and association 
with NMDA receptors, which are known to be critical for much LTP, NO is a 
strong candidate for such a role.
After much controversy, it has gradually become clear that NO functions in 
many, but not all forms of LTP and LTD. Blockade of LTP by inhibitors of
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NOS and/or NO scavengers has been found in several brain areas, including 
the hippocampus, cerebellum, amygdala and cortex (Holscher, 1997; Huang, 
1997; Prast & Philippu, 2001). Unexpectedly, however, knockout mice for 
either nNOS or eNOS demonstrated normal hippocampal LTP, though 
double knockouts lacking both isoforms were impaired (Son et al., 1996). A 
subsequent study, on the other hand, reported that LTP was impaired in 
eNOS knockouts (Kantor et al., 1996). At the time, there was evidence that 
eNOS was present in CA1 pyramidal neurons but this has now been 
considered an artefact and both immunocytochemistry and in situ 
hybridization indicate that eNOS is present only in blood vessels (Blackshaw 
et al., 2003). The implication is that NO from blood vessels contributes to 
LTP, perhaps by providing a tonic level of NO needed for the plastic changes 
to take place (Bon & Garthwaite, 2003). nNOS, which is present in CA1 
pyramidal cells (Burette etal., 2002), may additionally function as a stimulus- 
evoked signal during the triggering of LTP (Bon & Garthwaite, 2003). The 
results using genetic approaches remain incoherent, however. Complications 
may arise in the nNOS knockout animals because of the activity of the 
nNOSp and y splice variants which are upregulated in these animals 
(Eliasson etal., 1997). In eNOS knockouts, there may be aberrations in other 
second messenger pathways resulting in abnormal synaptic plasticity, as 
indicated by studies in the dentate gyrus (Doreulee et al., 2001).
Concerning a retrograde messenger role for NO, there is evidence consistent 
with postsynaptic release in CA1 pyramidal cells and in cerebellar granule 
cells (Arancio etal., 1996; Maffei etal., 2003; Schuman & Madison, 1991). In 
these cases, diffusion of NO to the presynaptic terminal then induces 
NO(GC) receptor- and cGK-dependent synaptic potentiation (Arancio et al., 
2001; Maffei et al., 2003). Possible downstream effectors of presynaptic 
change include endocytotic processes by which vesicles are recycled to the 
readily-releasable pool (Micheva et al., 2003) and, on a longer time scale, 
synaptic remodelling (Nikonenko et al., 2003). NO-dependent LTP that is 
also sensitive to inhibition of NO(GC) receptors and cGK has been 
demonstrated in areas including CA1 (Kleppisch et al., 2003), the amygdala 
(Chien et al., 2003) and neocortex (Wakatsuki et al., 1998) but the sources
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and targets of NO in these synapses have not been established. Indeed, it 
may be erroneous to think of NO as acting solely in one direction or another 
across the synapse. At CA1 hippocampal synapses, for example, in addition 
to its presynaptic targets, NO can also act postsynaptically to induce 
phosphorylation of the transcription factor “cAMP response element binding 
protein” (CREB) and this pathway is also important in late stages of LTP (Lu 
& Hawkins, 2002). Additionally, in cultured hippocampal neurons, application 
of glutamate induces NO-dependent clustering of both pre- and post-synaptic 
proteins, presumably in preparation for synaptogenesis (Wang et al., 2005). 
This process appears to involve modulation of the actin cytoskeleton and as 
such is reminiscent of NO/cGMP-induced relaxation of smooth muscle 
whereby actin organisation is inhibited via cGK phosphorylation and 
inhibition of RhoA GTPase and disinhibition of myosin light chain 
phosphatase (Sauzeau et al., 2000). Synaptic clustering appears to involve 
actin organisation and is stimulated by NO, while in smooth muscle NO 
inhibits actin organisation, suggesting that NO may be able to act 
bidirectionally on actin structure, depending on cell type.
LTD that depends on NO has also been reported in the hippocampus. The 
mechanism is less clear but it also appears to require cGMP/cGK-dependent 
processes and may involve presynaptic Ca2+-release from ryanodine- 
sensitive stores (Reyes-Harde et al., 1999) and selective inhibition of vesicle 
release from the readily releasable pool (Stanton etal., 2003).
Plasticity of the parallel fibre-Purkinje cell synapse in the cerebellum is 
unusual as coincident presynaptic activity and postsynaptic excitation (in the 
form of Ca2+ spiking) cause LTD, rather than LTP, while parallel fibre 
stimulation alone induces LTP. In certain experimental paradigms, LTD can 
be induced by substituting NO or postsynaptic cGMP for parallel fibre 
stimulation, and intracellular Ca2+ elevation for Purkinje cell depolarisation 
(Lev-Ram et al., 1997). In addition, inhibitors of NOS, NO(GC) receptors and 
cGK block LTD induction (Boxall & Garthwaite, 1996; Casado et al., 2002; 
Daniel et al., 1993; Hartell, 1994; Lev-Ram et al., 1995; Lev-Ram et al.,
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1997b) indicating that, at least in some situations, NO and Ca2+ are 
necessary and sufficient for LTD to occur. Other studies suggest, however, 
that metabotropic glutamate receptor (mGluR) and protein kinase C 
activation are also required (Ito, 2001). Recent work has shown that, like 
hippocampal plasticity, cerebellar LTD depends on NMDA receptor 
stimulation but, in the cerebellum, NMDA receptors are expressed 
presynaptically on parallel fibres (Casado etal., 2002), as is nNOS (Vincent 
& Kimura, 1992), while LTD is expressed postsynaptically (Ito, 2001), as are 
NO(GC) receptors and cGMP (Ariano et al., 1982; Honda et al., 2001). In 
these cerebellar synapses, therefore, NO appears to act as an anterograde 
messenger, being released from axon terminals and acting on postsynaptic 
spines. The mechanism for NO-dependent LTD expression following cGK 
activation is likely to involve G-substrate, which is highly expressed in 
Purkinje cells (Detre et al., 1984). Downstream, LTD manifests as a 
reduction in AMPA receptor sensitivity. Inhibition of PP2A, which can occur 
via G-substrate, has been shown to increase phosphorylation of AMPA 
receptors and decrease synaptic currents in a manner that occludes LTD 
(Launey et al., 2004), suggesting a plausible mechanism for the expression 
of NO-mediated LTD.
NO-mediated LTP can also occur in the cerebellum following parallel fibre 
stimulation, an outcome favoured when the postsynaptic Ca2+ concentration 
is low. Fibre stimulation at 1 Hz induces postsynaptically-expressed LTP 
which is dependent on NO, but not cGMP, and which can reverse LTD (Lev- 
Ram et al., 2003). Higher frequency stimulation (4-8 Hz) induces 
presynaptic LTP which does not reverse LTD but which may be similarly NO- 
dependent (Jacoby etal., 2001; Lev-Ram etal., 2003).
Interestingly, in the cerebellum, LTD and presynaptically-expressed LTP can 
spread to non-stimulated parallel fibre synapses on the same Purkinje cell 
(Jacoby et al., 2001; Reynolds & Hartell, 2000; Reynolds & Hartell, 2001). 
These heterosynaptic changes are also dependent on NO synthesis, 
postsynaptic Ca2+ and, in the case of LTD (but not LTP), cGMP and cGK.
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NO is a likely candidate for mediating the spread, due to its diffusibility, a 
possibility supported by evidence that heterosynaptic LTP can be blocked by 
an NO scavenger (Jacoby et al., 2001). Other forms of NO-dependent 
plasticity may spread in a similar way, for example hippocampal LTP 
(Schuman & Madison, 1994).
A lack of synapse-specificity of NO-mediated plasticity (should it occur in 
vivo) will impinge on its ability to influence neuronal computation. It would 
appear to forbid Hebbian-like learning and rather require computations 
dependent on clusters of synapses. While such learning rules could still 
produce functional organisation and change (Krekelberg & Taylor, 1996), the 
properties of these neuronal circuits would be somewhat different from those 
involving synapse-specific modifications. The extent to which heterosynaptic 
spread of plasticity occurs physiologically is, therefore, of much relevance 
and requires further assessment. Stimulation of fewer neurons might be 
expected to produce less NO and thus less spread of NO-mediated plasticity. 
In the cerebellum, however, weaker stimulation, recruiting a smaller parallel 
fibre bundle, did not affect the degree of spread of LTD (Reynolds & Hartell, 
2000). NO-dependent LTD can even occur on activation of a single parallel 
fibre (Casado et al., 2002), suggesting that very localised NO signals are 
sufficient to produce plasticity, but whether or not such spatially limited NO 
production permits LTD to spread to adjacent synapses has not been tested.
In addition, the temporal coincidence requirements for NO and Ca^+ 
elevation in the postsynaptic cell are narrow (<10 ms; Lev-Ram et al., 1997) 
which may limit the spread of LTD. If small or temporally precise NO signals 
cannot mediate heterosynaptic plasticity, brief, sparse activation of parallel 
fibres would still allow Hebbian learning, while prolonged activation of groups 
of fibres would engage a different learning rule. Clearly many questions 
remain as to the nature and relevance of this form of synaptic modulation, 
which can only be answered by probing the specificity of NO-mediated 
plasticity further and studying its dependence on various parameters of 
stimulation.
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1.4 NO in pathophysiology
In addition to the extensive physiological roles that NO plays in the brain and 
body as a whole, NO has also been implicated in pathological processes 
leading to tissue damage in several different conditions. As discussed 
above, NO can be cytotoxic and indeed, this is one of its functions, when 
released from macrophages as part of the immune response against 
invading pathogens. Dysregulation of the processes that lead to this 
biologically beneficial NO production may, however, lead to damage to the 
host itself. For example in sepsis, widespread induction of iNOS by cytokine- 
release following bacterial infection can lead to patholological vasodilation 
and tissue damage (Titheradge, 1999). In the brain, NO may contribute to 
cell death during multiple sclerosis, Alzheimer’s disease, Parkinson’s disease 
and cerebral ischaemia, via oxidative stress processes (Calabrese et al., 
2000). The role of NO in cerebral ischaemia has been the best studied of 
these conditions and has been substantially reviewed (ladecola, 1997; 
Keynes & Garthwaite, 2004; Samdani et al., 1997). Following medial 
cerebral artery occlusion (an animal model of focal cerebral ischaemia), 
infarct volumes are reduced in nNOS and iNOS knockout mice, implicating 
NO in ischaemic cell death. Consistent with these findings, inhibitors of 
iNOS (1400W) and nNOS (7-nitroindazole; 7-NI) also reduce infarct volumes. 
These results are consistent with a model of NO-mediated cell death 
whereby excitotoxicity ensuing from ischaemic energy-depletion and 
consequent glutamate release leads to overactivation of nNOS, massively 
increased NO concentrations and cell death, followed by later iNOS induction 
and delayed phases of cell death. Cytotoxicity was hypothesised to result 
from direct inhibition of cellular respiration by the elevated NO and also by 
formation of the highly oxidising species peroxynitrite (ONOO'), generated by 
reaction of NO with superoxide (0 2 *'), itself produced from leakage of 
electrons from the electron transport chain, particularly on reperfusion. 
ONOO' has numerous neurotoxic effects, from irreversible inhibition of 
respiratory enzymes, to DNA damage, protein nitration and induction of lipid 
peroxidation (Murphy, 1999; Samdani etal., 1997).
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Previous measurements of NO levels following cerebral ischaemia 
suggested NO could reach 2 pM (Malinski et al., 1993a), sufficient to cause 
considerable inhibition of respiration. As discussed above, however, the 
sensor used in these studies was found to be somewhat non-selective for 
NO and later estimates of NO reached during and immediately following 
animal models of ischaemia have been substantially lower (2 -  40 nM; 
Leonard et al., 2001; Lin et al., 1996; Liu et al., 1997; Wu et al., 2001b), 
indicating that NO is unlikely to sufficiently compromise cellular respiration to 
directly induce cell death. Indeed, much higher concentrations of NO ( ~ 1 0  
pM) were required to kill organotypic hippocampal slices by respiratory 
inhibition (Keynes et al., 2004). These findings suggest that endogenous NO 
is unlikely to ever reach levels at which it can be directly toxic and that any 
NO-mediated pathology in models of ischaemia is due to other mechanisms.
NO in fact appears to also have a protective role in cerebral ischaemia: 
eNOS knockout mice and broad spectrum NOS inhibition actually show 
increased infarct volumes, indicating that the facilitative effects on blood flow 
caused by the action of endothelium-derived NO on the vasculature 
(vasodilation and inhibition of vascular “plugging” by platelets and 
leukocytes) are beneficial to recovery from ischaemic episodes (ladecola, 
1997). Additionally, NO may have a role in stimulating angiogenesis and 
neurogenesis, inhibiting apoptosis and in ischaemic preconditioning, where a 
mild ischaemia protects from a subsequent more severe insult (Keynes & 
Garthwaite, 2004).
The situations in which NO plays a cytotoxic or cytoprotective role remain to 
be fully determined, but are likely to depend on the concentrations achieved, 
the environment of its synthesis and therefore the nature of the oxidative 
products formed.
48
Chapter 1: General Introduction
1.5 NO breakdown
NO plays a number of physiological roles and is also implicated in 
pathophysiology. The properties of NO signals and the situations in which 
NO could potentially become toxic must depend on the balance between the 
synthesis of NO, discussed above, and its termination. As NO is such a 
highly diffusible molecule, it is possible that its effects are brought to a close 
simply by diffusion away from its site of action. There are several other 
pathways, however, by which NO can be consumed.
1.5.1 Chemical reactivity of NO
1.5.1.1 Autoxidation
NO reacts with molecular oxygen (O2) in aqueous solution to form NO2' 
according to the following scheme (Ignarro et al., 1993; Lewis & Deen, 
1994):
2 N 0  + 0 2 -----> 2  N 0 2
2 N 02 + 2 NO  > 2 N20 3
2 N20 3 + 2  H20 -----> 4 N 02‘ + 4 H+
Overall: 4 NO + 0 2 + 2  H20 -----> 4H+ + 4N 02‘
Determination of the kinetics of these reactions by detecting rates of 
formation of NO2' and H+ or of the disappearance of NO indicate that this 
“autoxidation” reaction follows second order kinetics with respect to NO and 
first order kinetics with respect to O2 (Kharitonov et al., 1994; Lewis & Deen, 
1994; Wink et al., 1993). The third order rate constant for the reaction is 6  -  
9x10® M‘2s"1 at 25 °C and 13.6 x 1 0 ® M 'V 1 at 37 °C (see Ford etal., 1993; 
Schmidt et al., 1997).
This second order dependence of the rate of autoxidation on NO means that 
at high NO concentrations, the half-life of NO in simple buffers is relatively
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short but becomes increasingly longer at lower, physiological NO 
concentrations. At 1 pM NO, for example, its half-life is 9 min, but rises to 
900 min at 10 nM NO (Kelm, 1999), the higher end of the expected 
physiological NO range. In contrast, the half-life of NO in the presence of 
biological material is much shorter. When perfused through aortic strips in 
an organ bath, the vasodilatory effects of NO had a half-life of 4 s (Palmer et 
al., 1987), while NO perfused through guinea pig hearts had a half-life of only 
100 ms, which was 30-fold faster than observed in buffer alone (Kelm & 
Schrader, 1990). This indicates that something in biological tissue 
accelerates NO decay.
1.5.1.2 Reaction with Superoxide
A component of NO breakdown in the perfusion cascade experiments can be 
accounted for by reaction with O2”, as its half-life is prolonged by the addition 
of superoxide dismutase (SOD) (Gryglewski et al., 1986; Palmer et al., 
1987). O2 ' can be generated in tissue by leakage of electrons from the 
electron transport chain, especially under conditions of respiratory inhibiton 
(Beckman & Koppenol, 1996), from xanthine oxidase, which is expressed 
with NOS in synaptosomal brain preparations (Deliconstantinos & Villiotou, 
1996), and also from NOS itself, in conditions of low substrate availability 
(Xia et al., 1998a; Xia et al., 1998b; Xia et al., 1996). Addtionally Krebs- 
Henseleit type buffers can also generate 0 2 *', particularly when exposed to 
ultra-violet light from laboratory lighting (see Beckman & Koppenol, 1996). 
The reaction between NO and O2" is almost diffusion limited (k = 1.9 x 1010 
M'1s_1; Kissner et al., 1997) and forms the cytotoxic agent ONOO‘ . To 
protect cells, SOD is present at high levels to effectively scavenge 0 2". 
Cu/Zn SOD makes up 0.5 % of all brain cytosolic protein, and at these 
concentrations (4 - 1 0  pM), normal unstressed O2" levels are maintained at 
under 1 nM. For NO to be consumed by reaction with 0 2 “, it must therefore 
outcompete SOD for O2*'. It is predicted that in normal conditions, 2  -  4 pM 
NO would have to present to convert 50 % of the O2*' produced into ONOO"
50
Chapter 1: General Introduction
(Beckman & Koppenol, 1996; Wink & Mitchell, 1998). As discussed above, 
this is far above the physiological NO range. It seems likely, therefore, that 
reaction of NO with O2” is only a relevant reaction pathway in conditions of 
enhanced NO or O2" production, for example during respiratory inhibition, 
and as such is only of relevance to the fate of NO during pathophysiological, 
rather than physiological situations. Indeed, in some experiments, addition 
of SOD has only a minor effect on the half-life of NO in biological tissue 
(Kelm & Schrader, 1990). Additional factors must contribute to biological NO 
consumption.
1.5.1.3 Accelerated autoxidation
NO and O2 accumulate in biological membranes (Moller et al., 2005), due to 
their increased solubility in hydrophobic compared to hydrophilic 
environments. This leads to an apparent 13-fold acceleration of the rate of 
autoxidation reaction in lipid membranes at a typical tissue concentration (Liu 
et al., 1998b). This increase in autoxidation may allow it to play more of a 
role in the physiological metabolism of NO, but even a 13-fold increase in the 
rate of breakdown via autoxidation would only decrease the half-life of 10 nM 
NO from 900 min to 69 min, such that a discrepancy remains between the 
observed half-life and that predicted by simple reaction with O2. Indeed, 
active consumption of NO by enzymatic processes is also known to play a 
role in its physiological metabolism.
1.5.2 Enzymatic NO consumption
1.5.2.1 Haemoglobin
Binding and reaction of NO with Hb is likely to be an important way in which 
physiological NO is metabolised. NO binds at an almost diffusion limited 
rate, with oxygenated haemoglobin (oxyHb) (3.4 x 107 M'1s'1; Eich et al.,
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1996), and reacts with the bound O2 , oxidising the haem and forming 
methaemoglobin (metHb) and NO3', according to equation 1.1:
oxyHb(Fe2+) + N O  - metHb(Fe3*) + N 03‘ Eq. 1.1
The rate of binding of NO to deoxygenated haemoglobin (deoxyHb) is of the 
same order (2.2 x 107 M'1s'1; Eich et al., 1996), and is reversible (equation 
1.2).
deoxyHb(Fe2+) + NO Hb(Fe2+)NO Eq. 1.2
NO also binds to metHb, but at a slower rate (1.0 x 104 ; Eich et al., 1996). 
Physiologically, this reaction is likely to be of little importance, as binding to 
oxy- and deoxyHb is so fast and the concentration of metHb is low (< 0.4 % 
of total haemoglobin (Hb) in human red blood cells (RBC; Pennell, 1964) , 
due to reduction of oxidised haem in RBC by methaemoglobin reductase.
The rapid binding of NO to ferrous Hb and the high concentration of Hb in 
blood predicts a half-life of NO in blood of only 2 ps (Liu et al., 1998a). This 
would pose problems for the bioactivity of endothelial-derived NO, forming a 
potent sink to scavenge NO and massively attenuate its actions on smooth 
muscle and yet more critically on targets within the blood (e.g. platelets, 
leukocytes; Lancaster, Jr., 1994). The reaction of NO with Hb encapsulated 
into RBC has been found to be around three orders of magnitude slower 
than predicted on the basis of its reaction with free Hb, however (Liu et al., 
1998a; Vaughn et al., 2001). This is due to the existence of a RBC-free zone 
at the blood vessel wall, caused by intravascular flow (Liao et al., 1999), and 
diffusional barriers for NO in the form of an unstirred layer around each 
erythrocyte (Liu et al., 2002; Liu et al., 1998a) and by cytoskeletal proteins 
bound to erythrocyte membranes (Huang et al., 2001; Vaughn et al., 2000; 
Vaughn et al., 2001). An alternative explanation for the ability of NO to 
remain vasoactive in the presence of high haem concentrations is the 
formation of SNO-Hb following NO binding to a deoxygenated haem. NO is
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proposed to be transported in this manner in the bloodstream until the rest of 
the Hb molecule becomes deoxygenated and the NO molecule is released 
(Gow et al., 1999; Gow & Stamler, 1998). As discussed above, however, 
evidence for this hypothesis remains controversial and is likely to be due 
simply to erroneous measurements of in vivo S-nitrosothiol formation 
(Giustarini et al., 2004) and the application of boluses of high NO 
concentrations, rather than more physiological NO generation with slower 
donor-mediated release (Han eta!., 2002).
The reaction of NO with circulating RBC decreases the physiological 
vasodilatory response to applied serotonin (Liao et al., 1999), demonstrating 
the relevance of the erythrocyte sink to NO signalling. Despite being slowed 
by the above factors, its half-life in blood is still predicted to be less than 2  
ms (Liu et al., 1998a) and it is therefore likely that the metabolism of NO in 
the brain will at least in part occur in the vasculature. The relative 
contribution of blood vessels will necessarily depend on their proximity to an 
NO source and the inactivation properties of neural tissue.
1.5.2.2 Other globins
Myoglobin (Mb) is predominantly expressed in skeletal and cardiac muscle 
and shares many properties with Hb. NO rapidly binds to both oxy- and 
deoxy- forms of Mb and, like oxyHb, oxymyoglobin can metabolise NO, 
resulting in the formation of metmyoglobin and NO3' (Eich et al., 1996). The 
physiological relevance of Mb-NO binding is less clear, however, and to date 
studies have relied on the use of knockout mice, which show normal muscle 
function due to numerous compensatory mechanisms (Brunori, 2001). As 
evidence for a modulatory role of Mb on NO levels, inhibition of endogenous 
NO synthesis increases vasoconstriction more in hearts of Mb knockout mice 
than wild-types. Conversely, bradykinin-induced vasodilation is increased in 
knockouts compared to wild-types (Flogel et al., 2001). This study suggests, 
therefore, that Mb acts as a sink for both tonic and stimulated NO levels. 
Another study, however, found no difference between Mb-knockouts’ and 
wild-types’ responses to NO, as there was no genotype-dependent change in
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the decrease in O2 consumption observed following either addition of 
exogenous NO, or bradykinin-stimulated NO production (Li etal., 2004). The 
lower intracellular concentrations of Mb compared to Hb (Hb -  5 mM; 
Pennell, 1964; Mb -  0.2 mM; Brunori, 2001) and the competition between 
Mb and CcO (see below and Pearce et al., 2002) also suggest a limited role 
for Mb in the control of NO levels. The role of Mb in modulation of NO levels 
in skeletal and cardiac muscle is therefore unclear. Its expression patterns 
argue against its involvement in NO breakdown in the central nervous 
system and it could only theoretically affect neural NO signalling properties in 
the periphery, where NO could be synthesised in the proximity of muscle.
Other recently discovered globins are, however, present in the brain. 
Neuroglobin (Nb) is expressed in distinct neuronal populations in the brain 
(Burmester et al., 2000; Laufs et al., 2004; Mammen et al., 2002) and can 
bind NO with similar kinetics to Hb and Mb (Van et al., 2003). It seems to 
play a protective role in ischaemic injury, as its upregulation increases cell 
viability while its inhibition increases cell death (Sun et al., 2001), but in this 
study, the toxicity of exogenous NO was unaffected by either increasing or 
decreasing Nb function. Nb remains a potential site of NO breakdown, but 
actual metabolism of NO by Nb and a physiological role for NO-Nb 
interactions remain to be demonstrated.
Cytoglobin is similar to Nb in structure (Sugimoto et al., 2004) and is 
expressed ubiquitously throughout many tissues, where it may target to the 
nucleus (Geuens et al., 2003). If it is subsequently found to share NO* 
binding properties with the other globins, it too could represent a potential 
cellular sink for NO in the brain.
1.5.2.3 Cytochrome c Oxidase
CcO is the terminal enzyme of the mitochondrial electron transport chain and 
catalyses the oxidation of ferrocytochrome c and the reduction of 0 2 to H20, 
in the process generating a proton motive force that subsequently drives
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ATP synthesis. O2 binds to the haenrWCiiB binuclear centre which receives 
electrons from two other redox-active metal sites in the protein. 0 2 -binding 
is competitive with NO and as discussed previously, NO-mediated inhibition 
of CcO may have a role in the control of cellular respiration. Additionally, 
however, NO consumption may also be catalysed by CcO. NO can bind to 
either the haema3 site or the Cub site in the binuclear centre. Three potential 
mechanisms for its breakdown have been proposed. NO has been reported 
to bind at the ferrous haema3 site and be reduced to N2O, in anaerobic 
conditions (Borutaite & Brown, 1996; Zhao et al., 1995). Subsequently no 
anaerobic catalytic consumption of NO was demonstrated over a 
physiological timescale (>30 min) and it was suggested that the apparent 
inhibition of NO decay by cyanide was not evidence of a CcO-dependent 
process, but rather of the delay in which NO could bind (but not react with) 
the haema3 while cyanide dissociation occurred (Stubauer et al., 1998).
NO can stoichiometrically bind both the fully oxidised, and the partially 
reduced CcO enzyme at the CuB site (Giuffre et al., 2 0 0 0 ). This binding is 
rapid and forms a Cub+-NO+ complex which is rapidly hydrated to NO2' 
(Cooper et al., 1997; Torres et al., 1998). While this N0 2 - has a slow off-rate 
and hence can contribute to NO-mediated inhibition of CcO, in reducing 
conditions the NO2' is ejected from the active site by the influx of an electron, 
such that rapid catalytic oxidation of NO to NO2' can occur (Torres et al.,
2 0 0 0 ). The binding of NO to oxidised CuB rather than to reduced haema3 
predominates in circumstances of low electron flux through the enzyme (Sarti 
et al., 2 0 0 0 ), for example in resting muscle or pathophysiological conditions 
when the respiratory chain is compromised (Cooper, 2002). When there is 
high electron flux, binding to the reduced haema3 predominates, inhibiting the 
enzyme. The dominant view is that this binding is reversible (Brunori et al., 
2004; Cooper, 2002; Giuffre et al., 1996; Sarti et al., 2000) but it has also 
been claimed that NO binding to reduced haema3 can lead to its consumption 
and production of N0 2 - (Pearce et al., 2003). NO consumption by CcO may, 
therefore, depend on the redox state of the enzyme, producing N0 2 - when it 
is partially or fully oxidised, and possibly also when it is fully reduced. Either 
way, the finding that stimulation of cardiac myocytes leads to NO production
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that is rapidly and wholly converted to NCV, rather than NO3' (Pearce et al., 
2 0 0 2 ), suggests that NO metabolism by CcO can outcompete its reaction 
with oxymyoglobin and is consistent with a physiological role for CcO in NO 
consumption, at least in some mitochondria-rich tissues. For this reason, it is 
possible that CcO might represent a physiologically relevant route for NO 
metabolism in brain, but this awaits demonstration.
1.5.2.4 Lipoxygenases and peroxidases
Lipoxygenases are non-haem iron-containing enzymes that catalyse the 
oxidation of the unsaturated fatty acids, arachidonate and linoleate. Recent 
work has demonstrated that NO is catalytically consumed by purified 15- 
lipoxygenase (15-LOX) and 12/15 lipoxygenase (12/15-LOX) and cells 
expressing these isoforms (Coffey et al., 2001; O'Donnell et al., 1999). 
Consumption by these enzymes was avid enough to impair in vitro 
stimulation of purified or constitutively expressed GC by exogenously applied 
NO, indicating that this consumption could potentially be of physiological 
relevance in the regulation of NO signalling. LOX-mediated NO 
consumption inhibited product formation and required substrate to be 
present. The mechanism of NO inhibition and consumption in 15-LOX is via 
a termination reaction with reduced enzyme-bound lipid peroxyl radicals 
(LOO*), forming an alkyl peroxynitrite (LOONO), which hydrolyses to the lipid 
hydroperoxide (LOOH) and N0 2 - (Fig. 1.5). This process also inhibits the 
enzyme, as the reduced enzyme must be reactivated by oxidation via 
reduction of LOOH before it can continue in the catalytic oxidation of 
substrates. High levels of NO can also bind to ferrous or ferric iron in the 
active site to form nitrosyl complexes, but as these levels of NO (> 50 pM) 
are not achieved physiologically, or even pathophysiologically, these 
reactions are not of relevance to the in vivo situation. NO consumption by 
15- and 12/15-LOX is likely to affect physiological NO signalling in the 
vasculature, where these enzymes are expressed (Kuhn & Thiele, 1999). 
12-15 LOX and other LOX isoforms are expressed in the nervous system 
(Nishiyama et al., 1993; Pratico et al., 2004), and it awaits further 
experimentation to determine whether they contribute to NO breakdown in
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neural tissue. NO will react in the same manner as above with lipid peroxyl 
radicals formed non-enzymatically (O'Donnell et al., 1997), such that 
consumption of NO in brain by this process may occur in situations of 
oxidative stress and ongoing lipid peroxidation.
H+
LH
LH
LOOH
LOOH^I LOOH 
r^ed
NO”
LOOH + NO*'
OH*
Fig. 1.5 : Scheme of dioxygenase cycle of LOX, demonstrating cycling between reduced 
(Ered) and oxidised enzyme (Eox), consumption of NO by binding to the lipid peroxyl radical 
(EredLOO*), consumption of NO to N02' and inhibition of LOX function by formation of Ered- 
Modified from (O'Donnell etal., 1999).
NO is also catalytically consumed by prostaglandin H synthase-1 (PGHS-1), 
a haem enzyme which also catalyses the oxidation of arachidonate 
(O'Donnell et al., 2000). Activation of platelets with arachidonate led to NO 
consumption, inhibition of NO-mediated cGMP production and decreased 
NO-mediated inhibition of platelet aggregation. PGHS-1 has two activities, a 
cyclooxygenase that converts arachidonate to PGG2 and a peroxidase that 
converts PGG2 to PGH2. The ability of PGHS-1 to also consume NO in the 
presence of hydrogen peroxide (H20 2 ), suggested that NO acts as a 
reducing substrate for PGHS-1 (Fig. 1.6), reducing the haem while being 
oxidised to NO+ and ultimately forming N0 2 -. In a similar vein, NO acts as a 
reducing substrate and is consumed by myeloperoxidase, eosinophil 
peroxidase and lactoperoxidase (Abu-Soud & Hazen, 2000) and can also be 
consumed by catalase (Brunelli etal., 2001).
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LOOH LOH
Native enzyme Fe3* -------- pe4+—  o Compound 1
NO NO
NO
Compound 2
Fig. 1.6: Scheme of NO interaction with the peroxidase of PGHS-1. NO reduces the haem 
and is oxidised to NO+ (O'Donnell etal., 2000).
Consumption of NO via LOX and peroxidase-mediated oxidation are both 
potential routes of endogenous NO breakdown. Demonstration that the 
effects of endogenously synthesised NO are reduced by these enzymes 
waits, before their role in physiological NO inactivation can be assigned.
1.5.2.5 NO dioxygenases
Bacterial flavohaemoglobins consume NO in a cyanide-sensitive process 
that requires NAD(P)H, FAD and O2 and produces N0 3 - according to a 
suggested reaction scheme shown below (Fig. 1.7). Induction of such 
proteins is thought to confer resistance to NO-mediated toxicity. Recently, a 
similar process has been observed in several mammalian cell lines, and 
most avidly in a human colorectal cancer cell line (CaCo-2; Gardner et al.,
2001). In the mammalian cells, consumption was 0 2 -dependent, formed 
NO3' and sensitive to the haem poisons, cyanide, phenylhydrazine and 
carbon monoxide and the flavoenzyme inhibitor diphenyleneiodonium (DPI). 
Like in bacteria, this suggests that there is a mechanism for NO degradation 
that involves a haem and flavin-containing protein, which may follow a similar 
reaction scheme to that in figure 1.3. The identity of this mechanism is as
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yet unknown and varies considerably in activity in the different cell lines. 
Primary lung tissue was also found to consume NO, though it is unclear 
whether it shared the inhibition profile of the cultured cells. Further 
identification of this process and its existence in different primary tissues, 
including brain, is required to assess its physiological relevance.
(1) NAD(P)H + FAD + H *—► NADfP)* + FADHj
(-) CN-
(2) 2 F e * + FADHa —► 2Fe2* + FAD + 2H +
(3) 2Fez< + 20a  — 2Fe3* - Qf
(4) 2 Fe®*-02' + 2 N 0  —► 2F03* + 2NCV
(5) 2 NO + 20 i + NAD(P)H —► 2NCV + NADfPf + H*
Fig. 1.7: Suggested reaction scheme for NO consumption by bacterial flavohaemoglobins 
(Gardner ef a/., 1998).
1.5.3 Inactivation of NO in brain tissue
There are a number of potential routes by which NO may be broken down in 
tissue. In addition to autoxidation, these processes involve either reaction of 
NO with free or bound radicals, or binding or redox reaction with transition 
metal centres of various enzymes. Of the processes discussed above, only 
the reaction between NO and oxyHb, and possibly oxyMb, have been shown 
to influence levels of endogenously produced NO, such that the precise 
physiological relevance of the other mechanisms remains to be adequately 
determined. Additionally, few of the potential breakdown mechanisms are of 
direct relevance to neural NO signalling. The reaction with circulating RBC in 
the cerebral vasculature is likely to be of importance, and accelerated 
autoxidation will also occur in neural membranes, though may be still be too
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slow to be of importance. Some of the other putative degradation enzymes 
are expressed in the brain (e.g. CcO, neuroglobin) but as discussed above, 
their relevance for NO signalling remains unknown.
It has been demonstrated that brain tissue does avidly inactivate NO, 
however. NO accumulation on application of NO donors is severely 
attenuated in suspensions of cerebellar cells or whole brain homogenates, 
compared to buffer (Fig. 1.8; Griffiths et al., 2002; Griffiths & Garthwaite, 
2001). Assuming a first-order process and extrapolating to whole tissue, the 
breakdown was found to have a rate constant of 8 s'1, predicting a half-life of 
NO in brain tissue of 83 ms. Using concentrations of an NO donor 
(DETA/NO) that releases NO at a constant rate approximating to the 
maximum NO synthase activity in rat brain (5 -  50 nmol g'1 min'1) the 
consumption process initially held NO at a much lower level than in buffer 
(55 nM compared to 800 nM), but saturated after three minutes, such that 
the NO level rose to approach that seen in buffer. This consumption process 
in brain is therefore able to keep NO levels at a low, physiological 
concentration for short periods of time. Prolonged release, such as may 
occur pathophysiologically, can overcome this consumption process, 
however, allowing NO levels to rise to potentially toxic concentrations. This 
functioning of this mechanism therefore represents a fascinating potential 
link between NO acting as a physiological messenger and a pathological 
agent.
This process is 02-dependent, generates N0 3 - as the ultimate breakdown 
product of NO metabolism (Griffiths et al., 2002) and is sensitive to 
degradation by proteinase K, suggesting that it is a protein. It cannot, 
however, be inhibited by scavengers of O2", cyanide, indomethacin (which 
inhibits PGHS) or eicosatetraynoic acid (ETYA; inhibitor of LOX), indicating 
that the observed consumption activity is novel and not due to CcO, PGHS, 
LOX or the NO dioxygenase observed in CaCo-2 cells.
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Fig. 1.8: NO consumption by cerebellar cells. NO accumulates less in cells compared to 
buffer, following addition of NO donors with different half-lives (DEA/NO: 2 min, PROLI/NO: 
1.8 s, DETA/NO: 20.5 hours all at 37 °C; Griffiths & Garthwaite, 2001).
This ability of brain to inactivate NO, moreover, through an apparently novel 
mechanism, has many implications for neural NO signalling and raises 
several further questions which require answers. The identity of this process 
is naturally of immense interest, as is its modulation. As discussed 
previously, it is also important to assess whether this process is relevant for 
physiological NO signalling. This question can be approached in a couple of 
ways. If methods of modulating the activity of the mechanism are known, 
increasing or decreasing its activity should affect the responses of brain 
tissue to endogenously produced NO. This could be demonstrated by 
changes in the level of cGMP produced in response to NMDA stimulation of 
nNOS, for example. Alternatively determination of the kinetic characteristics 
of the mechanism allows predictions to be made as to the relative
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importance of this process compared to diffusion, in models of NO signals. 
Naturally both of the above approaches are preferable to fully understand the 
relevance of the mechanism to physiological processing and would also be 
valuable in assessing the effects of such an inactivation process on the role 
of NO in pathophysiology.
1.6 Aims
The general aim of this project was to glean further understanding of the 
brain’s ability to inactivate NO and to determine what limitations this process 
conferred onto physiological NO signals. Initially kinetics of the inactivation 
process were characterised in tissue slices of rat cerebellum. This 
preparation is more valid than the dispersed preparations previously used, as 
it conserves neuritic processes and intercellular connectivity. The predicted 
effects of such a process were then predicted using simple models of 
endogenous NO synthesis. Later chapters deal with the process of 
identifying NO consumption processes in dispersed cells and slices.
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2.1 Materials
Compound Abbreviation Source
(±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2- 
carboxylic acid
Trolox Sigma
1 -Hydroxy-2-oxo-3-(N-ethyl-2-aminoethyl)-3-ethyl-1 - 
triazene
NOC12 Alexis
3,3-diaminobenzidine DAB Sigma
4-(2-hydroxyethyl)-1 -piperazineethanesulfonic acid Hepes Sigma/ Life 
Technologies
Anti-GFAP antibody DAKO
Anti-MAP2 antibody Sigma
Anti-OX-42 antibody BD Biosciences
Anti-S100 antibody BD Biosciences
Ascorbate Sigma
Ascorbate oxidase AO Sigma
Atrial naturietic peptide ANP Sigma
Bovine serine albumin BSA Sigma
Butylated hydroxytoluene BHT Sigma
Calcium chloride CaCI2 VWR
D(-)-2-Amino-5-phosphonopentanoic acid D-AP5 Tocris
DEA NONOate: 2-(N,N-Diethylamino)-diazenolate-2- 
oxide. diethylammonium salt DEA/NO Alexis
Dehydroepiandrosterone DHEA Sigma
Deoxyribonuclease DNase Sigma
DETA NONOate (NOC18): (Z)-1-[2-(2-Aminoethyl)-N- 
(2 -ammonioethyl)amino]diazen-1 -ium-1 ,2 -diolate
DETA/NO Alexis
Diethylenetriaminepentaacetic acid DTPA Sigma
di-Sodium hydrogen orthophosphate Na2HP04 VWR
Donkey anti-mouse biotinylated secondary antibody Chemicon
Donkey anti-rabbit biotinylated secondary antibody Chemicon
Donkey anti-rabbit fluorescein secondary antibody Chemicon
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Donkey anti-sheep biotinylated secondary antibody Chemicon
DPX mounting medium VWR
Ethylenediaminetetraacetic acid EDTA Sigma
Glucose VWR
Glucose oxidase GO Sigma
Haemoglobin Hb Sigma
Hank’s balanced salt solution HBSS Life Technologies
Horse serum HS Life Technologies
3-lsobutyl-1 -methylxanthine IBMX Sigma
Kynurenic acid Sigma
L-Nitroarginine L-NA Sigma
Magnesium sulphate MgS04 VWR
Mayers haemalum Raymond Lamb
Minimum essential medium MEM Life Technologies
Mn(lll)tetrakis(4-Benzoic acid)porphyrin Chloride MnTBAP Alexis
N-Methyl-D-aspartic acid NMDA Sigma
Penicillin-streptomycin Life Technologies
Phosphate buffered saline PBS Sigma
Poly-D-lysine Sigma
Potassium chloride KCI VWR
Potassium dihydrogen orthophosphate KH2PO4 VWR
PROLI NONOate: Disodium 1-[2- 
(Carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolate. 
methanol
PROLI/NO Alexis
Proteinase K Sigma
Sodium chloride NaCI VWR
Sodium cyanide NaCN Sigma
Sodium dithionite VWR
Sodium hydrogen carbonate NaHC03 VWR
Sodium hydroxide NaOH VWR
Sodium nitrate NaN03 Sigma
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Sodium nitrite NaN02 VWR
Sodium pyruvate Life Technologies
Soybean trypsin inhibitor Sigma
Spermine NONOate: (Z)-1-{N-[3-Aminopropyl]-N-[4-(3- 
aminopropylammonio)butyl]-amino}-diazen-1 -ium-1,2- 
diolate
Sper/NO Alexis
Superoxide dismutase SOD Sigma
Thiobarbituric acid TBA Sigma
Tissue-Tek O.C.T. Raymond Lamb
Trichloroacetic acid TCA Sigma
Tris(hydroxymethyl)aminomethane hydrochloric acid Tris Sigma
Tritiated cyclic guanosine monophosphate 3H-cGMP Amersham
Triton-X-100 Sigma
Trizma Base Tris Base Sigma
Trypsin Sigma
Vectastain Elite ABC complex Vector Labs
p-Nicotinamide adenine dinucleotide, reduced disodium 
salt
NADH Sigma
p-Nicotinamide adenine dinucleotide 2'-phosphate 
reduced tetrasodium salt
NADPH Sigma
Table 2.1: Source of compounds used.
Suppliers:
Alexis Biochemicals, Nottingham, 
U.K.
Amersham Biosciences, Bucks. 
U.K.
BD Biosciences, Oxford, U.K. 
Chemicon International, Harrow, 
U.K.
DAKO Ltd., Ely, U.K.
Life Technologies Ltd. (GIBCO-BRL), 
Paisley, U.K.
Raymond Lamb, Eastbourne, U.K. 
Sigma Tocris Cookson, Bristol, U.K., 
Dorset Vector Labs Ltd., Peterborough 
U.K.
VWR International, Dorset, UK, U.K.,
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2.2 General Solutions
1. Artificial cerebrospinal fluid (aCSF) -  gassed with 95 % 0 2; 5 % C02: 
120 mM NaCI, 2 mM KCI, 26 mM NaHC03l 1.19 mM MgS04, 1.18 mM
KH2PO4, 11 mM glucose, 2 mM CaCb, ± 100 pM L-NA, ± 1 mM kynurenic
acid.
2. NO donors
Stock solutions were made at 100x final concentrations in 10 mM NaOH, and 
kept on ice until use.
3. Inactivation buffer (for cGMP radioimmunoassay)
50 mM Tris, 4 mM EDTA, pH 7.4 at room temperature.
4. Incubation buffer (IB)
15 mM Tris, 130 mM NaCI, 5 mM KCI, 1.2 mM Na2HP0 4 , 11 mM glucose ± 2  
mM CaCI2> pH 7.45 at 37°C.
5. Platelet buffer (PB)
137 mM NaCI, 0.5 mM MgCI2, 0.55 mM NaH2P 04, 2.7 mM KCI, 25 mM 
Hepes, 5.6 mM glucose, pH 7.45 at 37°C.
6. Tris buffer
25 mM Tris, pH 7.45 at 37°C.
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2.3 General Methods
2.3.1 Protein determination
Protein concentrations were determined by comparison to BSA standards 
using the bicinchoninic acid method (BCA Protein Assay Kit, Pierce, Illinois, 
U.S.A.).
2.3.2 Measurement of NO concentrations
NO concentrations were determined using an amperometric NO electrode 
(Fig. 2.1; ISO-NOP, World Precision Instruments, Stevenage, U.K.). NO is 
oxidised at the surface of an electrode, generating an electrical current. 
Selectivity versus other dissolved gases is achieved by means of the 
potential at which the electrode is held, and therefore whether oxidation of 
NO is possible. Further selectivity against non-gaseous dissolved species is 
conferred by the encapsulation of the electrode within gas-permeable 
hydrophobic membranes. According to the manufacturers, the electrode 
shows no interference with N2, O2, CO, NO2 but shows some interference 
with CO2. The electrode calibration was determined by generation of a 
standard curve from the equimolar liberation of NO from sodium nitrite 
(NaN02; 0 . 1 - 1  pM) in 0.1 M sulphuric acid and potassium iodide. 
Experimental NO concentrations were calculated by comparison with this 
curve, following determination of the baseline current in the absence of NO
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by addition of -  7 pM oxyHb. OxyHb was prepared by reduction with a 10- 
fold molar excess of sodium dithionite, which was washed out by dialysis in 3 
litres of water.
Solutions (1 ml) were maintained at 37 °C, by a water jacket surrounding the 
chamber and stirred by a magnetic stirrer at the chamber base. Depending 
on experimental requirements, the chamber could be left open to the air or 
sealed, using a stopper through which the NO electrode could be inserted. 
When open, solutions could be gassed across the surface of the chamber 
(Fig. 2.2). During experiments, stock solutions of compounds were injected 
using a 10 pi Hamilton syringe. Unless stated, all experiments using the NO 
electrode included 1000 U/ml SOD to scavenge any O2” present.
gas permeable 
membr.
stainless steel 
sleeve
com! 
working / counter 
electrode
locking cap
probe
handle
to meter
Fig. 2.1: The ISO-NOP NO electrode.
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NO electrode
gas
water out
experimental solution
water in
stir bar
Fig. 2.2 : NO electrode set-up.
2.3.3 Statistical Analysis
Statistical analyses were conducted using SPSS for Windows v11.5 (SPSS 
U.K. Ltd., Woking, U.K.).
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3.1 Introduction
The study of NO inactivation in brain tissue has previously involved the 
application of NO donors to suspensions of cells or homogenates. 
Electrochemical measurement of the NO concentrations thus generated and 
comparison with levels reached in tissue-free buffers has allowed 
determination of the kinetic parameters of NO inactivation in these dispersed 
preparations. Inactivation follows Michaelis-Menten kinetics with a Km of 67 
nM and, when extrapolated to intact tissue protein levels, a Vmax of 1 pM/s 
(C. Griffiths & J. Garthwaite, personal communication).
The extension of the study of NO inactivation to an intact tissue preparation 
is important for verifying its physiological relevance and assessing its role in 
neuronal signalling, being closer to the in vivo situation than dispersed cells 
and homogenates in terms of the cell types present, connectivity and 
preservation of cellular function. Slices of rat cerebellum were chosen as an 
appropriate preparation. As discussed in Chapter 1, the cerebellum has the 
highest endogenous NOS activity of the brain and also strongly expresses 
the other components of the NO-cGMP signalling pathway (e.g. the GC(NO) 
receptor, cGK, G-substrate). Figure 3.1 illustrates the basic synaptic 
connectivity of the cerebellum. The primary source of NO appears to be the 
parallel fibres (Shibuki & Kimura, 1997) though, in addition to granule cells, 
NOS localises to basket and stellate cells (Southam et al., 1992). NO 
release from parallel fibre terminals following NMDA receptor stimulation is 
implicated in cerebellar LTP and LTD (Casado et al., 2000). While sub- 
cellularly, PDE activity may be high (e.g. in Purkinje cells), the overall PDE 
activity of the cerebellum is low, such that cGMP reaches a stable level 
following NMDA stimulation of cerebellar cells or slices (Garthwaite, 1982). 
This is of practical benefit for these studies as shall be seen below, and 
predominantly reflects cGMP accumulation in astrocytes (Bellamy et al., 
2000).
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Fig. 3.1: Synaptic organisation of the cerebellum.
a & b) There are two major afferent connections to the cerebellum: The mossy fibres, which 
originate in the spinal cord and brainstem nuclei and convey sensory information from cortex 
and the body and the climbing fibres, which originate in the inferior olive and convey 
somatosensory, visual or cortical information. The mossy fibres stimulate granule cells in 
the granule cell layer, which send axons up towards the surface of the cerebellum, into the 
molecular layer, where they bifurcate, forming parallel fibres. These parallel fibres project 
perpendicularly to the planar dendritic trees of Purkinje cells, forming excitatory synapses 
with many different Purkinje cells, each Purkinje cell receiving many thousands of 
connections from different parallel fibres. Climbing fibres also make excitatory synapses 
with Purkinje cells but in general, only one climbing fibre innervates a single Purkinje cell, 
forming many synapses with its soma and dendritic tree. Interneurons (Golgi, stellate or 
basket cells) form inhibitory connections with Purkinje cells. Purkinje cells’ axons are the 
sole output from the cerebellum, forming GABAergic connections with deep cerebellar nuclei 
neurons which in turn project to motor areas of the brain. The circuit is thought to act as a 
comparator, detecting differences in predicted and expected sensory input during motor 
tasks and issuing an error command to adjust ongoing motor performance. Plasticity in 
these pathways underlies forms of motor learning.
c) In the 8 day rat, as used in the following studies, the cerebellum is not fully developed. An 
external granule cell layer exists at the pial surface, where granule cells are formed before 
migrating down the processes of Bergman glia (brown) to the internal granule cell layer. 
When fully developed, the external granule cell layer disappears. (References: (Carpenter, 
1996; Bastian eta!., 1999; Ghez & Thach, 2000)
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While vital, the use of slices rather than dispersed preparations to study NO 
consumption by brain presents two major methodological challenges, 
requiring alternative experimental approaches: Firstly, while the
electrochemical probe is the only reliable method of NO quantification, it is 
too large to penetrate the tissue and it is therefore impossible to directly 
measure the NO concentrations therein. The relative activity of the GC(NO) 
receptor and the resulting level of cGMP thus produced can, however, be 
used as an indirect indicator of the level of NO in the slice. This is possible 
due to the desensitising nature of the GC(NO) receptor activity (Bellamy et 
al., 2000). Exposure to a given concentration of NO activates the enzyme to 
a given degree, producing cGMP, after which it desensitises and its activity 
rapidly decreases. Little further cGMP is produced and, as the cerebellum is 
low in PDE activity, cGMP is only slowly degraded, such that the steady- 
state level of cGMP produced is an accurate indicator of the initial level of 
activity of the GC(NO) receptor and hence the NO concentration present.
The second complication arises due to the absence of homogeneity of NO 
concentration and distribution in slices, compared to the situation in a well- 
stirred suspension of cells or homogenate. Applied donor will release NO 
throughout the slice and bathing solution. Consumption of NO within the 
tissue will, however, reduce local NO levels such that external NO will be 
able to diffuse down a concentration gradient into the slice. The NO 
concentration in the slice is therefore determined by three factors: biological 
breakdown, donor release and diffusion, each with their own kinetics. 
Dissection of the relative contribution of these factors to the NO levels 
produced in the slice is difficult and the contribution of biological inactivation 
cannot be accurately assessed without simplification. This study used two 
methods to simplify the situation and assess the extent of NO inactivation in 
cerebellar slices: firstly abolishing NO in the bathing solution and secondly 
maintaining a stable level of external NO.
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3.2 Materials and Methods
3.2.1 Cerebellar slice preparation
Experiments used brain tissue from 8 day-old Sprague Dawley rats. In P8 
cerebellum the cGMP system is well-developed (Garthwaite, 1982) and 
inactivation properties are similar (Griffiths, C. personal communication). The 
animals were killed by decapitation as approved by the British Home Office 
and the local ethics committee. 400 pm sagittal slices of cerebellum were 
prepared using a Mcllwain tissue chopper. Slices were incubated in shaking, 
gassed (95% CO2; 5% O2) artificial cerebrospinal fluid (aCSF) at 37°C 
containing (mM): NaCI (120), KCI (2), NaHC03 (26), MgS04.7H20  (1.19), 
KH2PO4 (1.18), glucose (11), CaCh (2), L-nitroarginine (0.1) and kynurenic 
acid (1). L-NA is included to block any endogenous NO synthesis, kynurenic 
acid, a non-specific glutamate antagonist, to minimise excitotoxic damage. 
After 1 hour recovery, slices were transferred to kynurenic acid-free aCSF. 
All slice experiments were carried out in gassed aCSF at pH 7.45 and at 
37°C.
3.2.2 NO measurement
For NO measurements, samples (1 ml) were incubated in a stirred vessel (at 
37°C) equipped with an NO electrode as discussed in Chapter 2.3. The 
chamber was open and gassed with 95% CO2 and 5% O2. The NONOate 
donors NOC-12 and Spermine/NO adduct (Sper/NO) were used to deliver 
NO. No SOD was present during these measurements, to replicate the 
situation experienced by slices.
3.2.3 Haemoglobin-agarose preparation
Haemoglobin-coated beaded agarose (Hb-agarose; Sigma, Poole, UK) were 
used to scavenge bath NO. A 50% v/v suspension was prepared by 
washing with 20 volumes of Tris-HCI (pH 7.4) and resuspension in the same
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buffer following filtration at 0.4 pm. The Hb was reduced using 10 mM 
sodium dithionite, which was removed by filtration and washed with more 
than 50 volumes of aCSF. Finally, the haemoglobin beads were 
resuspended in aCSF to make a 50 % v/v suspension and kept on ice until 
use. Hb reduction was confirmed spectrophotometrically, by observation of 
the shift in the Soret peak at 412-15 nm (Fig. 3.3; (Feelisch et al., 1996). 
Immediately prior to use, the aCSF was aspirated and replaced with freshly 
gassed aCSF at 37°C.
O
O
400 500 
X  (nm)
600
Fig. 3.3 : Absorbance spectra of 4% Hb-agarose before (black line) and after (red line) 
reduction of Hb with sodium dithionite and washing.
Use of Hb-agarose required some additional optimisation: assuming that the 
beads were solid, NMDA stimulation of cerebellar slices produced 
significantly less cGMP accumulation in the presence of beads than in 
control slices (control: 147 ± 17 pmol/mg protein; Hb-agarose: 90 ± 3 
pmol/mg protein; t = 3.28, p = 0.04), indicating that either the beads have an 
adverse effect on the slices’ responsiveness, or that the beads actually 
contain some solution which dilutes the applied NMDA. Two methods were 
used to determine the extent to which these effects occur. Firstly, 50 pi of 
tritiated cGMP (3H-cGMP) was added to 1 ml aCSF in the presence and
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absence of 0.67 ml of 100 % Hb-agarose. 350 pi of the supernatant was 
then added to 10 ml scintillation fluid (Optiphase ‘HiSafe’3, Fisher Chemicals, 
Loughborough, U.K.) and the counts per minute were recorded on a 
scintillation counter (Beckman LS 6500, Beckman-Coulter, High Wycombe, 
U.K.). Comparison with aCSF alone revealed that only 30 of the 50 pi of 3H- 
cGMP was left in the supernatant, leaving 20 pi in the Hb-agarose. 
Assuming that this is at the same concentration as that in the supernatant 
(i.e. 30 pl/ml), then the Hb-agarose contains 20/30 = 0.67 ml of solution that 
the 3H-cGMP can become diluted into. This is the total volume initially added 
and thus, the whole of the apparent volume of the beads appears to be free 
solution which can interchange with the bathing solution added to the beads.
Secondly, Hb-agarose at 40% v/v (suspended in aCSF) was pelleted by 
burst centrifugation at 1000 g, the supernatant aspirated and resuspended in 
20 mM Tris buffer. The osmolarity of aCSF is high (308 ± 1 mOsm, n = 2), 
while that of 20 mM Tris is low (43 + 1 mOsm, n = 2). When resuspended in 
Tris, the osmolarity of the supernatant increases to 131 ± 1  mOsm (n = 2), 
indicating that some aCSF was retained in the volume of the Hb-agarose. 
Were the Hb-agarose of negligible volume 40 % of the supernatant would be 
aCSF, and the osmolarity would be given by equation 3.1:
osmolarity of supernatant = (0.4 xaCSF osmolarity) + (0.6 * Tris osmolarity)
= (0.4 *3 0 8 )+  (0.6 *43)
= 123.2 + 25.8
= 149 mOsm (Eq. 3.1)
This is clearly higher than experimentally found, thus the Hb-agarose does 
have a discrete volume. If x is the fraction of the supernatant that is Tris, and 
y  is the fraction that is aCSF, then the percentage volume of the Hb-agarose 
can be calculated as follows (equation 3.2):
x + /  =1
x = 1 - y
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131 = 43x + 308y
= 43(1-y) + 308y 
= 265y + 43 
265y =88
v =33 % (Eq. 3.2)
So rather than making up 40 % of the total solution, aCSF is only 33 %. 
According to this method, the apparent volume of the Hb-agarose is 
therefore made up of 33/40 = 82% of solution which is interchangeable with 
the bathing solution and 18% of “dead space”. Thus the two methods used 
give slightly different estimates as to the free solution contained within the 
Hb-agarose, but both agree that “solid” Hb-agarose actually contains much 
solution that can diffuse into the experimental solution and therefore dilute 
any added compounds, potentially explaining the decreased response to 
NMDA. Future experiments assumed no “solid” volume of the Hb-agarose, 
both for simplicity and as the maximum error, were 18% of their volume 
inaccessible, would be only 18% x 40% = 7.2%. Instead of 1 ml, the volume 
would instead be 0.928 ml, and added compounds would be 1.08 times more 
concentrated than expected. When the volume of the beads was assumed 
to be fully interchangeable with that of the incubating solution, the cGMP 
response to NMDA stimulation with and without Hb-agarose was not 
significantly different (control: 343 ± 27 pmol/mg protein, Hb-agarose: 275 ± 
14 pmol/mg protein; t = 2.26; p = 0.09).
3.2.4 cGMP measurement
For quantitative cGMP detection, following the experiment, slices were 
immediately inactivated by immersion in boiling buffer (Tris 50 mM, EDTA 4 
mM, pH 7.4) then were sonicated. A sample was taken for protein 
determination and the remainder was centrifuged at 10 OOOg for 5 minutes at 
4°C to remove tissue debris. cGMP in the supernatant was measured using 
a standard cGMP radioimmunoassay (Steiner et a!., 1972) based on a
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commercially available kit (Amersham Pharmacia, Amersham, U.K.). Protein 
concentrations were measured by the bicinchoninic acid method (BCA 
Protein Assay Kit, Pierce, Illinois, U.S.A.).
Alternatively, cGMP was visually detected by enzyme-linked 
immunocytochemistry. Slices were fixed for 2 h in 4% paraformaldehyde in 
0.1 M phosphate buffer (pH 7.4) at room temperature. Cryoprotection was 
achieved by overnight incubation in 20% sucrose solution in the phosphate 
buffer at 4°C. The tissue was then frozen in Tissue-Tek O.C.T. (Raymond 
Lamb, Eastbourne, UK). 10 pm frozen sections were cut perpendicular to 
the plane of the slice and collected on chrome alum/gelatin-coated 
microscope slides. Slides were rinsed in Tris-buffered saline (TBS) with 0.1 
% Triton X-100 (pH 7.6) and incubated with first normal donkey serum for 30 
min, then the primary sheep anti-cGMP antibody overnight at 4°C (1:8000, a 
gift from J. de Vente, University of Maastricht, The Netherlands). After 
rinsing, the sections were incubated with donkey anti-sheep biotinylated 
secondary antibody for 1 h at room temperature (1:200). Slides were 
washed and incubated with Vectastain elite ABC complex for 45 min, 
stained for 4 min with 0.05 % DAB (3,3’-Diaminobenzidine) then
counterstained with Mayers haemalum for 15 s. Finally slides were air-dried 
and mounted in DPX mounting medium.
3.2.5 Modelling
Mathematical modelling used MathCad (MathSoft Engineering and 
Education, Inc., Surrey, U.K.) the pdepe partial differential equation solver in 
MATLAB 6.5 (The Mathworks Inc., Natick, MA). Results in one dimension 
were the same as those produced using a more computationally expensive 
script that explicitly calculated the progression of NO into the slice over these 
small bins of time and space, as used by Lancaster (Lancaster, Jr., 1994; 
Lancaster, Jr., 1997), but using the odeeulerfunction in MATLAB.
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3.3 Results
3.3.1 Method 1: Abolish NO in bathing solution
The first strategy employed to simplify the experimental paradigm utilised 
haemoglobin-coated beaded agarose (Hb-agarose) to scavenge NO 
released outside the slice (Fig. 3.3). As discussed in Chapter 1, NO reacts 
extremely rapidly with free oxyHb to form metHb and N0 3 - (k » 107 M‘1s‘1; 
(Eich et al., 1996). The Hb-agarose beads have a diameter of 45 -  85 pm 
(mean = 60.2 ± 3.5 pm, n = 11) so are too large to penetrate the tissue. NO 
outside the slice can therefore be maintained at zero and cannot diffuse into 
the slice from the bath. Once the donor has equilibrated throughout the 
slice, the NO levels in the slice and the resultant cGMP levels will simply be 
dictated by the balance between the rates of the release of NO from the 
donor (which, when using NONOate donors, is highly predictable) and that of 
its breakdown.
Quantification of the rate of NO metabolism by the tissue becomes possible 
through the use of an NO donor with a long half-life. This ensures that over 
several minutes, the rate of release of NO is essentially constant. On 
addition of this donor to the slice, equilibrium will be reached when the rate of 
NO breakdown by the tissue equals the rate of release from the donor (Eq.
3.1). The rate of release from the donor is the product of the rate constant of 
release (/c), the stoichiometry of release (x; typically 1.6 mol NO per mol 
donor) and the donor concentration. The rate constant can be calculated 
from the half-life according to equation 3.2 and the rate of breakdown of NO 
is given by the Michaelis-Menten equation. Assuming a constant Km, the NO 
level generated in the slice by different donor concentrations can be 
predicted for different maximum rates of breakdown (Vmax) by rearranging 
equation 3.1 (Fig. 3.4a).
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Fig. 3.3 : Factors affecting [NO] in a slice following application of an NO donor to the bathing 
solution.
(a) Cross-section through a cerebellar slice. The donor (pale blue circles) releases NO (dark 
blue circles) throughout the bathing solution and the tissue. NO consumption by the tissue 
reduces the level within the slice so NO can also diffuse into the slice down a concentration 
gradient.
(b) Hb-agarose scavenges NO in the bathing solution but is too large to penetrate the tissue. 
NO only gets into the slice via release from donor within the tissue.
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Fig. 3.4 : cGMP production in slices can be predicted using mathematical modelling.
(a) Predicted NO concentrations in the slice in response to applied Sper/NO, with Vmax for 
biological NO inactivation of 0.5, 1 and 2 pM/s (red, black and blue lines respectively).
(b) cGMP accumulation in cerebellar cells in response to 1, 3, 10, 30, 100 and 250 pM 
DETA/NO, as a fraction of the maximum (100 and 250 pM DETA/NO; original data from 
(Griffiths & Garthwaite, 2001). Data are plotted against the measured (filled symbols) or 
extrapolated (open symbols) clamped NO level generated by each respective DETA/NO 
concentration. The red line represents a fit to the Hill equation.
(c) Predicted cGMP concentrations produced by applied Sper/NO, based on predicted NO 
concentrations from (b) and kinetic parameters for the GC(NO) receptor calculated in (a), 
with Vmax for inactivation as in (b).
(d) Predicted cGMP concentrations produced by applied NOC12, calculated as seen for 
Sper/NO in (c).
cGMP accumulation in dispersed cerebellar cells was measured in response 
to NO by Griffiths and Garthwaite (2000). Here, this data was best fitted with 
the Hill equation with a slope of 2, and a Km of 1.6 nM. In this preparation, 
therefore, the GC(NO) receptor has a Km of 1.6 nM and as the data is
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normalised, a V max of 1 (Fig. 3.4b). This Hill equation can then be used to 
predict the cGMP response to the predicted NO concentrations generated in 
figure 3.4a (Eq. 3.3).
1X [A/O]2 
(1.6x10-3)2 + [A/0]5o g m p = Eq-  3. 3
The resulting donor/cGMP concentration-response relationship (Fig. 3.4c & 
d) can be compared to experimental data to quantify the V max for biological 
inactivation of NO in cerebellar slices. Here, are shown the predicted results 
with the NONOate donors Spermine/NONOate (Sper/NO) and NOC12, 
which have a half-lives at 37°C of 39 and 100 minutes, respectively. If the 
Vmax for inactivation is similar to that seen in dispersed preparations, the 
maximal cGMP accumulation will be generated by approximately 1 mM 
Sper/NO or 3 mM NOC12. To be able to measure the entire donor-cGMP 
concentration relationship, the concentration of Hb-agarose required to 
scavenge all NO released into the bath by these concentrations of donor 
must, therefore, be determined. 10 % v/v Hb-agarose was able to eliminate 
the NO released from only 30 pM NOC12 (Fig. 3.5a). The amount of Hb- 
agarose was therefore increased and probed with 300 pM NOC12, the NO 
released from which was only entirely scavenged by 40 % Hb-agarose (Fig. 
3.5b). No more Hb-agarose was added as it was considered likely that a 
further increase at the expense of aCSF would be disadvantageous for the 
health of any incubated tissue. It is therefore only possible to study the lower 
half of the donor-cGMP concentration-response relationship using this 
method. Nevertheless, this should provide enough information to be able to 
form conclusions as to the rate of NO inactivation in brain slices.
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Fig. 3.5: NO produced from 300 pM NOC12, but not above, can be clamped at zero by 40 
% v/V Hb-beads.
(a) NO produced from 30 pM, 300 pM and 3 mM NOC12 (red, blue and black circles, 
respectively) in the presence of 10 % Hb-beads.
(b) NO produced from 300 pM NOC12 in the presence of 10, 20, 30 and 40 % Hb-beads 
(black, red, blue and green squares, respectively). Grey squares represent NO levels after 
an additional 300 pM NOC12 was added to 40 % beads.
It is important that the level of cGMP in the slices is assayed once it has 
reached steady-state, i.e. once the donor has diffused throughout the slice 
and once the rates of release and breakdown have equilibrated. Time- 
courses were therefore conducted for single concentrations of NOC12 and 
Sper/NO (Fig. 3.5) in the presence of 40 % Hb-agarose to scavenge NO 
outside the slice. The accumulation is markedly slower than the expected 
time for diffusion into the slice for molecules of their size. NMDA (MW =
147.1) stimulation, for example, results in stable cGMP levels within 2 
minutes (Garthwaite, 1982), while the similar sized NOC12 (MW = 176.2)
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and Sper/NO (MW = 262.4) take 6 to 8 minutes, respectively. It is not clear 
why it should take so long for equilibrium to be established, but it is possible 
that diffusion into the slice is slowed such that donor accumulates 
preferentially by cells near the outside of the slice. The existence of a 
transporter for spermine in cerebellar astrocytes may be a possible 
contributor to such an effect (Dot et a/., 2000). The suggestion of non­
homogeneity of donor distribution throughout the slice, though not proven, 
would invalidate the analysis involving the modelling in Fig. 3.4. This, plus 
the inability of this method to probe the whole concentration-response curve 
led to this approach being abandoned in favour of an alternative. Rather 
than abolish external NO, the bathing concentration was maintained at a 
stable level.
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Fig. 3.6: cGMP accumulation in cerebellar slices incubated with 40 % v/V Hb-agarose and 
100 pM NOC12 (a) or 50 pM Sper/NO (b). (a) cGMP does not significantly change after 6 
min. (b) cGMP does not significantly change after 8 min. (One way ANOVAs with post hoc 
tests, n = 5)
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3.3.2 Method 2: Apply a constant NO concentration to cerebellar slices
As discussed above, the NO level within a brain slice exposed to a solution 
containing NO donor and NO will be influenced by NO release within the 
slice, diffusion from the surrounding solution and inactivation by the tissue. 
However, as revealed above (Fig. 3.6) donor diffusion into the slice is slow, 
so likely to be less important than NO diffusion and inactivation. Additionally, 
the use of Hb-agarose represents a way of dissecting cGMP produced via 
donor release within the slice from that of the other two processes. By firstly 
modelling the effects of diffusion and inactivation, then accounting for the 
additional effects of any NO release within the tissue, predictions of NO and 
cGMP levels within the slice can be made and compared to experimental 
data.
Slices can be exposed to a constant bathing concentration of NO by 
exploiting the properties of NO donors with long half-lives. On application to 
a buffer, e.g. aCSF, the NO concentration increases until a plateau is formed 
when the rate of release from the donor equals the rate of breakdown by 
autoxidation. As illustrated with Sper/NO, this plateau is typically reached 
within 5 minutes and is stable for over 12 minutes (Fig. 3.7a). Different 
concentrations of donors form different plateau NO concentrations (Fig. 
3.7b).
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Fig. 3.7: NO generated from Sper/NO
(a) NO concentrations generated in aCSF gassing with 95% 0 2, 5% C02 following addition 
of 50 (blue symbols), 200 (red symbols) and 2000 (black symbols) pM Sper/NO. The [NO] 
has reached a plateau and is stable between 10 and 12 minutes.
(b) The mean of the NO concentration between t = 1 0 - 1 2  min is shown for different 
Sper/NO concentrations (0.05 pM -  2 mM). Data represents mean ± S.D. (n = 2 -10).
The theoretical effect of exposing a slice to a constant external NO 
concentration with or without NO inactivation is illustrated in figure 3.8. In 
figure 3.8a the tissue does not consume NO. An applied concentration of NO 
equilibrates across the thickness of the slice and the GC(NO) receptor is 
equally stimulated throughout the slice. The cGMP produced in the slice 
simply reflects the potency of NO for the GC(NO) receptor, i.e. it is half- 
maximal at the EC50 of around 1 nM and maximal at 20 nM (Fig. 
3.4b,(Griffiths et al., 2003; Gibb et a\.y 2003). Figure 3.8b illustrates the
1    1---------------- ■---------------- 1-----------------•---------------- 1
0 4 8 12
Time (min)
*
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situation when tissue does consume NO, such that a concentration gradient 
is formed across the slice. At bath NO levels above that required for 
maximal GC(NO) receptor stimulation, the centre of the slice experiences a 
lower NO concentration and less cGMP may be produced. This can be 
tested experimentally in two ways: visualising the distribution of cGMP
throughout the slice using immunohistochemistry and quantifying the levels 
produced within the whole slice by radioimmunoassay; if the slices inactivate 
NO, the concentration-response curve will be right-shifted compared to that 
of dispersed cells or the purified enzyme.
Positionin slice
Position in slice
Fig. 3.8 : The predicted cGMP response to applied NO in cerebellar slices, if intact brain 
tissue is unable (a) or able (b) to consume NO.
3.3.3 Modelling diffusion and inactivation allows quantification of 
inactivation kinetics
Diffusion of NO into the slice will follow Fick’s second law of diffusion, while 
inactivation in dispersed preparations appears to follow Michaelis-Menten
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kinetics. The overall change in concentration over time at a given position in 
the slice (x) is therefore given by the net of these two processes (Eq. 3.4).
d[N O ]= d2[NO] Vmax [A/O] F n o 4
dt dx2 Km + [NO] q' '
D is the diffusion constant for NO (3.3 x 1CT5 cm2/s (Malinski et a l 1993), 
[NO] is the NO concentration and, as above, Vmax and Km are the kinetic 
parameters for inactivation determined from the combined homogenate and 
cell suspension data adjusted to a typical in vivo tissue protein concentration 
of 100 mg/ml ((Mcllwain, 1963); Vmax = 1 pM/s and Km = 67 nM; C. Griffiths & 
J. Garthwaite, personal communication). Numerically solving this equation 
for a range of bath NO concentrations generates predicted profiles of NO 
concentration across the slice (Fig. 3.9a). As shown in cartoon form above, 
NO consumption is predicted to produce a sharp gradient of NO across the 
slice, such that the centre of the slice is exposed to a much lower NO 
concentration than the outside.
The NO profiles above result in activation of the GC(NO) receptor and can 
therefore be used to predict cGMP distribution across the slice, (Fig. 3.9b). 
The cGMP at a given position in the slice is therefore given by the Hill 
equation using the kinetic parameters for the GC(NO) receptor fitted above 
(Fig. 3.4b; Eq. 3.3), such that cGMP profiles across the slice can also be 
generated (Fig. 3.9b). The fraction of the maximal cGMP response can be 
calculated by expressing the area under each cGMP profile as a proportion 
of the total area (for a 400 pm slice, 0.04 cm x 1 = 0.04 cm2). Calculation of 
this value for a range of bath NO concentrations allows the generation of a 
predicted NO-cGMP concentration-response curve for cerebellar slices. A 
family of such curves (Fig. 3.9c) was generated using a number of different 
values for the Vmax for NO decay including the value derived from dispersed 
preparations (1 [M/s). The NO(GC) receptor undergoes desensitisation, so 
it was investigated whether this would affect the precicted NO-cGMP curves. 
Incorporating GC activity which, on exposure to NO, rises and falls with the
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same kinetics as measured in cerebellar cells (Bellamy et al., 2000), 
produced NO-cGMP curves which overlaid those in figure 3.9c.
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Fig. 3.9 : Inactivation of NO is predicted to limit penetration of external NO into brain tissue
(a) Steady-state NO profiles across a 400 pm slice were modelled following exposure to 
constant bath NO. Predicted profiles are shown for bath NO levels of 0.003 - 10 pM, with 
Vmax = 1 pM/s and Km = 67 nM. (b) The NO concentrations shown in (a) were converted 
into predicted cGMP profiles across the slice, using calculated kinetic parameters for the 
GC(NO) receptor, (c) Predicted NO-cGMP concentration-response curves can be 
generated by finding the area under the cGMP profiles in (b) for several bath NO 
concentrations. Values of Vmax of 0 - 8 pM/s were used to generate a family of such curves 
(as labelled).
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3.3.4 Cerebellar slices inactivate NO: NO inactivation limits
penetration of external NO into cerebellar slices
Sper/NO was pre-equilibrated in aCSF (gassing with 95 % 0 2, 5 % C 02). At 
10 minutes, when the level of NO is stable (Fig. 3.7a), cerebellar slices were 
added. After 1 minute, the cGMP level was stable (Fig 3.10). 2-minute 
incubations were therefore used for all future experiments.
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Fig. 3.10: cGMP levels are stable after 1 minute incubation with pre-equilibrated donor 
Slices are added to aCSF pre-incubated for 10 min with 50 (blue symbols), 200 (red 
symbols) and 2000 (black symbols) pM Sper/NO. cGMP levels are stable after 1 min. Data 
represents mean ± SEM (n = 3 -15).
After exposure to different bath NO concentrations, cerebellar slices were 
fixed, sectioned and stained for cGMP, using peroxidase-linked 
immunocytochemistry. In the absence of NO addition, no cGMP was 
detected in any layer of the cerebellum (Fig. 3.11a). After 4.22 ± 0.30 pM 
NO, cGMP was found throughout the slice (Fig. 3.11c). An intermediate bath 
NO concentration (102 ± 3 nM) produced a band of cGMP-staining around 
the edge of the tissue (Fig. 3.11b), indicating that there is a gradient of NO 
across the slice. This demonstrates that NO is consumed within cerebellar 
slices as without inactivation, NO would be ~100 nM (i.e. supramaximal for 
the GC(NO) receptor) throughout the tissue, so cGMP would be present
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maximally throughout the slice. Instead, at low bath NO concentrations, the 
absence of cGMP in the centre reflects the predicted cGMP profiles 
modelled in figure 3.9b. The thickness of the band of cGMP staining is 
roughly uniform, indicating that the NO inactivation mechanism has a grossly 
similar distribution throughout the cerebellar layers.
Fig. 3.11: Inactivation limits penetration of external NO into cerebellar slices 
10 pm sections (see cross-section indicated in Fig. 3.8) of 400 pm cerebellar slices were 
labelled by peroxidase-linked immunocytochemistry for cGMP (dark staining): Nuclei are 
stained with haemalum (pale staining). Slices were incubated for 2 min with (a) 0, (b) 102 
nM and (c) 4.22 pM NO, produced from 0, 5 pM and 2 mM Sper/NO, respectively. Sections 
are representative of ^ 4 slices from two independent experiments. EGC: external granule 
cell layer; ML: molecular layer; PC: purkinje cell layer; IGC: internal granule cell layer.
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3.3.5 Cerebellar slices inactivate NO: The concentration-response 
relationship is right-shifted compared to that of dispersed cells.
Quantification of the levels of cGMP generated to different bathing NO 
concentrations was achieved by incubating slices in a range of constant NO 
concentrations (0.02 ± 0.01 pM -  4.22 ± 0.30 pM; n = 2 - 10) for 2 minutes 
and measuring the cGMP in the slice by radioimmunoassay. cGMP levels 
were expressed as a fraction of the maximal cGMP, produced by incubation 
with 100 pM DEA/NO for 2 minutes (Fig. 3.13). The resulting NO-cGMP 
concentration-response curve is right-shifted compared to that in cells (Fig. 
3.12). Due to the dispersed nature of the cell suspension, all cells 
experience the same NO concentration and the NO-cGMP curve follows that 
of the NO(GC) receptor. As discussed above, however, inactivation of NO 
produces a concentration gradient of NO gradient across the slices and a 
right-shift in the curve. Indeed, the EC50 in slices is three orders of 
magnitude greater in slices than in cells (~ 1 pM compared to 1.6 nM), 
indicative of a substantial degree of NO consumption by slices. 
Quantification of inactivation can be achieved by comparison of the 
experimental data to the predicted curves, based on the diffusional model 
above (Fig. 3.14a). The data follow the same shape as these predicted 
curves, albeit with a steeper gradient and is consistent with the kinetic 
parameters derived in cells, as it suggests a Vmax of at least 1 pM/s, 
indicating that inactivation is at least as fast in intact tissue as in isolated 
cells and homogenate.
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Fig. 3.12: The NO-cGMP concentration-response curve is right-shifted in slices compared 
to cells, indicating considerable inactivation of NO by brain slices.
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Fig 3.13: cGMP accumulation in cerebellar slices is maximal after 30 pM DEA/NO and 
reaches steady-state after 1 min.
(a) Concentration of cGMP at 2 min. following DEA/NO stimulation. There is no significant 
increase in cGMP over 30 pM DEA/NO (One way ANOVA with Tukey post-hoc tests; p > 
0.05; n = 3 -4 ) .
(b) Time course of cGMP accumulation in cerebellar slices following stimulation with 300 pM 
DEA/NO (n = 4).
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3.3.6 Release of NO from Sper/NO within the slice produces a steeper 
concentration-response curve
A complication of this method using steady-state NO delivery is that Sper/NO 
may enter the slice and release NO within the tissue, increasing cGMP 
production above that predicted. The measured cGMP (cGMP total) is 
therefore given by equation 3.5, where cGMP bath n o  is that produced by 
diffusion of NO into the slice from the bathing solution and cGMP donor n o  is 
that released from the donor within the slice.
cGMP total ~ CGMP bath NO + CGMP donor NO Eq. 3.5
To investigate the significance of this effect, Hb-agarose was used to 
scavenge external NO, isolating the effect of NO release from donor within 
the tissue. The beads were of a diameter of 45 -  85 pm (mean = 60.2 ± 3.5 
pm, n = 11) and so could not penetrate the tissue. A 40% v/v bead 
suspension was able to scavenge all external NO in the presence of up to 1 
mM Sper/NO for the period of the experiment (not shown). cGMP was 
measured following 2 min exposure to Sper/NO ( 0 - 1  mM), in the presence 
of 40 % v/v haemoglobin-agarose. The cGMP levels were then normalised 
and plotted against the NO produced from each Sper/NO concentration were 
no haemoglobin-agarose present (Fig. 3.13b). This data was fitted with a 
logistic function, constrained to a minimum cGMP of 0 and a maximum of 1. 
This function was used to predict the relative effect of donor release within 
the slice at all concentrations.
The rapid diffusion of bath NO results in steady-state cGMP levels within 1 
min (Fig. 3.10), while NO release from donor takes longer to increase cGMP, 
reaching steady-state after 10 min (Fig. 3.6). Release of NO within the slice 
will therefore only have an effect on cGMP levels in places where external 
NO diffusing inward has not already maximally stimulated the GC(NO) 
receptor. If the simplifying assumptions are made, that i) a given part of the 
slice is either empty or full of cGMP, ii) the donor is equally distributed
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throughout the slice and iii) that donor release within the slice follows the 
same kinetics in the presence and absence of beads, then equation 3.6 
follows, where cGMPbeads is the measured effect of Sper/NO in the presence 
of haemoglobin-agarose.
cGMP donor NO = CGMP beads NO (1-CGMP bath No) Eq. 3.6
A failure to meet assumptions (i) and (ii) above will simply reduce the effect 
of donor-release within the slice beneath that predicted here. Assumption 
(iii) may not hold, however, at high Sper/NO concentrations when high bath 
NO (in the absence of external Hb-agarose) can inhibit respiration such that 
the slices may become acidic, increasing the rate of NO release from the 
donor within the slice, compared to the situation in the presence of Hb- 
agarose, when NO levels are low and will not inhibit respiration. While this 
assumption is hard to test experimentally, the stability of cGMP levels over 
time would indicate this does not happen to a large degree, as if NO 
increased over time, it would be expected that cGMP levels would 
concomitantly increase. This model therefore is likely to represent the 
maximum possible contribution of internal NO release. Combining equations 
3.5 and 3.6 gives equation 3.7.
cGMP total = cGMP bath NO + CGMP beads NO (1 — CGMP bath No) Eq. 3.7
Adjusting the predicted concentration-response curves according to equation 
5 steepens the slopes considerably (Fig. 3.14c), such that high values of 
Vmax produce curves that converge close to the experimental data. This is 
consistent with the Vmax of inactivation being at least 1 pM/s, but means that 
it could, in fact, be several-fold higher.
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Fig. 3.14: In cerebellar slices NO inactivation has a Vmaxof at least 1 pM/s 
(a) cGMP produced from 2 min exposure of cerebellar slices to constant NO (0.02 -  4.22 
pM) generated from Sper/NO (0.05 pM -  2 mM). The data falls to the right of the predicted 
curve with Vmax= 1 pM/s. Data represent means ± SEM (n = 4-21). (b) cGMP response at t 
= 2 min, following incubation with Sper/NO (50, 200, 500 and 1000 pM) and 50 % v/v 
haemoglobin-agarose. cGMP is plotted against the plateau NO that would be generated 
from these Sper/NO concentrations, were external NO not being scavenged by 
haemoglobin-agarose. Data represent means ± SEM (n = 4 - 8) and are fitted with a logistic 
function, (c) Predicted curves adjusted for effect of donor release of NO from within the slice 
(solid lines). Dotted lines show curves without adjustment. Data points are as in (a).
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3.3.7 Modelling NO signals at physiological concentrations
The new kinetic parameters were used to model in vivo NO signals. In the 
absence of detailed kinetic data for NO synthesis in brain, I used a number of 
approximations for in vivo nNOS activity, looking at prolonged and transient 
global stimulation and also local, spatially discrete nNOS activation. nNOS 
activity was estimated from measurements in tissue. In rat cerebellar 
homogenate, nNOS activity is 50 nmol/min/g tissue (Salter et al., 1995), 
corresponding to 800 nM/s. Following physiological stimulation with NMDA, 
nNOS activity reaches only 1% of this maximum (Griffiths & Garthwaite, 
2001). Thus, for the models of global nNOS stimulation, a range of 8 -  800 
nM/s was used, encompassing both likely physiological nNOS activity and 
the maximum possible synthesis rates.
First I investigated the effect of step-wise activation of nNOS for 1 s 
generating steady-state physiological NO concentrations. The following 
derivations of the Michaelis-Menten equation describe the generation of the 
NO signal at various rates of NO synthesis (Eq. 3.8) and the decline once 
NO production is halted (Eq. 3.9).
d m  = v U  V - [A IQ] Eq 3 8
dt K + [A/O]
Here v1 = the rate of NO production (nM/s), [NO] = the NO concentration 
(nM), Vmax = the maximum rate of NO degradation (1000 nM/s) and Km = 67 
nM. The decline of NO concentration following cessation of synthesis was 
derived by the following equation where [N O ]^  = the steady-state NO 
concentration (nM) at t = 1 s:
d[NO] VmJ N O ]
dt Km +[NO]
I used Mathcad (2001/, MathSoft, Cambridge, MA) to solve the equations for 
a range of NO production rates (10 - 140 nM/sec), chosen to generate NO 
signals in the physiological range (0.5 -  10 nM; (Bellamy et al., 2002). The
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predicted NO profiles during 1 s of NO production and the subsequent 
decline are shown in figure 3.15a. Across this range, inactivation of NO 
causes these different rates of NO production to be translated into steady- 
state NO concentrations that are directly proportional to the rate of synthesis 
(i.e. doubling v1 doubles the plateau concentration achieved). 90% of the 
physiological signal amplitude is achieved in less than 200 ms, while the half- 
life (tv2) of decay is -5 0  ms.
The impact of varying the Km and Vmax upon the NO signal was also 
investigated at the rate of NO synthesis which generated a NO concentration 
in the middle of the sensitivity range for the GC(NO) receptor (4 nM NO). 
Halving the Km reduced the steady state by approximately half (from 4.3 to
2.1 nM) and accelerated the kinetics of the signal rise and fall, halving tm 
(from 48 to 24 ms). Doubling the Km had the opposite effect. Conversely, 
and as expected, doubling the Vmax halved the plateau NO concentration (to
2.1 nM) and accelerated the signal kinetics, decreasing the tv2 to 24 ms, 
while halving Vmax doubled both the ft* and the plateau height.
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Fig. 3.15: Predicted temporal profiles of in vivo NO signals
(a) NO profiles were modelled using the derived parameters for Km and Vmax and a range of 
NO production rates (at 10-140 nM/s). The traces represent NO concentration during 1 s of 
NO production at each given rate, then following cessation of activity (t = 1 s). (b) Time 
courses of nNOS activity during a typical synaptic Ca2+ transient, generated from equation 
12, with maximum activity rates of 10, 100, 400, 600 and 800 nM/s. (c) Time courses of NO 
signals predicted from nNOS activity profiles in (b).
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3.3.8 NO signals produced from a typical synaptic calcium transient
In the cell, the Ca2+-dependence of nNOS ties its activity to intracellular Ca2+ 
dynamics. When Ca2+ elevation is prolonged, such as during repeated 
neuronal activity, NO profiles will reach a steady-state as modelled above. 
Following a synaptic Ca2+ transient, however, the profiles will be heavily 
influenced by the kinetics of nNOS activation. I modelled NO signals 
produced from a typical single Ca2+ transient in a cell. Sabatini et al. (2002) 
used measurements of Ca2+ concentrations to simulate Ca2+-calmodulin 
binding in dendritic spines following synaptic stimulation of NMDA receptors. 
Assuming that nNOS activation matches that of Ca2+-calmodulin binding, 
nNOS activity was modelled using equation 3.10.
The rate of NO synthesis (v: nM/s) at time t (s), is given by the product of the 
maximum activity (v1: nM/s) and two exponential functions, the parameters 
for which (k1 and k2) are adjusted to match the kinetic profile of Ca2+- 
calmodulin binding (e.g. peak activity at ~80 ms). Values for maximum 
synthesis from 50 to 800 nM/s were used (Fig. 3.15b) to generate NO 
profiles over a physiological concentration range (Fig. 3.15c). These were 
calculated by finding the net of synthesis and inactivation (Eq. 3.11).
NO inactivation ties the dynamics of the NO signal to that of the underlying 
Ca2+ transients and subsequent nNOS activation. Both the time to peak [NO] 
and time to fall to 5% of the peak height occur within 100 ms of the 
corresponding points in the nNOS activity profile.
v(t) = v1 x (1 -e  Mf)x e  k2t Eq. 3.10
— (/) = [v1x(1-e *1f)x e  k2t
dt
max Eq. 3.11
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3.3.9 NO profiles following spatially discrete NO synthesis
The models above assume that NO synthesis and inactivation occur 
uniformly throughout the tissue. While, based on current knowledge, this is a 
good assumption for inactivation, especially given the homogeneous 
distribution in cerebellar layers indicated by figure 3.11b, this is not the case 
for NO synthesis, as the major source of NO in the cerebellum is thought to 
be parallel fibre terminals (Shibuki & Kimura, 1997; Crepel & Penit-Soria, 
1986). The above models also do not consider diffusion away from the site 
of synthesis and assume that global NO stimulation occurs concurrently 
throughout the tissue. Spatially discrete NO signalling was investigated by 
modelling diffusion, synthesis and inactivation in three dimensions and 
constraining NO synthesis to 0.5 pm diameter “terminal boutons” 
(dimensions in (Palay & Chan-Palay, 1974). The relevant equation (Eq. 
3.12; (Crank, 2002) describes radial diffusion away from a central point, 
where NO synthesis (v1) is positive within boutons and zero outside them.
d[A/0]
dt
D d2[NO] , 2 d[A/0] | Vmax[A/0]
\ dr* + r dr
+ y1 _ •-ma.r— J Eq. 3.12
Km + [NO]
The density of parallel fibre synapses in rat cerebellum is just under 109 
synapses/ pm3, or approximately 1 synapse/ pm3 (Napper & Harvey, 1988). 
Assuming that nNOS is distributed uniformly within but constrained to 
boutons, then half of the total tissue volume is capable of producing NO, 
such that the maximum rate of synthesis within a bouton will be 1600 nM/s, 
rather than 800 nM/s. Values for v1 of 8, 16, 800 and 1600 nM/s were 
therefore used. For all conditions investigated increasing v1 simply linearly 
increased the peak NO produced (Fig. 3.16 insets). The effect of inactivation 
was gauged by calculating profiles with and without Michaelis-Menten 
inactivation with a Vmax of 1000 nM/s, distributed homogeneously throughout 
“boutons" and “non-boutons”.
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I solved the diffusion equation for three dimensions using the pdepe function 
in MATLAB. This returns a solution in one dimension and therefore assumes 
rotational symmetry around the central NO producing bouton.
At the physiologically relevant synthesis rate of 16 nM/s, a single source 
produces a NO peak of only 0.15 pM (Fig. 3.16a) and its profile is almost 
entirely dictated by diffusion rather than inactivation as, with and without 
inactivation, the profiles are almost indistinguishable. I then investigated the 
effect of the simultaneous activation of several NO-producing boutons, the 
centres being 1 pm apart (the measured density in rat cerebellum; (Napper & 
Harvey, 1988). Due to the rotational symmetry assumed, “boutons” become 
hollow spheres 0.5 pm thick, separated by 0.5 pm-thick spheres of non-NO 
producing tissue, all surrounding a central bouton. While this is non- 
physiological, it is a computationally-inexpensive way of probing the three- 
dimensional properties of NO signals produced by different source strengths, 
numbers and separations. Increasing the number of sources from 1 to 10 to 
20 increased the peak NO produced, the radial spread of NO and also the 
limiting effect of inactivation on the signal (Fig. 3.16b).
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Fig. 3.16: Predicted spatial profiles of NO after release from synaptic boutons 
NO release from 0.5 pm diameter synaptic boutons. In all the main figures the rate of NO 
synthesis (y1) is 16 nM/s. Insets show the peak [NO] reached at different values of v1 for 
each condition in the main figure. Blue lines represent profiles with no inactivation of NO. 
Black lines represent profiles when NO is inactivated with a Vmaxof 1000 nM/s. (a) NO profile 
when NO is released from 1 bouton. (b) NO when released from 10 (dashed line) and 20 
boutons (solid lines) at 1 pm separation.
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3.4: Discussion
Previously, NO inactivation in dispersed cells and homogenised brain was 
found to have an apparent Km and Vmax of 67 nM and 0.62 nmol/mg 
protein/min respectively (Griffiths and Garthwaite, personal communication). 
When extrapolated to intact tissue, this predicts a Vmax in vivo of 1 pM/s. 
Correspondingly, cGMP accumulation in intact cerebellar slices fitted a 
model of NO diffusion and Michaelis-Menten inactivation with a Vmax of at 
least 1 pM/s. Immunohistochemical staining for cGMP after low bathing 
NO concentrations revealed a uniform band of cGMP, and therefore NO, 
around the edge of the slice. This indicates that the inactivation mechanism 
has a grossly uniform distribution throughout the layers of the cerebellum.
Brain slices therefore have the ability to inactivate NO and the kinetics of this 
process have been determined. If and how such a mechanism may impact 
on the properties of physiological NO signals remains to be assessed. As it 
is not possible to directly measure the small concentrations of NO that occur 
endogenously, an alternative technique is to model the predicted NO profiles 
based on kinetic parameters measured in vitro. A number of studies have 
adopted this approach (Lancaster, Jr., 1994; Wood & Garthwaite, 1994; 
Philippides et al., 2000), all essentially modelling NO signals as diffusion 
away from a site of synthesis, by solving the diffusion equation with a source 
and a sink term. Differences arise in terms of the assumptions made. For 
example Wood and Garthwaite assume a point source from which NO is 
produced and diffuses, and hence are able to calculate analytical solutions. 
Lancaster and Philippides et al. both also use compartmentalisation of space 
and time to define sources and sinks and to numerically solve the equation. 
The findings from these studies broadly agree that the peak NO achieved 
physiologically close to a single site of synthesis is in the low micromolar 
range and that biologically relevant NO concentrations diffuse over 100 - 200 
pm.
104
Chapter 3: Inactivation of NO by cerebellar slices
This wide diffusional spread, and hence the large number of synapses that 
will experience NO from a single source (2 million according to calculations 
by Wood and Garthwaite), indicate that NO signalling must function in a 
volumetric rather than point-to-point manner. Synaptic specificity has long 
been considered a critical property of associative learning mechanisms but 
this does not, however, obviate an involvement for NO in synaptic plasticity 
and learning. Neural network models of learning that incorporate a 
requirement for raised levels of a diffusional messenger such as NO can 
undergo reorganisation of synaptic weights consistent with learning (Gaily et 
al., 1990; Schweighofer & Ferriol, 2000). Indeed, as discussed above in 
Chapter 1, heterosynaptic spread of NO-dependent synaptic plasticity over at 
least 100 pm has been observed (Jacoby et al., 2001; Schuman & Madison, 
1994).
The electrophysiological findings indicate that NO can act as a volumetric 
rather than synapse-specific messenger, and the neural network models 
show that this is computationally plausible. It is the diffusional models that 
suggest that this is the only possible way in which NO signalling could 
behave and this conclusion derives from at least two flaws in the previous 
models. Firstly, in the absence of accurate kinetic data about physiological 
NO synthesis rates, all the models adjust this parameter to generate profiles 
that match those measured by Malinski at the surface of an endothelial cell 
(Malinski eta!., 1993). As discussed in Chapter 1, this sensor is now known 
to cross-react with several species (Stingele et al., 1998; Lin et al., 1996) and 
much evidence now points to physiological NO concentrations being much 
lower than detected with this electrode. If instead of micromolar levels, 
nanomolar levels are actually produced, then the sphere of influence of NO 
becomes much less than previously thought.
The second problem with the previous models is that they do not use an 
appropriate value for the inactivation of NO. Biological breakdown in these 
models was assumed to have a half-life of 5 s, based on the duration of the 
ability of NO to relax a cascade of strips of rabbit aorta (Palmer et al., 1987; 
Palmer et al., 1988). This degree of inactivation had no effect on the
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diffusional spread of NO, though a ten-fold faster half-life did reduce NO 
distant to the source (Wood & Garthwaite, 1994). The effect of localised NO 
sinks were considered, in the form of free haemoglobin, which reduces the 
half-life of NO to 1 ms and dramatically altered the NO profile close to the 
source (Lancaster, Jr., 1994; Philippides et al., 2000). Neither a half-life of 5 
s or 1 ms is appropriate, however. Hb encapsulated into red blood cells 
consumes NO more slowly than free Hb (Liu et al., 1998) such that blood 
cells will have a diminished role in shaping the NO profile. Additionally, the 
inactivation of NO deduced in this work appears to have a half-life of -  50 ms 
at physiological NO concentrations. Neural tissue as well as the vasculature 
may therefore also contribute to shaping NO signals. Incorporating both 
lower, more physiologically relevant NO concentrations and the newly 
determined kinetics of NO inactivation by brain tissue will therefore be highly 
informative about the properties of NO signals and the extent to which they 
may be shaped by inactivation.
The kinetic parameters for NO metabolism were therefore evaluated in three 
models of neural NO signalling, chosen to encompass the variety of patterns 
of NO synthesis possible in the brain.
Firstly I assumed that the distribution of sites of NO synthesis and 
inactivation were homogenously distributed throughout the tissue and 
synchronously activated. This simulates the activity pattern that might be 
expected during event-related activation of a topographical subdivision of the 
brain, for example in the cerebellum during movement of a finger 
(Thickbroom et al., 2003). It also has the advantage that the effect of 
diffusion can be neglected so that the profile of NO reflects purely the 
balance between synthesis and breakdown.
In brain, NO production is dependent on the activation of the 
Ca2+/calmodulin-dependent nNOS following Ca2+ influx into the cell. In 
conditions of prolonged Ca2+ elevation, such as following repeated parallel 
fibre activity in the cerebellum, NO is produced for several seconds (Shibuki 
& Kimura, 1997). Modelling this situation using step-wise activation of nNOS
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reveals that because the Km of NO inactivation is 67 nM, over the 
physiological range (0.5-10 nM) breakdown rises in a first-order manner to 
match the rate of NO production. This allows the translation of different rates 
of prolonged NO synthesis to directly proportional steady-state NO 
concentrations, thus “amplitude-coding” NO synthesis rates to a graded, 
steady NO output. Breakdown also shapes the NO signal such that 90% of 
the steady-state is achieved in less than 200 ms and decays with a ti/2 of -  
50 ms. Alterations to the Km and Vmax values changed the profile in a 
predictable way, reducing the plateau height and accelerating the kinetics 
when the Km was increased or the Vmax was decreased, and vice versa.
In situations of transient Ca2+ elevation, e.g. after synaptic NMDA receptor 
stimulation, I assumed that nNOS activity parallels the time-course of 
Ca2+/calmodulin binding (Sabatini et al., 2002). As during prolonged activity, 
inactivation ensures that the ensuing NO response is tightly constrained to 
the kinetics of the upstream elements of the pathway. Both the time to peak 
and time to fall to 5 % of the peak height occurred within 100 ms of the 
analogous parts of the nNOS activity profile.
That the temporal profiles of NO signals produced by both prolonged and 
transient periods of NO synthesis are heavily restricted by a mechanism of 
signal termination is therefore in keeping with a role for NO as a 
neurotransmitter involved in events such as LTD and LTP. In the absence of 
any bioinactivation, the decay of physiological NO concentrations would be 
slow (minutes to hours; (Schmidt et al., 1997) which is hard to reconcile with 
the rapid coincidence requirements of LTP and LTD of only tens of 
milliseconds (Lev-Ram et al., 1997). The kinetic parameters of NO decay 
determined in this study therefore enable NO signals to be sharply tuned to 
the underlying activity of the neuron and conserve the temporal resolution of 
the signalling pathway.
If, rather than global activation of an area of brain, sparser activation occurs, 
the spatial profile of NO signals becomes of critical importance in 
understanding its role as a signalling molecule. As discussed above, the
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sphere of influence of NO following various patterns of, for example, parallel 
fibre stimulation may determine the degree of synaptic specificity possible in 
NO-mediated plasticity and therefore, the type of computations in which such 
a pathway can be involved. I modelled the effect of diffusion and inactivation 
of NO on such profiles by restricting NO synthesis to 0.5 pm diameter 
“parallel fibre boutons” (Palay & Chan-Palay, 1974) with and without 
uniformly distributed inactivation. If only one source/ parallel fibre bouton 
was active, the NO inactivation mechanism had no effect and the spatial 
profile was solely determined by diffusion. Even at a rate of NO synthesis of 
1600 nM/s, corresponding to the maximum measured rate of synthesis in 
brain homogenate (Salter etal., 1995), the peak NO achieved was only -15  
pM, indicating that activation of only one parallel fibre terminal would never 
produce enough NO to generate a signalling effect via the GC(NO) receptor.
When more sources are activated, the peak NO concentration achieved 
increases, as does the contribution of inactivation to the spatial profile. With 
the estimated physiological NO synthesis rate of 16 nM/s, 20 sources spaced 
at 1 pm separation would be required to achieve threshold stimulation of 
cGMP production. In these conditions, the concentration falls to half the 
peak height within 20 pm (i.e the location of the most distal source). While 
this is of insufficient spatial resolution to mediate specificity of plasticity at the 
single synapse level, it would allow locally distributed modifications in small 
groups of synapses and neurons, as observed in NO-dependent LTP in the 
hippocampus (Zhuo et al., 1993) and in LTD and LTP in the cerebellum 
(Reynolds & Hartell, 2000; Wang et al., 2000; Jacoby et al., 2001; Reynolds 
& Hartell, 2001).
Since this work was conducted, Garthwaite (Garthwaite, 2005) has modified 
his model of a single point source, assuming a maximum synthesis rate of 20 
000 molecules/s, based on 1000 NOS molecules in a synapse synthesising 
NO at a steady state rate of 20 molecules/s. This is five-fold faster than the 
maximum rate measured of 3 - 4 molecules/s (Stuehr et al., 2004), though 
this was measured at 10 °C so is likely to be considerably slower than at 37
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°C. Also it does not take into account the considerable auto-inhibition of NO 
on nNOS, but this may be reduced if NO can simply diffuse away into the 
tissue. As used here (Fig. 3.15) Garthwaite varies NOS activity, according to 
the Ca2+ concentration in a dendritic spine and produces NO levels of 2 nM 
at the surface of the spine to 70 pM at 5 pm away. Applying the same 
steady-state source strength distributed throughout a parallel fibre bouton, 
this equates to a synthesis rate of 500 pM/s and generates the profile in 
figure 3.17. Again the profile is purely determined by diffusion not 
inactivation, the NO at the surface of the bouton is 3.3 nM and at 5 pm from 
the centre of the bouton is 150 pM. Considering that here I used a constant 
rate of synthesis rather than a changing profile over time, the results 
presented here are consistent with those of Garthwaite.
 no inactivation
• ■ • • + inactivation4
2
0
0 2 4
Distance (pm)
Fig. 3.17: Diffusion from a single 0.5 pm bouton synthesising NO at a rate of 500 pM/s, with 
(dotted line) and without (solid line) homogenously distributed biological inactivation.
In summary, depending on the assumptions of the physiological rates of NO 
synthesis, it seems unlikely that a single parallel fibre terminal could ever 
produce an NO signal capable of activating the GC(NO) receptor. By 
recruiting more sources, and by increasing the strength of these sources, a 
wide variety of NO profiles could be achieved. Where NO is released at a 
local scale, this could produce a signal that decays sharply across the brain, 
allowing changes in connectivity that are restricted to at least small groups of
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synapses. On recruitment of more sources, the sphere of influence of NO 
will increase, potentially allowing heterosynaptic spread of NO-mediated 
plasticity. As more and more sources are recruited across the brain, NO 
may play a more general modulatory role in controlling neuronal activity. 
NO-release from granule cells increases the spontaneous firing rate of 
Purkinje cells (Smith & Otis, 2003), while in the thalamus, NO release onto 
thalamocortical afferents dampens oscillatory activity, mediated by lh (Pape & 
Mager, 1992). It is likely that in these situations, the activity of the NO 
inactivation mechanism is crucial, holding NO at a steady low level. If NO 
decay were compromised, however, such widespread activation of NO 
synthesis could potentially now produce pathologically high concentrations of 
NO.
The determination of kinetic parameters for NO inactivation has allowed 
insight into the signalling properties of the NO pathway. Our modelling 
predicts that at a very local level, NO signalling is solely determined by 
diffusion. In contrast, as release becomes more widespread, NO inactivation 
is critical in shaping the spatial and temporal profiles of NO signals to match 
the sensitivity range of its receptor, the GC(NO) receptor, and in preventing 
NO reaching pathophysiological concentrations. The modelling conducted 
here is, however, very simple and there are a number of ways in which 
modifications could allow more sophisticated analysis of NO signalling. 
Application of a temporally changing source to the three dimensional models 
would be more physiological than the constant rates of synthesis used here 
and would allow investigations of the conditions that lead to summation of 
the NO signal. Alterations that removed the requirement for rotational 
symmetry would be helpful to investigate the spatial summation of different 
sources and the effect of different patterns of source spacing. Finally, the 
relative involvements of diffusion and inactivation by neural tissue and blood 
vessels would be well-addressed by incorporation into a model that does not 
make assumptions of physiological concentrations of NO in the micromolar 
range. Identification of the mechanism underlying neural NO consumption 
will be of importance in determining its distribution and any effects this might 
have on predicted signals. Development of such future models and, more
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importantly, the accurate experimental determination of the endogenous 
synthesis rates of nNOS and the concentrations of NO actually achieved in 
the brain will be crucial for furthering our understanding as to the range of 
biological effects of this molecule.
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4.1 Introduction
Suspensions of rat cerebellar cells and whole brain homogenate avidly 
inactivate NO by a saturable mechanism that is dependent on O2 and, in 
homogenate, is inhibited by proteinase K treatment but is insensitive to haem 
poisons or inhibitors of other enzymes known to degrade NO (Griffiths et al., 
2002; Griffiths & Garthwaite, 2001). Recently the mechanism by which NO 
is consumed in this manner has been identified as being via reaction with 
lipid peroxyl radicals (LOO’) during ongoing lipid peroxidation of the 
dispersed tissues (Keynes et al., 2005).
Polyunsaturated fatty acid side chains of membrane lipids are able to 
undergo peroxidation by abstraction of a bis-allylic hydrogen atom by a 
radical (e.g. the hydroxyl radical, ’OH) to form a lipid radical (L’). The lipid 
radical then reacts with O2 to form the lipid peroxyl radical (Fig. 4.1) which 
can itself abstract an adjacent bis-allylic hydrogen, generating a further lipid 
radical and hence propagating the reaction (Scheme 4.1).
LH + ’OH —► L’ + H20
L’ + 0 2 — LOO’
LOO’ + LH - *  LOOH + L’ Scheme 4.1
.RH ;
/ ; a  .........
Oi l  Jo!
' V S / V / '  ' N / V *T
Fig. 4.1: Lipid peroxidation: Abstraction of an allylic hydrogen and conjugated diene 
formation (taken from Hogg & Kalyanaraman, 1999)
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Initiation of lipid peroxidation can occur by the generation of hydroxyl radicals 
from hydrogen peroxide (H2O2) and iron or copper, by Fenton chemistry, 
according to equation 4.1.
Fe2+/Cu* + H20 2 — Fe37Cu2* + OH + ‘OH Eq. 4.1
Redox cycling of the transition metals, by reduction (to Fe2+ or Cu*) by 
biological antioxidants (e.g. ascorbate), allows the metals to act as catalysts, 
further increasing the concentration of ‘OH present and hence the degree of 
ongoing lipid peroxidation (Buettner & Jurkiewicz, 1996). Iron is found in 
brain tissue (Halliwell & Gutteridge, 1986) and also in vitro as a contaminant 
in buffers and from use of Hamilton syringes (Buettner & Jurkiewicz, 1996).
NO can interact with the lipid peroxidation process in two ways: if NO levels 
are low relative to the concentration of 02*‘, ONOO' is formed which can itself 
abstract hydrogen from lipids and initiate lipid peroxidation. When more NO 
is present than 02*', however, it inhibits lipid peroxidation by binding to LOO* 
at an almost diffusion-limited rate (k = 2 x 109 M'1s'1), thus terminating the 
chain of lipid peroxidation (O'Donnell et al., 1997). The resulting LOONO is 
unstable but can either rearrange to form LONO2 or dissociate forming L0‘ 
and N 02*, which, as for autoxidation, can react with another NO, forming 
N2O3 before being hydrolysed to N02-. L0 ‘ can then bind another NO to 
form LONO, accounting for the finding that at least 2 molecules of NO are 
consumed per L 0 0 ‘ radical (O'Donnell etal., 1997).
Several data point to the consumption of NO observed in dispersed rat brain 
tissue being due to reaction with lipid peroxyl radicals (Keynes et al., 2005). 
The consumption activity was found to require recombination of both the 
membrane pellet and cytosolic supernatant following high speed 
centrifugation of brain homogenate. Purification of inactivation activity in the 
membrane pellet yielded a highly enriched fraction containing predominantly 
phospholipids. The active ingredient in the supernatant was identified as 
ascorbate, which was also present in homogenate. NO consumption was 
fully restored on application of exogenous ascorbate in place of supernatant
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to both pellet and a phospholipid mix, mimicking that found in purified pellet, 
while degradation of ascorbate with ascorbate oxidase (AO) abolished 
activity in homogenate. Activity in homogenate and pellet plus supernatant 
was also abolished by the antioxidant Trolox, which inhibits lipid peroxidation 
in several tissues including brain homogenates (Britt et al., 1992) and the 
transition metal-chelator, diethylenetriaminepentaacetic acid (DTPA). NO 
consumption therefore depends on the presence of lipid, transition metals, 
and ascorbate and is inhibited by inhibitors of lipid peroxidation. As such it is 
wholly consistent with a mechanism by which H2O2 generated from SOD by 
dismutation of O2” forms ‘OH by means of iron-dependent Fenton chemistry, 
which then induces lipid peroxidation and NO consumption by lipid peroxyl 
radicals. Involvement of lipid peroxidation explains the 0 2 -dependence of 
the process, as O2 is required to form LOO*, and the saturability as NO 
terminates the lipid peroxidation reaction, preventing generation of fresh 
LOO* to react with NO. The reason for the proteinase K dependence is 
simply due to the instability of ascorbate in the presence of proteinase K.
Intact cerebellar cells were also shown to undergo ongoing lipid peroxidation 
and consumption was inhibited by AO, Trolox and DTPA, indicating that 
reaction with lipid peroxyls accounts for much of cells’ ability to consume NO. 
Residual NO metabolism persisted after lipid peroxidation inhibition in 
cerebellar cells, but this could be accounted for by red blood cell 
contamination of the preparation (Fig. 4.2).
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Fig 4.2: Inactivation of NO in cerebellar cell suspensions can be accounted for by lipid 
peroxidation and red blood cell contamination.
(a) Data courtesy of Keynes et al (2005). Representative traces of NO accumulation on 
addition of 100 pM DETA/NO to buffer and a suspension of cerebellar cells at 20 x 106 
cells/ml in the presence or absence of the inhibitors of lipid peroxidation, DTPA, AO and 
Trolox.
(b) Mean traces of NO accumulation on addition of 100 pM DETA/NO to 0.1 (black symbols), 
0.2 (dark grey symbols) or 0.4 (light grey symbols) x 106 RBC/ml. These concentrations are 
the equivalent of contaminating RBC at 0.5, 1 and 2 % of a 20 x 106 cells/ml cerebellar cell 
suspension. The NO profile in 0.4 x 106 red blood cells/ml is not affected by addition of the 
inhibitors of lipid peroxidation (blue symbols).
(c) Data courtesy of Keynes et al. (2005). Summary data from experiments shown in (a) and
(b) (* = p > 0.05; ns = not significant; n = 3).
(d) RBC contamination of cerebellar cell suspensions (n = 4).
While NO consumption by lipid peroxidation is unlikely to be of relevance to 
physiological signalling, it is of importance to pathophysiology. Lipid 
peroxidation is a feature of a plethora of disease states, including 
neurodegenerative disorders (Moosmann & Behl, 2002). In vitro, inhibition of
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lipid peroxidation by exogenously applied NO increases the viability of 
human leukaemia cells (Kelley et al., 1999), while endogenously produced 
NO protects mouse astrocytes from peroxide induced death (Robb et al., 
1999). NO may therefore play a protective role to counter lipid peroxidative 
stress. The consumption of NO in this manner may also have implications for 
the functioning of its physiological signalling pathway i.e. the stimulation of 
the GC(NO) receptor and production of cGMP. NO consumption by 
lipoxygenases has been shown to decrease the GC(NO) receptor activity 
(O'Donnell et al., 1999) in vitro. NO-mediated protection from lipid 
peroxidation may therefore be at the expense of physiological signalling. 
Further work is clearly required to assess the relative protective and 
pathophysiological effects of NO breakdown via lipid peroxidation both in 
vitro and in vivo.
Ongoing lipid peroxidation consumes NO in dispersed brain preparations. It 
is important, therefore, to determine whether inactivation in cerebellar slices 
is mediated by the same process. This was achieved by incubation with the 
lipid peroxidation inhibitors DTPA and Trolox. The outcome reflects whether 
the mechanism is likely to be of physiological or pathophysiological 
relevance and therefore the validity of the models of physiological NO 
signals. For reasons that will become apparent, the study was extended to 
cultured glial cells.
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4.2 Materials and Methods
4.2.1 Cerebellar slice preparation
Cerebellar slices were prepared as previously described (Chapter 3.2.1), 
except on occasions when intracardial perfusion was required. In these 
cases, 8-day old rats were submitted to terminal anaesthesia with 
intraperitoneal injection of pentobarbital (150 pi of 10 % pentobarbital in 
PBS) then intracardially perfused with 10 ml of PBS at 30 -  37°C, prior to 
decapitation, removal of the cerebellum and slice preparation as previously 
described. Slice responses to NO were measured as described in Chapter 
3. Briefly, slices were exposed to 10 pM Sper/NO (pre-equilibrated with 
gassing aCSF for 10 min) or 100 pM DEA/NO for 2 min, and then inactivated 
in boiling Tris/EDTA buffer for 15 - 30 min before quantification of protein and 
cGMP.
4.2.2 Lipid peroxidation assay
In experiments requiring measurement of lipid peroxidation, each cerebellar 
slice was inactivated by addition to 400 pi of ice cold trichloroacetic acid 
(TCA; 10 % w/v). Slices were then homogenised by sonication and the 
precipitated protein removed by centrifugation at 2000 g for 10 min. 
Thiobarbituritic acid reactive species (TBARS) were then detected according 
to a published protocol (Esterbauer & Cheeseman, 1990). Briefly, 300 pi of 
supernatant, 10 pi of butylated hydroxytoluene (BHT, 10 % w/v) and 300 pi 
of thiobarbituric acid (TBA) were mixed and heated to 90°C for 20 min, 
cooled to room temperature and 200 pi was transferred to a 96-well plate. 
Absorbance at 532 and 600 nm was measured spectrophotometrically. The 
ratio (A532-X600)/X600 was compared to that generated from malonaldehyde 
standards to determine the amount of TBARS present.
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4.2.3 Cerebellar cell suspension preparation
Solution Composition
1 Ca2+-free aCSF
2 Solution (1) + 3 mg/ml BSA
3 Solution (2) + 0.25 mg/ml trypsin
4 Solution (2) + 0.08 mg/ml DNAse, 0.52 mg/ml soybean trypsin inhibitor, 1.55 mM MgS04, 0.1 mM D-AP5
5 84 % solution (2), 16 % solution (4) (v/v)
6 Solution (2) + 1 mM CaCI2, 1.24 mM MgS04
7 15 mM Tris.HCI, 130 mM NaCI, 5 mM KCI, 2 mM CaCI2, 1.2 mM Na2HP04, 11 mM glucose, adjusted to pH 7.45 at 37 °C
8 Solution (7) without CaCI2, adjusted to pH 7.45 at room temperature
9 Solution (8) + 40 mg/ml BSA (filtered at 0.45 pm)
Table 4.1: Solutions required for the preparation of a cerebellar cell suspension.
The solutions required are shown in Table 4.1. Solutions 1 - 6  were gassed 
with 95 % 02, 5 % CO2. For each preparation, twelve 8 day-old Sprague 
Dawley rats were killed by decapitation as approved by the British Home 
Office and the local ethics committee and the cerebella removed. Three 
cerebella at a time were chopped at 400 pm intervals in the sagittal and 
parasagittal planes using a Mcllwain tissue chopper. The resulting blocks 
were washed into 10 ml of solution 2 chilled to 10 - 1 5°C and triturated gently 
to disperse them. Once the blocks had settled, the supernatant was 
aspirated and the blocks were incubated in 10 ml of solution 3 for 15 min, 
shaking at 37°C and gassing with 95 % O2, 5 % CO2. Next, 10 ml of solution 
5 was added and the suspension of blocks pelleted by centrifugation at 150 g 
for a few seconds. The supernatant was removed; the pellet resuspended in 
2 ml of solution 4 and triturated approximately 20 times with a long-tipped 
glass Pasteur pipette. After settling of any remaining blocks, the 
supernatant, containing a suspension of free cells, was removed and added 
to 3 ml of solution 6. A further 2 ml of solution 4 was then added to the
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blocks and the trituration and removal of free cells repeated three times until 
no intact blocks remained. The tubes containing the suspended cells were 
then made up to 10 ml each with solution 6 before being under-laid with 1 ml 
of solution 9 and centrifugation for 5 minutes at 150 g to remove any cellular 
debris. After aspiration of the supernatant, the pellet was washed in 10 ml of 
solution 8, spun for a further 5 minutes at 150 g and resuspended into 
solution 7. Cell viability was determined using trypan blue staining, cells 
were counted using a haemocytometer and made up to the desired 
concentration of 20 x 106 cells/ml with solution 7. 100 pM L-nitroarginine
was added to block endogenous NO synthesis and the cells were recovered 
for an hour at 37°C in a shaking water bath.
4.2.4 Preparation of whole brain homogenate
8 day-old Sprague Dawley rats were decapitated as above and the whole 
brain removed into ice-cold PBS. Brains were then washed into 20 mM Tris 
(pH 7.45 at 37 °C) and homogenised by sonication. Hb content was 
measured by comparison of absorbance at 410 nm compared to standards.
4.2.5 Preparation of cultured cerebellar mixed glia
Nunclon 500 cm2 dishes (Fisher Scientific UK Ltd, Loughborough, UK) were 
coated with poly-D-lysine (2 pg/cm2 in dH20 ) at room temperature overnight, 
washed twice for 15 min in dH20  and left to air dry. A maximum of ten 7- 
day-old Sprague-Dawley rats were decapitated, as approved by the British 
Home Office and the local ethics committee and the cerebella removed into 
ice-cold minimum essential medium (MEM) supplemented with 10 mM Tris 
Base and penicillin-streptomycin (100 U/ml and 100 pg/ml, respectively). 
Cerebella were triple-chopped by hand using a razor blade and washed into 
10 ml Ca2+/Mg2+-free Hank’s balanced salt solution (HBSS), containing 1 mM 
sodium pyruvate, 10 mM Hepes, 0.35 % w/v NaHC0 3  and penicillin- 
streptomycin, again at 100 U/ml and 100 pg/ml, respectively (solution 10). 
10 ml of solution 10, supplemented with trypsin (5000 U/ml) was added to
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give a final concentration of 2500 U/ml and the blocks were incubated at 
37°C in a shaking water bath for 15 min. 1 ml of solution 10 plus 0.88 mg/ml 
DNase and 110 mM MgCh and another 1 ml of solution 10 plus 6.65 mg/ml 
soybean trypsin inhibitor were then added and the blocks incubated for a 
further 10 min at 37°C. 5 ml of culture media (50 % v/v MEM, 25 % v/v
heat-inactivated horse serum, 25 % v/v HBSS and pencillin-streptomycin at 
100 U/ml and 100 pg/ml, respectively, buffered to pH 7.3 with 5 mM Tris 
Base and 0.35 % w/v NaHCOa) were added and the suspension of blocks 
triturated 6 times with a 25 ml pipette. Any remaining blocks were pelleted 
by centrifugation at 150 g for a few seconds and the suspension of dispersed 
cells was collected and incubated at 37°C while a further 10 ml of culture 
media was added and the trituration and collection of cells repeated until no 
blocks remained. The cells were pelleted by centrifugation at 150 g for 5 
min then resuspended in culture media. The viability and concentration of 
the cell suspension was determined using trypan blue staining and a 
haemocytometer, then cells were seeded at a density of 20 -  30 x 106 
cells/dish in 60 ml of culture media and maintained in a humidified incubator 
at 37°C. Half the volume of media was changed the following day and then 
every 2-3 days. Cultures were used after 6 - 1 0  days in vitro, when fully 
confluent.
To prepare the suspension of mixed glia for studies of cGMP accumulation 
and NO consumption, dishes were washed with ~100 ml cell incubation 
buffer (20 mM Tris.HCI, 130 mM NaCI, 5 mM KCI, 1.2 mM Na2HP0 4 , 11 mM 
glucose, adjusted to pH 7.45 at 37 °C) and incubated with 30 ml 
trypsin/EDTA for 15 min at 37°C. Dishes were then banged 20 times onto 
the bench to maximise dissociation from the dish, cells were collected and 
added to 10 ml culture media, pelleted by centrifugation at 150 g for 5 min, 
washed with 5 ml incubation buffer, then re-pelleted. Finally, cells were 
resuspended into a small volume of incubation buffer, their viability and 
concentration assessed using trypan blue staining and a haemocytometer, 
and cells were made up to a final concentration of 3 x 106 cells/ml. All
121
Chapter 4: Lipid peroxidation-independent inactivation of NO in brain tissue
experiments were conducted in the presence of 100 pM DTPA and 1000 
U/ml SOD.
For biochemical characterisation, cells contained the PDE inhibitor, 1 mM 3- 
isobutyl-1 -methylxanthine (IBMX). Following incubation with the relevant 
compounds, cells were inactivated by immersion in boiling inactivation buffer 
(see Chapter 2) and cGMP was assayed as described for slices (Chapter 3).
4.2.6 Immunocytochemical characterisation of cultured cerebellar 
mixed glia
Cultured glia were prepared as described above, except that rather than 
using 500 cm2 dishes, 6-well plates or 24-well plates containing glass cover 
slips were used. After 6 - 1 0  days in vitro wells were washed with TBS for 5 
min then fixed in 4 % paraformaldehyde for 20 min and washed for 10 min in 
TBS a further three times. The primary antibodies anti-glial acidic fibrillary 
protein (anti-GFAP; in rabbit), anti-S100 (in mouse), OX-42 (in mouse) and 
anti-microtubule associated protein 2 (anti-MAP2, in mouse) all 1:1000 in 
TBS plus 0.1 % v/v Triton-X100 were added and incubated for 72 hours at 
4°C. Following three 10 min washes in TBS, the appropriate secondary 
antibodies were added (anti-rabbit, linked to fluorescein or biotinylated anti­
rabbit or anti-mouse), all at 1:300 in TBS and incubated overnight at 4°C. 
After three more 10 min washes in TBS, fluorescein-stained coverslips were 
mounted in Vectashield mounting medium with DAPI. Wells treated with a 
biotinylated secondary antibody were washed and incubated with Vectastain 
elite ABC complex for 45 min, stained for 4 min with 0.05 % DAB then 
counterstained with Mayers haemalum for 15 s. Finally wells were air-dried 
and coverslips were mounted in DPX mounting medium. There was no 
difference in staining between cells grown on 6-well plates and glass 
coverslips, though image quality was superior with glass coverslips, so 
photomicrographs and image analysis was conducted from these slides.
Mathematical modelling was conducted as described in Chapter 3.
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4.3 Results
4.3.1 NO inactivation in slices is not due to consumption by lipid 
peroxides.
It is important to determine whether the avid inactivation of NO seen in 
cerebellar slices is due to the same mechanism as observed in dispersed 
cerebellar cells and whole brain homogenate. As discussed above, lipid 
peroxidation is inhibited by iron chelation by DTPA and by scavenging of lipid 
peroxides by the antioxidant Trolox. The effect of these compounds on NO 
inactivation by cerebellar slices was therefore assayed in the same manner 
as discussed in Chapter 3. Slices were stimulated with 10 pM Sper/NO, pre­
equilibrated with gassing aCSF to give a steady-state NO concentration of ~ 
200 nM NO. This is well below the EC50 of 1 pM NO (see Chapter 3) thus 
maximising the window for any inhibitory effects to be seen. Any inhibition of 
inactivation should lead to an increased penetration of the tissue by NO, and 
thus increased cGMP levels in the slice. The maximum cGMP accumulation 
was also determined by stimulation with 100 pM DEA/NO.
Incubation with DTPA or Trolox did not significantly affect cGMP and 
therefore NO levels in the slice (Fig. 4.3a; Univariate ANOVA, F  = 1.324; d.f. 
= 2, 39; p = 0.278). Equally, there was no significant difference between 
control slices and those incubated with Trolox when endogenous NO 
synthesis was stimulated with 100 pM NMDA (Fig. 4.3b; Univariate ANOVA, 
F = 0.026; d.f. = 1, 22; p = 0.874). This suggests that NO inactivation in the 
cerebellar slice preparation is not due to ongoing lipid peroxidation. Indeed, 
when accumulation of the major products of lipid peroxidation (TBARS) were 
measured, unlike dispersed cerebellar cells (Keynes et al., 2005), cerebellar 
slices did not accumulate TBARS over time (Fig. 4.3c; Univariate ANOVA on 
TBARS at 0 and 60 min; F = 1.998, d.f. = 5,92; p = 0.086). Preincubation 
with 100 pM Trolox reduces basal levels of TBARS, however, (Tukey post 
hoc test, p = 0.009) and both 100 pM Trolox and 100 pM DTPA abolish the 
increase in TBARS stimulated by 10 pM Fe2S0 4  and 10 pM
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Fig. 4.3 : Inactivation of NO in cerebellar slices is independent of lipid peroxidation.
(a) cGMP accumulation in response to no stimulation, intermediate or maximal NO 
stimulation (10 pM Sper/NO and 100 pM DEA/NO respectively), following treatment with the 
lipid peroxidation inhibitors Trolox (100 pM, light grey bars) or DTPA (100 pM, dark grey 
bars) Control slices represented by white bars. Data represents mean ± S.E.M. n = 4 -  9.
(b) cGMP accumulation following treatment with NMDA or DEA/NO (100 pM) in control 
(white bars) and Trolox-treated (100 pM; light grey bars) slices. Data represents mean ± 
S.E.M. n = 4 -5 .
(c) Accumulation of TBARS in control cerebellar slices (white bars) and those preincubated 
with 100 pM Trolox (light grey bars) and 100 pM DTPA (dark grey bars), following 60 min 
incubation with 10 each of Fe2S04 and ascorbate. Data represents mean ± S.E.M, n = IQ- 
14.
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ascorbate (Control: significant increase in TBARS on incubation with Fe/Asc; 
Student’s t-test, t = -3.406; d.f. = 25; p = 0.003; Trolox: no increase in TBARS 
with Fe/Asc, t = -0.396; d.f. = 29; p = 0.695; DTPA: no increase in TBARS 
with Fe/Asc, t = -0.952; d.f. = 28, p = 0.348).
4.3.2 NO inactivation by cerebellar slices is not due to RBC, O2' or 
autoxidation
Slices do not, therefore, inactivate NO via the same mechanism as observed 
in dispersed cells and homogenate, so it becomes important to ascertain 
whether other established routes for NO breakdown are involved. Any 
contribution of the reaction of NO with O2' to form ONOO" or with oxyHb in 
circulating RBC was tested by incubating slices with 1000 U/ml SOD or 200 
pM of the cell-permeable SOD analogue, Mn(lll)tetrakis(4-Benzoic 
acid)porphyrin (MnTBAP) and by reducing the number of contaminant RBC 
by intracardial perfusion of the rats before decapitation and removal of the 
cerebellum.
MnTBAP significantly increased the accumulation of cGMP in the slices (Fig. 
4.4a; Univariate ANOVA with Tukey’s HSD post hoc tests: F  = 3.688; d.f. = 3, 
46; p = 0.018), suggesting a small contribution of intra- rather than 
extracellular O2*". Measuring the NO concentration generated by 10 pM 
Sper/NO in the presence of 200 pM MnTBAP revealed, however, that the NO 
concentration generated is dramatically increased compared to control (Fig. 
4.4b). Rather than reach a plateau at around 200 nM NO, the level rises to 
more than 500 nM before gradually falling, suggesting that MnTBAP may 
have increased the rate of release of NO from the donor, with a consequent 
decrease in the donor’s half-life. To determine whether it would be possible 
to use a lower concentration of MnTBAP that would not affect the NO 
release, the 02_ -generating properties of 25 mM Hepes buffer were exploited 
(Keynes et al., 2003). In the absence of SOD, the 02*' generated by the 
Hepes reacts with NO released from the donor (in this case 100 pM 
DETA/NO) and forms ONOO', thus decreasing the NO concentration 
present. The efficacy of different concentrations of MnTBAP at scavenging
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Fig 4.4 : 0 2", RBC or accelerated autoxidation cannot account for the inactivation of NO 
seen in slices.
(a) cGMP accumulation in response to 10 pM Sper/NO or 100 pM DEA/NO following 
incubation with 200 pM MnTBAP, 1000 U/ml SOD or following intracardial perfusion of rats 
prior to slice preparation. (Data represents mean ± SEM ; n = 3 -8 ) .
(b) NO generated from 10 pM Sper/NO in gassed aCSF in the presence of 200 pM MnTBAP 
(black symbols) and in control conditions (red symbols) (Data represents mean ± S.D., n = 
2).
(c) NO produced by 100 pM DETA/NO in 25 mM HEPES (red and black symbols) and 20 
mM Tris (blue line, solid: experimental data; dashes: extrapolated), due the reaction of NO 
with 0 2‘ generated by HEPES (Keynes et a/., 2003).
(d) Plotting cGMP accumulation in the presence of 200 pM MnTBAP (data from a) against 
the NO concentration present reveals that the data falls on the NO-cGMP concentration- 
response relationship previously observed.
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this O2*' can be gauged by comparing the NO level reached to that in the 
presence of SOD or in Tris buffer, which does not generate 02*’ (Fig. 4.4c). 
MnTBAP at 20 pM increases donor release to a small extent, but subsequent 
addition of 1000 U/ml SOD further increases the NO level to that seen in 
Tris. 20 pM MnTBAP is therefore a poor O2" scavenger. In the presence of 
200 pM MnTBAP, there is no additional benefit of adding SOD, indicating 
that it is a better O2” scavenger, but it increases the NO release dramatically, 
as seen previously in gassing aCSF. It is therefore not possible to use a 
concentration of MnTBAP that will both effectively scavenge 0 2 “ and not 
affect NO release from the donor. The normalised cGMP generated in the 
presence of MnTBAP can, however, be plotted against the actual NO 
present, as measured in figure 4.4b. This reveals that the MnTBAP data falls 
on the NO-cGMP concentration response curve determined in Chapter 3 
(Fig. 4.4d). Intracellular O2*' production does not, therefore, appear to 
contribute to NO inactivation in cerebellar slices.
Another known mechanism by which NO is broken down is by autoxidation. 
While this reaction is thought to be too slow to be relevant at physiological 
NO concentrations, it has been shown to be thirteen-fold “accelerated” in 
physiological levels of biological membranes, due to the increased solubility 
of NO in the hydrophobic phase (Liu et al., 1998b). The presence of 
membranes in the slice, combined with the supra-physiological NO 
concentrations applied in these experiments, could potentially sufficiently 
increase the rate of autoxidation to account for the NO inactivation seen in 
slices. To test this, the Michaelis-Menten inactivation kinetics in equation 3.4 
were replaced with autoxidation kinetics and the resulting equation (Eq. 4.1) 
was numerically solved in the same manner as in Chapter 2 to generate a 
predicted NO-cGMP concentration-response curve.
d [ / V O ]  = D a 2 [ A / 0 ] _ ^ [ 0 2 ] [ A / 0 ] 2  E q 4 i
dt dx-
O2 was assumed to be the same concentration throughout the slice as found 
in gassing aCSF (1 mM; Vanderkooi et al., 1991) While not accurate, this
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overestimates the rate of autoxidation and therefore any contribution of 
autoxidation to observed inactivation. At 37 °C, the rate constant for 
autoxidation (k) in buffer is 13.6 x 106 M 'V 1 (Schmidt et al., 1997), which 
was multiplied by 13 to model the accelerated autoxidation expected due to 
the presence of hydrophobic compartments. There is no difference 
between the curves generated with normal and accelerated autoxidation 
(Fig. 4.5) and both fall well to the left of the concentration-response curve 
seen in slices. Autoxidation cannot, therefore, account for NO inactivation in 
the slices.
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Fig. 4.5 : NO inactivation in cerebellar slices cannot be accounted for by autoxidation, even 
when it is accelerated in hydrophobic membranes. Experimental data (solid symbols, see 
Fig. 3.11) lies far to the right of the predicted curves were NO broken down by autoxidation 
(solid line) or accelerated autoxidation due to accumulation of NO in hydrophobic 
membranes (blue dots).
The avid inactivation demonstrated by rat cerebellar slices cannot, therefore, 
be accounted for by lipid peroxidation, RBC contamination, reaction with O2" 
or autoxidation.
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4.3.3 Cerebellar cell suspensions also demonstrate lipid peroxidation- 
independent NO inactivation
It is curious why such a phenomenon should exist in an intact preparation but 
not in dispersed preparations, where following saturation of the lipid 
peroxidation- or RBC-dependent components, NO levels rise and rapid NO 
consumption is not apparent (Fig. 4.2). In a sealed chamber, however, cell 
suspensions are subject to continually decreasing O2 levels, due to cellular 
respiration. At the cell concentration used in the experiments in both figure
4.2 and the following figure (Fig. 4.6; 20 x 106 cells/ml), this corresponds to a 
rate of consumption of -  5 pM/min (Griffiths & Garthwaite, 2001). 
Maintaining O2 in cerebellar cells at air-equilibrated levels (185 pM; Schmidt 
et al., 1997) by removing the top of the chamber, however, dramatically 
alters the profile of NO accumulation in response to DETA/NO (100 or 250 
pM; Fig. 4.6a). In the presence of inhibitors of lipid peroxidation (in this 
case 100 pM Trolox), addition of DETA/NO to cells in a sealed chamber 
produces an initial shoulder, presumably due to RBC contamination, after 
which the NO levels rise. When the chamber is open, however, following the 
RBC phase, NO levels remain low and no apparent saturation occurs. This 
second phase of NO inactivation is also apparent when lipid peroxidation 
inhibitors are absent (Fig. 4.6b), though the time taken to reach this second 
plateau is increased.
Incubation with the cell-permeable iron chelator, deferoxamine, had no effect 
on the air-equilibrated profiles, indicating that there is no contribution of 
intracellular free iron-mediated reactions (e.g. lipid peroxidation, OH* 
production). Similarly, conducting the experiment in the dark neither 
increased nor decreased the inactivation activity as might be expected were, 
respectively, photo-labile NO-transition metal complexes (Hoffman & Gibson, 
1978; Wever et al., 1985) or light-generated free radicals (Tyrrell & Keyse, 
1990) involved (Fig. 4.6c). All experiments with dispersed preparations are 
routinely conducted in the presence of 1000 U/ml SOD, so reaction with 0 2 “ 
is unlikely. At this concentration, SOD is well able to compete with NO for
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Fig. 4.6: Lipid peroxidation-independent inactivation of NO also occurs in a cerebellar cell 
suspension.
(a) NO accumulation in cerebellar cells in a sealed chamber in response to 100 pM (open 
symbols) or 250 pM (closed symbols) DETA/NO in the presence of 100 pM Trolox (mean ± 
S.E.M., n = 3).
(b) The NO plateau reached after application of 250 pM DETA/NO to cells in an open 
chamber is the same in the presence of 100 pM Trolox as that eventually reached in cells 
without Trolox (representative data of three independent experiments).
(c) NO accumulation in response to 250 pM DETA/NO (mean ± S.D., n = 2 -  3) is identical 
to control (open circles) when the experiment is carried out in the presence of the 
intracellular iron-chelator, deferoxamine (open triangles) or in the dark (open squares). 
Accumulation in buffer is shown in solid circles.
(d) Accumulation of NO on application of 100 pM DETA/NO to RBC at 0.1 (red symbols), 
0.2 (blue symbols), 0.4 (green symbols) or 0.8 (maroon symbols) x 106 cells/ml in an open 
chamber, in the presence of Trolox (100 pM). The numbers by each trace denote the 
equivalent percentage of a 20 x 106 cells/ml suspension to which this RBC concentration 
relates. Data are representative of three independent experiments.
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reaction with O2" as when HEPES is used to artificially increase O2" 
production, 1000 U/ml SOD is able to scavenge 02*’ and prevent it from 
reacting with NO, allowing NO levels to reach the same levels as observed in 
the absence of (V'-generation (Fig. 4.4). It seems, therefore, that a lipid 
peroxidation-independent inactivation mechanism is present in dispersed 
cerebellar cells, but that it is 0 2 -dependent, such that lowering the 0 2 - 
concentration by cellular consumption decreases the activity. RBC are 
clearly still present, however. Initially, NO breakdown via reaction with the 
oxyHb contained in the RBC predominates when the chamber is open or 
closed. This activity saturates, however, revealing the 0 2 -sensitive 
inactivation mechanism. Any contribution of RBC to this second phase must 
also be assessed. Addition of 100 pM DETA/NO to different concentrations 
of RBC in an open chamber reveals that following saturation of the initial 
phase, NO rises to a level that is substantially different from buffer, at 
numbers of RBC which contaminate the cerebellar cell preparation (1.6 %: 
Fig. 4.2d; Fig. 4.6d). This second phase of inactivation by RBC is 
substantially less active than that seen in the cerebellar cell suspension, 
suggesting there is a significant contribution to NO inactivation of brain 
tissue. RBC contamination does, however, clearly confound further 
interpretation of the kinetics and character of this brain tissue-mediated 
component of NO inactivation.
4.3.4 Lipid peroxidation-independent NO inactivation is also present in 
whole brain homogenate
When NO accumulation in whole brain homogenate at 1 mg/ml is studied in 
the presence of inhibitors of lipid peroxidation, it too is less than observed in 
buffer, indicating that there may also be a lipid peroxidation-independent NO 
inactivation mechanism in homogenate (Fig. 4.7a). The inactivation is 
inhibited by protease K digestion (6.5 U/ml for 2 hours; Fig. 4.7b) and 
following centrifugation at 100 000 g for 1 hour, is present in the cytosolic, 
rather than membrane, fraction (Fig.4.6c). When this cytosolic fraction is 
spun through a 10 kDa filter (3000 g\ Centriplus® YM-10, Millipore UK Ltd., 
Watford, UK), the inactivation activity remains in the retentate, indicating that
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inactivation in homogenate is dependent on a cytosolic protein that is greater 
than 10 kDa in size (Fig. 4.7c).
0 10 20 
Time (min)
0 5 10
Time (min)
Fig. 4.7: Lipid peroxidation-independent inactivation is present in whole-brain homogenate, 
but can be accounted for by contaminant Hb.
(a) On addition of 100 pM DETA/NO, NO accumulation is less in 1 mg/ml whole brain 
homogenate (red symbols) than in buffer (black symbols).
(b) NO accumulation on addition of 100 pM DETA/NO to buffer (black symbols), buffer plus 
proteinase K (grey symbols), homogenate (red symbols), homogenate incubated at 37°C for 
2 hours, with (blue symbols) or without (maroon symbols) proteinase K. (Inset: proteinase K 
for 2 hours at 37°C digests the majority of the protein in the homogenate (D) compared to 
undigested protein (U). M indicates molecular weight markers.)
(c) NO profiles on addition of 100 pM DETA/NO to buffer (black symbols), 1 mg/ml 
homogenate (purple symbols), the resuspended pellet (maroon symbols) and supernatant 
(blue symbols) following centrifugation at 100000 g for 1 hour, and filtrate (green symbols) 
and retentate (red symbols) following 10 kDa filtration of the pellet.
(d) Profiles of NO accumulation following addition of 100 pM DETA/NO to buffer (black 
symbols), 1 mg/ml homogenate (blue symbols), 10 kDa retentate (green symbols) and 0.13 
(red symbols) and 0.26 (maroon symbols) pM Hb.
All data represent mean ± S.E.M, n = 4.
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It becomes apparent from examination of figure 4.7, however, that the 
greatest amount of inactivation always occurs in conditions that also 
demonstrate a substantial lag before NO rises and eventually forms a 
plateau. This lag phase is characteristic of the rapid reaction of NO with free 
oxyHb. Indeed, when the concentration of Hb in retentate and homogenate 
was measured (0.13 and 0.26 pM Hb, respectively) and NO accumulation 
assayed in the presence of these concentrations, Hb alone accounted for all 
the activity seen in both retentate and homogenate (Fig. 4.7d). The lipid 
peroxidation-dependent inactivation observed in whole brain homogenate is 
therefore solely due to reaction of NO with Hb.
4.3.5 Studying lipid peroxidation-independent NO consumption in a 
Hb-free preparation
The confounding effects on NO inactivation caused by contaminant Hb 
clearly overly complicate interpretation of studies in the cerebellar cell 
suspension and whole brain homogenate. Further investigation was 
therefore carried out on suspensions of cultured mixed cerebellar glia.
Immunocytochemistry was conducted to determine the cellular makeup of 
the mixed glia preparation. Cells were stained with the astrocytic markers 
GFAP and S100 (Fig. 4.8a, d & e), the neuronal marker MAP2 and the 
microglial marker 0X42. Counts of MAP2- and OX42-positive cells revealed 
them to be present at 7.2 ± 3.1 and 16.0 + 3.1 % of the total cells (Fig. 4.8h, 
n = 6 -  7). The astrocytic marker GFAP stained a proportion of the cells 
strongly but was present at lower levels in apparently all of the cells present 
(Fig. 4.8d compared to c). Varying GFAP expression levels have been 
previously reported in mammalian astrocytes, depending on developmental 
stage, brain area and subtype (Kalman, 2002; Walz, 2000). The percentage 
of GFAP-positive cells could not be determined due to their confluence, as 
no GFAP-negative cells could be observed, though other cell types were 
clearly present, from the MAP2 and OX-42 staining. Suffice it to say that by
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far the majority of the cells present are astrocytic (~ 80% if all the OX-42- and 
MAP2- negative cells are astrocytes).
As mentioned above, studies on acute cerebellar cell suspensions were 
conducted at 20 million cells/ml, equivalent of 1.25 mg protein/ml (Keynes et 
al., 2005). Initial indications were that at 3 million mixed glia/ml, the protein 
concentration was -  1 mg/ml, so further experiments were conducted at this 
concentration. Subsequently the corresponding protein concentration was 
found to be 1.12 ± 0.07 mg/ml (n = 7). Suspensions of mixed glia at this 
protein concentration are biochemically functional, as determined by cGMP- 
accumulation in response to stimulation of the particulate GC and NO- 
stimulated GC receptor systems by 1 pM atrial natriuretic peptide (ANP) and 
1 pM DEA/NO, respectively (Fig. 4.9a). Crucially, as well, NO-accumulation 
in an air-equilibrated mixed glial suspension on addition of 100 pM DETA/NO 
demonstrated avid NO inactivation (Fig. 4.9b). Thus cultured cerebellar 
mixed glia are a valid preparation in which to further study lipid peroxidation- 
independent NO inactivation.
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Fig. 4.8: Immunocytochemical characterisation of cerebellar mixed glial cultures. 
Representative photomicrographs of fluorescently labelled GFAP-positive cells (a) and, for 
the same field, cell nuclei (b). Peroxidase-linked immunocytochemistry showing background 
staining (c), and cells positive for GFAP (d), S100 (e), MAP2 (f) and 0X42 (g). The 
percentage of MAP2 and 0X42 positive cells per field was calculated (h; mean ± S.E.M., n = 
6 -7 ) .
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Fig. 4.9 : Mixed glial cultures respond biochemically appropriately and demonstrate lipid 
peroxidation-independent NO inactivation.
(a) cGMP accumulation following stimulation of the NO(GC) receptor with 1 pM DEA/NO 
(black symbols) and particulate GC with 1 pM ANP (red symbols). Data represent mean ± 
S.E.M., a? = 6.
(b) NO accumulation following application of 100 pM DETA/NO to buffer (black symbols) or 
a mixed glial suspension at 3 x 106 cells/ml (red symbols). Data represent mean ± S.E.M., n 
= 4.
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4.4 Discussion
4.4.1 Lipid peroxidation independent inactivation of NO in cerebellar 
slices
As the NO consumption previously observed in preparations of dispersed 
brain was accounted for by lipid peroxidation, it was expected that the avid 
inactivation by intact cerebellar slices would be caused by the same 
mechanism. Inhibition of lipid peroxidation was ineffective at inhibiting 
breakdown of NO by the slices, however, whether exogenous NO was 
applied or endogenous synthesis stimulated with NMDA. As neither iron- 
chelation (with DTPA) nor peroxyl radical-scavenging (with Trolox) had any 
effect, lipid peroxidation could not be responsible for NO consumption by the 
slices, be it initiated via iron-based Fenton chemistry or another mechanism. 
In keeping with this, unlike cerebellar cell suspensions, which consume NO 
by reaction with lipid peroxyls and undergo ongoing basal lipid peroxidation 
(Keynes et al., 2004g), lipids in cerebellar slices do not basally peroxidise, as 
assessed by accumulation of TBARS. This indicates that the inactivation of 
NO by cerebellar slices proceeds by a different mechanism from that in the 
dispersed preparations previously studied. Lipid peroxidation is a feature of 
several neurodegenerative disease states (Moosmann & Behl, 2002) and as 
such is of considerable pathophysiological relevance, but is likely to be of 
less importance to physiological NO signalling. As inactivation in slices is not 
due to lipid peroxidation, the possibility remains that the dynamics of the 
process may influence physiological signalling as assessed in Chapter 3. 
Obviously, though, the identity of the underlying mechanism must be 
discovered to determine the extent of its relevance to physiology and, 
indeed, pathophysiology.
Contaminant RBC could conceivably be present within the cerebellar slices 
and could, therefore, be contributing to breakdown of NO. Perfusion of the 
rats prior to removal of the cerebellum had no effect on the cGMP produced 
in the tissue, indicating that RBC are not present in sufficient numbers to
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affect the extent of NO inactivation. Another established route for NO 
breakdown, as discussed previously, is via autoxidation, which is apparently 
accelerated in the presence of biological membranes, due to the increased 
solubility of NO and O2 in hydrophobic environments (Liu et al., 1998b). 
Even accelerated autoxidation was much too slow to account for the avid 
breakdown observed in slices, however, according to predicted curves 
generated from the model used in Chapter 3. Extracellular O2" production 
and reaction with NO is not involved, as assayed by incubation with SOD. 
The cell permeable SOD mimetic MnTBAP initially appeared to reduce the 
degree of inactivation in the slices, indicating NO may be partially broken 
down by reaction with intracellular O2". Measurement of the NO profile in 
response to 100 pM DETA/NO revealed that at concentrations of 20 pM and 
above, MnTBAP radically increased the amount of NO generated from the 
donor. The cGMP generated in the cerebellar slice in the presence of 
MnTBAP was the same as that expected with this higher concentration of 
NO, thus there was no effect of scavenging intracellular 0 2 “ on NO 
inactivation.
The effect of MnTBAP on the donor release is of cautionary value, however. 
MnTBAP is a manganese (III) porphyrin (Fig. 4.10) that has been shown to 
protect endothelial cells from paraquat-induced damage with an EC50 of ~40 
pM (Day et al., 1995), and as such the concentrations used are often within 
the range found to affect NO release from DETA/NO. If MnTBAP is used 
with DETA/NO (and possibly other NONOates), then effects attributed to O2” 
-scavenging may instead be due to the increased NO concentration. 
Measuring the NO delivered in any given set of experimental conditions is 
therefore critical for accurate interpretation of data.
M ir
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Fig. 4.10: The structure of the metalloporphyrin ring and side chains of MnTBAP.
138
Chapter 4: Lipid peroxidation-independent inactivation of NO in brain tissue
4.4.2 Lipid peroxidation-independent inactivation of NO in dispersed 
preparations
Previously it seemed that all the NO consumption by dispersed cerebellar 
cells was due to lipid peroxidation and contaminant RBC. Here it was shown 
that, when exposed to high (air-equilibrated) O2 levels, dispersed cells are 
able to inactivate NO by a mechanism that is independent of lipid 
peroxidation. Saturation of lipid peroxidation-dependent NO consumption in 
air-equilibrated cells in the absence of inhibitors also reveals a similarly 
active process. This suggests that inhibition of lipid peroxidation merely 
unmasks a process that is present in cerebellar cells, independently of the 
degree to which lipid peroxidation has proceeded. Further studies in this 
preparation ruled out intracellular lipid peroxidation and reaction with light­
generated species that would not be present in the intact brain.
The presence of contaminant RBC in the cell suspensions is apparent from 
the initial shoulder in the NO profile following addition of DETA/NO. Studies 
on RBC alone revealed that after this initial component saturates some 
consumption of NO remains. At a typical concentration of 1 % RBC (Keynes 
et al., 2005), NO is held at 160 nM, compared to 260 nM in buffer and 20 nM 
in cerebellar cells. Clearly, the inactivation in cerebellar cells is not wholly 
accounted for by this second phase of consumption by RBC, but the 
presence of another process will necessarily complicate interpretation of 
experiments into the kinetics or identity of the breakdown mechanism in 
neural tissue.
A similar problem was experienced in studies in homogenate. Treatment 
with lipid peroxidation inhibitors also unmasked a lipid peroxidation- 
independent component of NO inactivation, which was subsequently 
accounted for by contaminant free Hb. Like in intact RBC, addition of 
DETA/NO to free Hb generates a profile whereby there is an initial phase of 
rapid NO consumption, which saturates and NO levels rise. Rather than 
return to buffer levels, however, there is some residual consumption of NO. 
As discussed in Chapter 1, NO binds at almost diffusion-limited rates to
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oxyHb (3.4 x 107 M'1s'1; Eich et al., 1996), oxidising Hb to metHb and 
producing NO3". Binding to deoxyHb is similarly fast (2.2 x 107 M'1s'1; Eich et 
al., 1996). In profiles of NO accumulation on addition of DETA/NO, this rapid 
consumption equates to the period during which NO is held at near zero 
following donor addition (Fig. 4.7d). When the NO level begins to rise, all the 
oxyHb must have been converted to metHb, or the rate of NO consumption 
would still be rapid. The residual consumption is therefore due to reaction 
with metHb. The rate constant for residual NO consumption can be 
calculated from the NO plateau heights. The rate of consumption equals the 
rate of release from the donor, minus the predicted rate of autoxidation at 
this NO concentration. Dividing by the Hb and NO concentrations present 
yields a rate constant of 2.2 ±1.7 x 104 M"1s‘\  which is similar to that for NO 
binding to metHb (1.0 x 104 M‘1s'1; Eich et al., 1996). Inactivation of NO by 
metHb could either be due to reversible binding of NO to metHb or to 
reductive nitrosylation of NO with metHb, forming nitrosylated (ferrous) 
deoxyHb (Han et al., 2002; Han et al., 2004). Reductive nitrosylation has 
been predominantly observed with bolus additions of very high NO 
concentrations (up to 100 pM) and is not thought to occur with lower, 
homogenous applications such as those achieved with donors (Han et al., 
2002). The concentrations of Hb used previously were also very high, 
however, (6-20 mM, versus 0.13-0.27 pM here) and used oxyHb, which must 
be first converted to metHb by reaction with NO for reductive nitrosylation to 
occur. It is unclear whether in the situation here, where all oxyHb has been 
converted to metHb, but yet NO release is ongoing, reductive nitrosylation 
will contribute to the residual NO consumption. Indeed, at least when NO 
binds to metmyoglobin (metMb), there is partial charge transfer between NO 
and the ferric iron, leading to a nitrosyl product with Fe2+-NO+ character 
(Wanat et al., 2002). This suggests that the process of reductive 
nitrosylation is partially ongoing even when NO binding is reversible and both 
processes may well be occurring concurrently. RBC also demonstrate a 
second phase of NO consumption on saturation of the, presumably oxyHb- 
mediated, first plateau. This could be due to the same processes as seen in
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free Hb, and also potentially to reduction of metHb to oxyHb by 
methaemoglobin reductase (Jaffe, 1964).
NO inactivation by both ferrous and ferric Hb in homogenates and also in cell 
suspensions severely confounds interpretation of the properties and kinetics 
of NO breakdown by neural tissue. Hb was therefore eliminated by use of 
cultured cerebellar glia. The glial preparation was predominantly astrocytic 
and was biochemically functional with respect to both the NO-cGMP 
signalling pathway and the ANP-activated particulate GC/cGMP pathway, as 
stimulation with either DEA/NO or ANP resulted in levels of cGMP that tallied 
with published data (Baltrons et al., 1997; Bellamy et al., 2000). As with 
acutely prepared cerebellar cells, the glial preparation also demonstrated 
considerable inactivation of NO when maintained at air-equilibrated 02, 
without the characteristic RBC “shoulder” apparent in the acute cell 
experiments. In these studies, cells were incubated with the lipid 
peroxidation inhibitor and iron chelator, DTPA, though in fact, other 
experiments have demonstrated that cultured mixed glia do not inactivate 
NO via lipid peroxidative mechanisms, possibly due to depletion of 
intracellular ascorbate (Keynes et al., 2005). In addition to the predominantly 
neural acute cerebellar preparation, then, glia are also able to inactivate NO 
in a lipid peroxidation-independent manner. As such, they represent a valid 
RBC/Hb-free preparation for further investigation into this mechanism.
In conclusion, the avid inactivation of NO by cerebellar slices is independent 
of lipid peroxidative processes which account for the previously published 
phenomenon in dispersed preparations. Inhibition of lipid peroxidation in 
cerebellar cell suspensions unmasks a further breakdown mechanism, 
however, which is reduced when O2 levels are allowed to fall. In acutely 
prepared cell suspensions and homogenates, this process is confounded by 
contaminant Hb, but this problem can be overcome by the use of cultured 
mixed glia, which also inactivate NO. Further characterisation of the 0 2 - 
dependence and kinetics and also the identity of this process are required to 
evaluate its relevance for in vivo NO signalling.
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5.1 Introduction
Rat cerebellar slices and suspensions of cells consume NO in a manner 
independent of ongoing lipid peroxidation. In cells, at least, this process 
appears to depend on the ambient O2 concentration as, in a sealed chamber, 
when the O2 level drops due to consumption by the cells, the mechanism is 
severely attenuated. This raises the possibility that NO inactivation may be 
insignificant at physiological levels of O2. If this is the case, much in vitro 
work, carried out in air-equilibrated (and thus hyperoxic) conditions, will 
severely underestimate the level of NO present. Physiological NO signalling 
will also be changed depending on the 0 2 -dependence of NO inactivation 
kinetics. nNOS is particularly sensitive to the O2 concentration (Km -  400 
pM; Abu-Soud et al., 1996) such that the rate of NO production will be 
modulated by the O2 tension at the site of synthesis. The relative 0 2 - 
dependence of NO breakdown will therefore determine the balance between 
synthesis and breakdown at a given 0 2 concentration and will therefore be 
critical in determining the properties of endogenous NO signals.
Kinetic characterisation of lipid peroxidation-independent NO inactivation and 
its 0 2 -dependence is therefore required to assess its impact on both 
physiological NO signalling and pathophysiological events.
In Chapter 3, the kinetic parameters of the inactivation pathway in slices 
were estimated using a model of diffusion and inactivation of NO, suggesting 
that the maximal rate of inactivation was at least 1 pM/s. The model 
assumed that the inactivation kinetics would be essentially the same as 
those previously observed in dispersed preparations, i.e. they would be 
Michaelis-Menten in character, with a half-maximal inactivation rate at 67 nM 
NO. As demonstrated in Chapter 4, however, the breakdown mechanism in 
slices is not the same as that previously observed in cell suspensions and 
homogenates, being independent of ongoing lipid peroxidation. The 
assumption that the mechanism in slices will behave according to Michaelis- 
Menten kinetics, with a Km of 67 nM is therefore invalid. In addition, O2
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consumption by the tissue will generate a gradient of O2 as well as NO 
across the slice, such that the rate of any 0 2 -dependent consumption 
process will vary according to this O2 gradient as well as the NO 
concentration present at any given position in the slice.
It is simplest to determine the kinetic characteristics of the NO consumption 
mechanism in a homogenous preparation, in this case a suspension of 
mixed glia, where the NO and O2 concentrations are the same throughout 
the preparation. Application of different concentrations of NO donors 
exposes cells to a variety of different release rates. When a steady NO 
plateau is achieved, the NO consumption rate equals that of release from the 
donor, so the NO concentration and the rate of consumption can be plotted 
against each other and the kinetic characteristics of the breakdown 
determined. Once the additional effect of NO breakdown via autoxidation is 
accounted for, the shape of this rate vs. concentration plot will indicate 
whether the consumption reaction is 1st order (if it is linear), 2nd order 
(quadratic) or Michaelis-Menten (hyperbolic) with respect to NO and allow 
determination of the relevant kinetic parameters. By altering the O2 
concentration, the manner in which these parameters change with relation to 
O2 can also be calculated.
The kinetic parameters thus determined can then be applied to the diffusion 
and inactivation model used for slices, and the best fit of the data achieved in 
Chapter 3 determined. The consumption of NO by slices is assumed to give 
a better indication of the likely in vivo kinetics of the mechanism than 
parameters directly derived in cells, as slices more resemble the connectivity 
and tissue structure present in the living animal. The physiological effects of 
slice kinetics can then be assessed in the models of physiological signalling 
used in Chapter 3.
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5.2 Materials and Methods
5.2.1 O2 detection
O2 was detected using a Clark-type electrode (Rank Brothers, Cambridge, 
UK) incorporated into the base of the chamber used for NO measurements 
(Fig. 5.1). Briefly, O2 diffuses through a Teflon membrane at the base of the 
chamber to reach the platinum working electrode, which is held at -0.6 V 
relative to the silver reference electrode. Any O2 reaching the working 
electrode is reduced, gaining 4 electrons, and current flows through the 
circuit, being conducted between the two electrodes by means of a piece of 
tissue saturated with 3 M KCI. At the reference electrode, silver is oxidised 
to silver chloride. The current flowing through the circuit is linearly related to 
the concentration of O2 in the solution.
Calibration of the electrode was achieved by addition of excess sodium 
dithionite, to remove all O2 from the chamber. The resulting current reading 
gives the zero value, while the current in the presence of air equilibrated 
buffer was taken as being 185 pM O2 (Schmidt et al., 1997).
The O2 level of solutions was manipulated, initially enzymatically, using 1 
U/ml ascorbate oxidase (AO) and 1 mM ascorbate or 4 U/ml glucose oxidase 
(GO) and 5 mM glucose. When this method proved problematic (see 
Section 5.3), O2 concentrations were instead altered by gassing across the 
top of the open chamber with various gases, following humidification. To 
decrease the O2 level, O2 was displaced by gassing with 100 % argon. 
When an appropriate current was reached, the gas was removed, the 
chamber sealed and the NO probe introduced. To raise O2, the solutions 
were gassed with 100 % O2 throughout the experiment. Because it was 
necessary to calibrate each O2 trace after the experiment (see Chapter 5.2), 
and as the calibration of the electrode was highly variable over a day, 
repeats of the experiment at equal lowered O2 concentrations were not 
possible and data at sub-air-equilibrated O2 instead represent only n = 1.
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Plunger 
Locking ring 
O” ring
Incubation chamber 
“O” ring
Teflon membrane
Reference electrode 
Electrode base 
Connecting lead
Working electrode 
Clamping screw
Fig 5.1 : The chamber used for 0 2 and NO measurements, showing the Clark-type 0 2 - 
electrode (figure based on www.rankbrothers.co.uk).
5.2.2 Modelling
Mathematical modelling was conducted using MathCad 2000i Professional 
(Mathsoft Engineering and Education, Inc., Bagshot, U.K.) and MATLAB 6.5 
(The Mathworks Inc., Natick, MA).
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5.3 Results
5.3.1 Controlling O2 concentrations
Firstly I aimed to modulate the O2 level enzymatically, using one of two 
systems, illustrated below (equations 5.1 and 5.2), where AO is ascorbate 
oxidase and GO is glucose oxidase.
2 L-ascorbate+02 — ^ —>2 dehydroasoorbate+2 H 20  Eq. 5.1
glucose+ 0 2 — >d -  glucono - 1,5 -  lactone + H 20 2 Eq. 5.2
In both cases, the enzymatic degradation of the substrate consumes 02, 
such that the concentration of O2 in the solution decreases and can be used 
to nearly eliminate O2 (Banks & Kerwin, 2004; Englander et al., 1987; 
Griffiths et al., 2002; Lo et al., 1996). As the amount of 0 2 -consumption is 
directly related to the amount of enzyme and substrate present (see Keynes 
et al., 2005; Lo et al., 1996), it should also be possible to control the amount 
of O2 degraded and thus achieve a range of ambient O2 levels. 
Unfortunately, when either 1 mM ascorbate and 1 U/ml of AO, or 5 mM 
glucose and 4 U/ml GO were incubated in 25 mM Tris in an open chamber, 
the NO generated from 250 pM DETA/NO was substantially reduced (Fig. 
5.2a). This suggests that species generated in the ongoing consumptive 
reaction are able to react with NO. Indeed, both ascorbate and the ascorbyl 
radical, formed during degradation by AO readily lose electrons to free 
radicals (Rice, 2000), indicating they may well react with NO. In addition NO 
can also bind, and reduce, oxidised AO (Leeuwen et al., 1975). Similarly, 
the product of the degradation of glucose, hydrogen peroxide (H2O2), may 
also interact with NO to generate hydroxyl radicals (*OH) (Haberstroh et al., 
2002; Nappi & Vass, 1998) which themselves also react with NO (Dalloz et 
al., 1997; Xu, 2000) and -OH will also be being produced from H2O2 by iron- 
catalysed Fenton chemistry as, in these traces, DTPA was not present. 
Catalase is often added to remove H2O2 generated by the oxidation of
147
Chapter 5: Kinetics of lipid peroxidation-independent NO inactivation
glucose by GO, but as it also consumes NO (Brown, 1995b), it was not 
appropriate for use in these experiments.
Rather than enzymatic degradation of O2, solutions were degassed with 
humidified 100 % argon, reducing O2 to the appropriate level before sealing 
the chamber, or O2 was increased by gassing throughout with 100 % O2. In 
the presence of cells, ongoing O2 consumption was countered by injection of 
1-2 pi air as necessary, to maintain a stable level of 0 2 (Fig. 5.2b). In buffer 
alone, and at very low O2 in cell suspensions, when their respiration was 
slowed, there was, however, a tendency for O2 to gradually seep into the 
chamber.
0 .8 1
0 . 6 -
3  0.4
0 .2 -
0 .0 -
80 2 6■2 4
D E T A /N O
0 40 80 120
Time (min)
Fig. 5.2 : Methods of 0 2-depletion
(a) 250 |jM DETA/NO added to 20 mM Tris buffer alone (black symbols) or with 1 mM 
ascorbate and 1 U/ml ascorbate oxidase (red symbols) or 5 mM glucose and 4U/ml glucose 
oxidase (blue symbols) in an open chamber.
(b) Four sequential additions of 50 pM DETA/NO followed by 250 pM DETA/NO to a mixed 
glia suspension at 3 x 106 cells/ml (black symbols), while oxygen (blue symbols) is 
maintained at low levels.
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5.3.2 Obtaining a Rate vs. NO plot
When the O2 level was as stable as possible, repeated additions of 20 - 250 
pM DETA/NO were made such that a profile of repeated plateaux was 
formed (Fig. 5.2b). The average O2 concentration was determined by 
averaging the O2 trace over the whole duration of the NO profile. The NO 
concentration at the various concentrations of DETA/NO and O2 were
determined from the different plateau heights. By definition, during a
plateau, the NO concentration does not change. The rate of change of NO is 
therefore zero and the rate of release must equal the rate of breakdown. As 
discussed in Chapter 3, the rate of release of NO is simply a function of the 
donor concentration and half-life, and can be calculated as follows (Eq. 5.3):
= k x [DETA/ NO] Eq. 5.3
where x is the stoichiometry of NO release from DETA/NO (1.6; Griffiths & 
Garthwaite, 2001) and k is the rate constant of DETA/NO decay and equals
9.4 x 1C6 s'1 (calculated according to equation 3.2, where ti/2 = 20.5 hours at 
37°C). The rate of breakdown is therefore also given by this equation.
Plotting the rate of breakdown against the NO concentration illustrates
certain kinetic differences between cells and buffer (Fig. 5.3). In buffer (Fig. 
5.3a), the shape of the relationship suggests a quadratic function as 
expected from the second-order dependence of autoxidation on the 
concentration of NO (Ford et al., 1993; Kharitonov et al., 1994; Lewis & 
Deen, 1994; Wink et al., 1993), the gradient of which increases with 
increasing O2. In cells, however, the rate of breakdown is accelerated and 
shows distinct kinetic characteristics (Fig. 5.3b). The relationship between 
rate and NO concentration is roughly linear at high O2, but as O2 decreases, 
the plots curve over and begin to form Michaelis-Menten type profiles, before 
rising once more at higher NO levels. This suggests that at high O2, NO is 
broken down via a reaction that is first-order with respect to NO, but as the 
O2 levels decrease, and NO levels increase, the rate of breakdown by this 
mechanism can no longer increase and instead levels off to form a
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maximum. At yet higher NO levels, the rate increases once again, 
suggesting that the inactivation mechanism may have been overcome and 
autoxidation has become the dominant method of NO breakdown. To 
assess the accuracy of this hypothesis, it is vital to determine the contribution 
of autoxidation and any biological inactivation to NO breakdown in the cell 
suspension. This can be achieved by subtracting the predicted rate of NO 
breakdown via autoxidation from the observed rate for each data point, 
leaving the rate of NO breakdown by other, presumably biological, 
mechanisms.
BUFFER
c/>
0
CDi_
C
<:o■o
CD0
CO
CO
0
0L_
C
£o-O
00i_
CO
8
6
4
103
106
110
185
346
2
0
1000 1500 20000 500
NO (nM)
CELLS
400
8 185
64
6
1091484
2
0
10000 500
NO (nM)
Fig. 5.3 : The rate of NO breakdown is differently related to the 0 2 and NO concentration in 
buffer (a) and a mixed glial cell suspension (b). The NO concentrations reached following 
sequential additions of DETA/NO were plotted against the rate of release of NO from each 
DETA/NO concentration for different [02] (coloured lines show representative results; labels 
give [02] in pM; n = 1-13).
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5.3.3 Autoxidation kinetics
As discussed previously (Chapter 1), autoxidation is second order with 
respect to NO and first order with respect to O2, and thus is described by 
equation 5.4:
= k [N0]2[02]Eq. 5.4
at
where k is the rate constant for autoxidation and is 13.6 x 106 M'2s'1 at 37°C 
(Schmidt et al., 1997). Some groups, however, observe that at relatively low 
NO concentrations (low micromolar levels), autoxidation appears to follow 
first order kinetics with respect to NO (Griffiths & Garthwaite, 2001; Sharpe & 
Cooper, 1998). In our system, NO degradation in buffer also follows atypical 
autoxidation kinetics. Figure 5.4 illustrates the difference between observed 
NO profiles following addition of various NONOate donors to 20 mM Tris 
buffer at pH 7.45 and the predicted profiles based on classical autoxidation 
kinetics. In the system studied here, the NO generated by each donor is 
substantially below that predicted. To accurately extract the biological rate of 
NO inactivation from that of autoxidation, it is necessary to accurately model 
the properties of NO degradation in buffer in this system.
PR O LI/N O
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Fig. 5.4 : Predicted (blue lines) and observed (symbols) NO profiles on addition of 100 pM 
(open squares) and 250 pM (open circles) DETA/NO (a) and 1 pM PROLI/NO and DEA/NO 
(b) to Tris buffer.
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To assess whether observed autoxidation in our system is first or second 
order with respect to NO, and whether the kinetics are buffer-dependent, the 
decay phases of NO profiles generated by addition of 1 pM PROLI/NO to 
various buffers were analysed. PROLI/NO has a half-life at pH 7.4 and 37°C 
of only 1.8 seconds, such that application of PROLI/NO is equivalent of 
adding a bolus amount of authentic NO. The kinetics of NO decay in buffer 
can therefore simply be followed using the electrochemical probes, in 
conditions of constant, air-equilibrated O2.
Were the reaction first order with respect to NO, the rate would be given by:
M  = K[/VO] 
dt 1 1
where K is the rate constant k multiplied by the O2 concentration. On 
integration, where c is the constant of integration:
\nlNO] = Kt + c
If [NO]o is the initial NO concentration, then:
c = ln[A/O]0
and:
|nJW °L = K f Eq. 5.5
[AIO]0
such that a plot of ln[NO]/[NO]0 is linear, if the reaction is indeed first order. 
Figure 5.5a shows such plots for addition of 1 pM PROLI/NO to 20 mM Tris 
plus and minus SOD and 100 mM sodium phosphate buffer, plus SOD, all at 
pH 7.45 and the equivalent data for predicted PROLI/NO profiles, based on 
published autoxidation kinetics. As expected, the predicted lines are non­
linear, as autoxidation is second-order. The experimentally observed data 
are more linear than the predicted lines, but still deviate from linearity,
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indicating that observed autoxidation in our system is not first order with 
respect to NO.
Equation 5.4 can be simplified to:
d[NO] _ ^ rA#^ l2
dt
which on integration becomes:
= K [NO] Eq. 5.6
1 = K t  + c Eq. 5.7
[NO]
such that a plot of 1/[NO] is linear if the reaction is second order with respect 
to NO. While a plot of 1/[NO] vs. t is linear for predicted PROLI/NO profiles, 
observed profiles are non-linear, indicating that observed autoxidation in our 
system is not second order with respect to NO. Neither first nor second 
order plots are linear for either of the buffers used (Fig. 5.5), indicating that 
the atypical autoxidation kinetics observed here are not simply due to a 
buffer. Similarly, the absence of any effect of SOD indicates that they are 
not due to any release of 02_ and subsequent reaction with NO.
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Fig. 5.5: Observed autoxidation is neither 1st nor 2nd order with respect to NO. 1 pM 
PROLI/NO was added to either 20 mM Tris.HCI (blue lines), 20 mM Tris.HCI plus SOD 
(black lines) or 100 mM sodium phosphate (green lines). The decay phase of the NO profile 
over time (see inset for example) was plotted on a first- (a) or second-order (b) plot. Neither 
is linear, indicating that the reaction is neither 1st nor 2nd order. Plotting predicted results 
based on published autoxidation kinetics (red lines) reveals that as expected, a 2nd order plot 
is linear with a stoichiometry of NO release from PROLI/NO of both 1.2 (dashes) or 1.6 (solid 
line).
The equation describing the rate of autoxidation as observed in our system is 
therefore:
where x is the order of the reaction with respect to NO. Taking natural logs 
of both sides gives:
\nK[NO] Eq. 5.8
= \nK + x\n[NO]
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The gradient of a plot of ln(breakdown rate) vs. ln[NO] therefore gives the 
order of the reaction, while the intercept is the natural log of K (k x [O2]).
To determine the rate of breakdown at a given NO concentration from a 
PROLI/NO trace involves smoothing the trace and differentiating, then 
plotting the derivative against the NO concentration at that point (Fig. 
5.6a&b). Extracting this data from profiles of sequential addition of 
DETA/NO is described above. Example plots for the two donor types are 
shown in Figs. 5.5b&c. The apparent order of the observed autoxidation 
reaction is between 1.0 and 1.5 (Fig. 5.6d). As data obtained at air- 
equilibrated O2 was deemed more accurate, because leakage of O2 into the 
chamber over longer 0 2 -depleted traces could potentially distort the results, 
an order of 1.5 was used for further analysis. Example data obtained at 106 
pM O2 fit a 1.5th order equation better than a quadratic (2nd order) equation 
(Fig. 5.6e).
To fully describe autoxidation kinetics in our system, the rate constant for the 
reaction must be also determined. This is given by K /IO 2] and can be found 
from the gradient of a plot of K vs. [O2] or from the intercept of a In/In plot as 
described above. Using the former method, the overall rate constant for our 
observed autoxidation of 3.8 x 104 M15s'1. This is within the range of those 
calculated from the intercepts of In/In plots (min = 8.8 x 103 M15s'1, max = 3.0 
x 107 M15s'1, median = 2.9 x 105 M15s‘1, n = 17), though the error in these 
values is large, due to the inherent inaccuracy in calculating parameters from 
the intercept of In/In plots. For this reason, the former value calculated from 
direct fits of ‘Rate vs. NO’ plots was used for further calculations. This rate 
constant of 3.8 x 104 M15s‘1 and an order of reaction of 1.5 with respect to 
NO generated predicted NO profiles from the donors illustrated in Fig. 5.4 
much better than did published autoxidation kinetics (Fig. 5.7 b-d). 
Additionally, independent manipulation of autoxidation parameters within 
modelling software suggested a subjective best fit of the three donor profiles 
with very similar parameters (Fig. 5.7 a-d; rate constant of 3.0 x 104 M15s'1;
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order of reaction with respect to NO of 1.5) to those derived directly from 
experimental data.
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Fig. 5.6: Observed autoxidation appears to be 1.5th order with respect to NO. The NO 
profiles following 1 pM PROLI/NO (see Fig.5.4b) or repeated additions of DETA/NO (see 
Fig.5.2b) were analysed, (a) The decay phase of a PROLI/NO trace was smoothed and 
differentiated to find how the rate of NO breakdown changes over time, (b) The natural log 
of the rate of breakdown was plotted against the natural log of the NO concentration at that 
time, and the apparent order of the autoxidation reaction determined from a weighted-least 
squares fit of the gradient (g). Similarly, with DETA/NO profiles the rate of reaction was 
determined from the concentration of applied donor and a In-In plot constructed as in (b) to 
determine the order for the reaction (e.g. data for 103 pM 0 2: c). Mean gradients for low 
(under 40pM), medium (40-110 pM), air-equilibrated (185 pM) and high (over 200 pM) 0 2 
levels were plotted (d, n = 4-8). The order of the autoxidation reaction is approximately 1.5 
with respect to NO. Typical DETA/NO data is fitted much better with a 1.5th order fit than a 
2nd order fit (e).
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Fig. 5.7: Observed autoxidation kinetics for NO.
(a) The “1.5th” order rate constants fitted as in fig.5.5e are plotted against their respective 0 2 
concentrations. The gradient of a linear fit to this line (red line) gives the overall rate 
constant for the reaction. These autoxidation kinetics were used to model NO profiles 
generated by 100 and 250 pM DETA/NO (b), 2 pM DEA/NO (c) and 1 pM PROLI/NO (d). 
The profiles generated by this new kinetics (red lines) better fit the experimental data (black 
lines and symbols) than traditional autoxidation kinetics (blue lines). Independently varying 
the rate constant to best fit the profiles produced both theoretical profiles and a rate constant 
that were similar to that derived experimentally (a-d; green lines).
5.3.4 Kinetics of biological NO inactivation
It is now possible to accurately describe the kinetics of breakdown of NO by 
autoxidation in buffer solutions in our system. This allows the contribution of 
autoxidation to be subtracted from the rates of breakdown in the presence of 
cells, according to equation 5.9, such that the biological rates of breakdown 
can be determined.
157
Chapter 5: Kinetics of lipid peroxidation-independent NO inactivation
dNO ( \ dNO , . - x x  cfA/O.. „  * (cells) =  (cells + buffer) — —— (buffer)
dt dt Eq. 5.9
= cells + buffer) -  3.8 x 104[O2][A/O]15
The rate of biological inactivation of NO by the cells appears roughly linear 
(i.e. first-order) with respect to NO at high O2 levels. At intermediate O2 
concentrations, pronounced Michaelis-Menten-type kinetics are observed, 
while at low O2 there is very little biological inactivation (Fig. 5.8a). Due to 
the apparent Michaelis-Menten kinetics, each profile was fitted with the 
Michaelis-Menten equation (see Eqs. 3.4, 3.8 & 3.9; e.g. Fig 5.8b). The 
values of Km and Vmax over different O2 concentrations are presented in Fig. 
5.8c. At intermediate O2 levels (45-170 pM), the values for Km and Vmax are 
reasonably stable (Km = 89 ± 13 nM; Vmax = 2.7 ±1.1 nM; n = 13), while as 
O2 increases to air-equilibrated levels and above, both parameters 
dramatically increase, reflecting the increasing linearity of the relationship. 
Below 45 pM O2 both the Km and Vmax values are zero, due to the absence of 
any observed biological inactivation in these conditions.
As both the Km and Vmax abruptly change as the O2 concentration rises 
beyond 170 pM NO, I investigated the effect that these parameter changes 
would have on the rate of NO breakdown at different ambient NO 
concentrations. Different NO concentrations were substituted into the 
Michaelis-Menten and first order equations fitted to the experimental data at 
the different O2 concentrations and the relationship between the rate of 
breakdown and O2 concentration plotted for these different NO levels (Fig. 
5.9). At physiological NO concentrations and above ( 1 - 1 0 0  nM), there was 
actually very little change in the rate of decay as O2 varied, as the increased 
Vmax was compensated for by the parallel increased Km. The only differences 
in breakdown rate emerged at highly supraphysiological NO levels (300 nM - 
1 pM) where the rate of breakdown increased substantially at high O2. This 
indicates that physiologically, the NO consumption rate may not vary 
dramatically with O2 concentration (except when O2 falls below -  40 pM).
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Fig. 5.8 : Kinetics of biological inactivation in dispersed mixed glia.
(a) Subtraction of autoxidation kinetics from data in figure 5.2b gives the rate of biological 
breakdown at different [NO] and [02] (coloured labels, pM). The rate appears to be linearly 
related to [NO] at high [02] but follow Michaelis-Menten kinetics at mid-range [02].
(b) Data at each [02] were fitted with the Michaelis-Menten equation as demonstrated here 
for data at 185 pM 0 2 (filled symbols: data, red line: fit) and 148 pM 0 2 (open symbols: data; 
blue line: fit).
(c) Michaelis-Menten parameters for all [02] studied.
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Fig. 5.9 : Rate of NO breakdown at different 0 2 and NO concentrations.
5.3.5 Kinetics of NO inactivation in cerebellar slices
This kinetic characterisation can be used to predict the effect such an 
inactivation mechanism would have on shaping cGMP responses to external 
NO as was studied experimentally in cerebellar slices (see Chapter 3). Once 
more, computer modelling was used to solve equation 3.4, but the model 
incorporated the 02-dependence of the kinetic parameters. Firstly, the O2 
concentration profile was modelled across the slice (Fig. 5.10a), assuming a 
bath O2 concentration in gassed aCSF of 1 mM, a Vmax of 41 pM/s and a Km 
of 1.5 pM (McGoron et al., 1997) and a diffusion constant for O2 of 1.5 x 10'5 
cm2/s (Ganfield et al., 1970). The profile was then analysed to give the 
positions in the slice where O2 fell in the following categories:
i) over 200 pM
ii) between 180 and 200 pM
iii) between 40 and 180 pM
iv) less than 40 pM
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At different positions in the slice, different kinetic parameters were used as 
determined by the O2 concentration at that point. At the highest O2 
concentrations, as discussed above, the relationship is linear, and a fit to the 
data revealed the rate constant (K) to be 0.02933 s'1. At tissue protein levels 
(100 mg/ml; Mcllwain, 1963), this equates to 2.933 s'1. At air-equilibrated 
(180 -  200 pM) and intermediate (40 -  180 pM) O2, the Michaelis-Menten 
parameters illustrated above were used (Fig. 5.8c and text), with the Vmax 
multipled by 100 to adjust for tissue protein levels. Below 40 pM O2 no 
inactivation was entered into the model. The effects of varying K and the 
various Vmax values were investigated. The most dominant factors on the 
cGMP profiles thus generated were alterations in K and the Vmax for 
intermediate O2 concentrations. In no case, however, did such variations 
produce a reasonable fit of the experimental data (Fig. 5.10b -  e). The 
kinetic parameters for O2 consumption were generated from studies in adult 
rat and cat, so may not be relevant for juvenile rat slices. Indeed rates of O2 
consumption in rat brain are known to increase after 10 postnatal days 
(Kreisman et al., 1989; Tyler & van Harreveld, 1942). The effect of a 10-fold 
increase or decrease in maximal O2 consumption was modelled (Fig. 5.10a), 
the corresponding positions in the slice determined at which the 0 2 level 
fitted the above four categories, and the model adjusted accordingly. When 
O2 consumption was accelerated, the main factors to affect the NO-cGMP 
relationships were changes to K and the Vmax at intermediate O2 (Fig 5.11b). 
Indeed, when the experimentally-determined rate constant was multiplied by 
30, the line fitted the data for higher concentrations of NO reasonably well, 
though at lower NO levels, the data rises more steeply than does the 
predicted curve. When O2 consumption is slowed, the level never drops 
below 200 pM so, throughout the slice, kinetics are predicted to be first order 
and dictated by K. Varying K, however, produces predicted profiles that rise 
much more shallowly than the experimental data.
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Fig. 5.10: Predicted slice NO - cGMP concentration-response relationships with 0 2 -
dependent NO inactivation.
(a) Predicted 0 2 profiles across a 400 pm cerebellar slice.
(b) Predicted NO -  cGMP concentration-response relationships with 0 2-dependent kinetic 
parameters as described in the text, varying the rate constant (K), at high 0 2 concentrations. 
Solid symbols represent experimental data (see Chapter 3).
(c) As for (b) but varying the Vmax at intermediate 0 2 concentrations.
(d) As above but varying both K and the intermediate 0 2 Vmax.
(e) As above but varying K and V maxes at all 0 2 concentrations.
From left to right, lines represent multiplying the kinetic parameters by 0, 1, 2, 4, 6 and 8. 
Dotted lines represent the adjustments for the effect of donor release within the slice.
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Fig 5.11: Different 0 2 consumption rates do not lead to a better fit of the data.
(a) Predicted 0 2 profiles across a 400 pm slice if the Vmaxfor 0 2 consumption is 10 x faster 
(blue line) or slower (red line). The black line shows the original predicted profile, from Fig. 
5.8a.
(b) With accelerated 0 2-consumption, the predicted NO-cGMP concentration-response 
relationships when the rate constant for breakdown at high 0 2 concentrations and the Vmax 
for breakdown at intermediate 0 2 concentrations are altered. From left to right, the lines 
represent multiplying the kinetic parameters by 0, 2, 6, 10, 30, 50 and 100.
(c) With slower 0 2 consumption, only the rate constant for breakdown at high 0 2 is relevant. 
This is altered by multiplication by 0, 1, 2, 4, 6, 8 and 30.
Dotted lines represent the profiles after compensation for donor release within the slice.
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5.4 Discussion
In this chapter, manipulation of the O2 and NO concentrations revealed 
unorthodox kinetics of autoxidation chemistry in our system. This was 
characterised in order that the rate of NO breakdown via simple reaction with 
O2 could be subtracted from the total rate of NO breakdown in cell 
suspensions. The biological inactivation rate demonstrated first order 
kinetics with respect to NO at high 02, Michaelis-Menten kinetics at 
intermediate O2 concentrations and was absent at low O2.
5.4.1 Autoxidation
The rate equation for autoxidation has been determined by several studies, 
using a range of techniques from conductivity changes, absorbance changes 
due to accumulation of NO2' and direct electrochemical or chemiluminescent 
detection of NO (Ford et al., 1993; Kharitonov et al., 1994; Lewis & Deen, 
1994; Schmidt et al., 1997; Wink et al., 1993). It is established, therefore, 
that the reaction of NO with O2 in aqueous solutions is second order with 
respect to NO and first order with respect to O2 and has a rate constant of 
the order of 8 - 1 3  x 106 M'2s‘1.
Schmidt et al. (1997) have developed a mathematical model, based on this 
kinetics, which allows the profile of NO concentration over time to be 
estimated, following addition of a NONOate donor to buffer, when 
autoxidation is the only method by which NO is broken down. Their model 
fits their experimental data well, generating the same peak NO 
concentrations and time courses as observed following addition of different 
DEA/NO concentrations to 100 mM sodium phosphate buffer at pH 7.4 and 
both 25 and 37°C. Application of the same model to DETA/NO addition 
predicted much higher steady-state NO levels than were observed 
experimentally in our setup. This was not due to the donor used, as neither 
profiles generated by PROLI/NO nor DEA/NO, fitted predicted profiles based
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on the established autoxidation kinetics. For some reason, the kinetics of 
autoxidation is different in our system.
Further analysis of the profiles generated by both PROLI/NO and DETA/NO 
allowed characterisation of the atypical kinetics, and indicated that the order 
was intermediate between first and second order with respect to NO. The 
best fit of the experimental data was achieved with a rate equation which 
was first order with respect to O2 but 1.5th order with respect to NO and had 
a rate constant of 3.8 x 104 M'15s'1. Confidence in the accuracy of these 
parameters for autoxidation in our system stems from the fact that they were 
consistent when derived from two methods of NO delivery (PROLI/NO and 
DETA/NO), using different methods of parameter calculation (In/In plots and 
rate vs. NO plots) and over a range of O2 concentrations. They were also 
remarkably similar to those achieved by simply manually adjusting 
parameters within the model of autoxidation to achieve the best fit. Unlike 
the standard autoxidation rate equation, the rate equation determined here 
fitted experimental NO profiles generated by DETA/NO and PROLI/NO, but 
also DEA/NO, indicating that it is an accurate representation of autoxidation 
kinetics in our system.
The reason for such a difference in autoxidation kinetics between those 
found here and the established values is unclear. Previous studies too, have 
reported observed autoxidation kinetics that are less than second order with 
respect to NO (Coffey etal., 2001; Griffiths & Garthwaite, 2001; O'Donnell et 
al., 1999; O'Donnell et al., 2000; Sharpe & Cooper, 1998). Some give no 
reason for the divergent kinetics, while others cite consumption by the 
electrochemical probe used or loss of NO to the gaseous phase, a process 
that can affect apparent autoxidation kinetics (Lewis & Deen, 1994). These 
may be contributing factors, but the presence of similarly abnormal kinetics in 
both a sealed and open detection chamber (e.g. this study compared to 
(Griffiths & Garthwaite, 2001), and the use of the same electrochemical 
probe by Schmidt et al., without any alteration to kinetics, would argue 
against the importance of these two factors. Many of the earlier studies used
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much higher NO concentrations (typically 5 -  1000 pM; Kharitonov et al., 
1994) than used here (under 1 pM) to measure the autoxidation kinetics, 
leaving the possibility that the characteristics of the reaction might change at 
lower levels of NO. Similarly, these studies all used authentic NO; so it could 
be argued that use of NO donor compounds could somehow change the 
observed kinetics, perhaps by reaction with the decayed donor. Schmidt et 
al (1997), however, not only used one of the same donors that was found to 
follow atypical kinetics in our system (DEA/NO) but also used relatively low 
NO levels (770 nM and above). The NO delivery system is therefore not 
responsible for the altered kinetics. Alternatively, while a variety of buffers 
have previously been used to determine autoxidation kinetics, none has used 
Tris, as used here, indicating that a buffer artefact may be altering the 
apparent kinetics in this system. Use of 100 mM sodium phosphate, one of 
the buffers used in the above studies (Schmidt et al., 1997; Wink et al., 1993) 
had no effect on the breakdown of NO released by 1 pM PROLI/NO, 
however, showing that this is not the case. It could be argued that the use of 
an electrochemical probe could alter the apparent autoxidation kinetics if its 
response time was significantly great compared with the decay rate of NO. 
The probe response time (~ 5 s) would only be expected to affect profiles 
where NO was generated as a bolus (i.e. from PROLI/NO), and not when a 
steady-state of NO release and breakdown is established, as following 
DETA/NO application. Atypical kinetics were observed following the use of 
donors with very different half-lives and, therefore, release rates (ti/2 = 1.8 s 
for PROLI/NO; 2 min for DEA/NO and 20.5 hours for DETA/NO) so the probe 
response time must not be responsible. The fact that Schmidt et al. used the 
same type of NO electrode as was used in these experiments, further rules 
out any contribution of the electrode response time in determining the 
observed autoxidation kinetics.
Examination of other apparent differences between our and other studies 
proved similarly fruitless in providing explanations of the difference in 
kinetics. We routinely have SOD present in experiments, but its omission did 
not alter the degradation profile of NO. As mentioned in Chapter 4, 
contaminant iron can be present in buffers (Buettner & Jurkiewicz, 1996).
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NO can reversibly bind to free iron (Cooper, 1999), but the lack of an effect 
of the iron chelator DTPA on the NO profile in response to 100 pM DETA/NO 
(e.g. compare Figs. 4.7a-d and 5.4a) rules out scavenging by free iron as a 
factor in determining the autoxidation kinetics.
The reason why autoxidation kinetics is atypical in our hands remains 
unclear. While this is of some concern, the full characterisation of the 
autoxidation kinetics serves as a valid control for the kinetic analysis of the 
biological breakdown. By conducting this characterisation, we can 
accurately deduct the rate of breakdown via autoxidation from that observed 
in the presence of cells, and be confident that we are then dealing simply 
with the kinetics of biological inactivation.
5.4.2 Biological consumption of NO
Extraction of the kinetics of NO breakdown due to the presence of cells, 
revealed that consumption of NO followed apparent first order kinetics at 
high (> 200 pM) 0 2 levels, with a rate constant, extrapolated to whole tissue, 
of 2.9 s'1. As O2 decreased, however, the process became more clearly 
saturable, progressively following Michaelis-Menten kinetics, which were 
stable at intermediate O2 levels (45 -  180 pM O2; extrapolated to tissue, Vmax 
= 270 nM/s, Km = 89 nM). At low O2 levels, no biological inactivation was 
apparent. Such a triphasic profile of inactivation kinetics is suggestive of 
several ongoing consumption processes that are differently relevant at 
different O2 concentrations. Without further knowledge as to the distribution 
and individual characteristics of such hypothetical processes, the 
implications of these inactivation mechanisms to the in vivo situation are 
naturally unclear. Nevertheless, if we consider the range of O2 
concentrations that exist in the brain, some predictions can be made.
Estimates of cerebral O2 concentrations are widely variable. Partial 
pressures reported in the literature can be converted to molar 
concentrations, using Henry’s Law (equation 5.10), where kH is Henry’s 
constant, ca is the concentration in the aqueous phase and pg is the partial
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pressure in the gaseous phase and kn in standard conditions is 1.9 x 10'3 M 
atm'1 (http://www.mpch-mainz.mpg.de/ ~sander/res/ henry.html, and 
references therein).
kH = ^ -  Eq. 5.10 
Pg
Using this conversion, arterial O2 is found to be between around 110 and 220 
pM, venous O2 around 70 -  80 pM and cerebral O2 can be between 2 and 
120 pM (Erecinska & Silver, 2001; Johnston et al., 2003). Such a wide range 
of O2 tissue levels presumably reflects different rates of O2 consumption in 
different brain regions and thus different O2 gradients between blood vessels 
and tissue. In physiological situations, the endogenous sources of NO in the 
brain are nNOS and eNOS, which show different dependence on 02, the Km 
for O2 for nNOS being 350 pM while that for eNOS is only 4 pM (Stuehr et 
al., 2004). nNOS is expressed in neurons and glia, while the only cerebral 
eNOS is present in endothelial cells (see Chapter 1). As eNOS is 
expressed in conditions of reasonably stable O2 (i.e. the blood vessel wall) 
where O2 levels will consistently be well above its Km, rates of NO production 
from eNOS will not be modulated by O2. nNOS, however, will experience 
very different O2 levels depending on its location relative to blood vessels 
and the metabolic activity of its surrounding tissue, and the whole 
physiological O2 range is below its Km for O2. Rates of NO production from 
nNOS will therefore be linearly related to the O2 present.
It would seem, therefore, that it would be sensible for NO consumption to 
also be linearly related to O2. Were this the case, as the O2 falls and the rate 
of NO synthesis correspondingly slows, NO breakdown would also decrease, 
such that a given stimulus could produce the same NO signal irrespective of 
the ambient O2 concentration and, hence, location of an NO source with 
respect to a blood vessel. In the system studied here, however, NO 
production and breakdown are differently related to O2 concentration. At 
very low O2 levels, NO synthesis will be much less than in the vicinity of a 
blood vessel, where O2 is high and, according to the breakdown kinetics
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above, biological breakdown will not occur (beneath around 40 pM NO), thus 
protecting the lowered NO signals from inactivation. As the relationship 
between O2 and NO consumption is triphasic rather than linear, NO signals 
will not be normalised. With the kinetics derived here, a source at a location 
with 50 pM O2 would be disadvantaged compared to one at 120 pM O2, as 
the breakdown rate would be the same, but the rates of synthesis would be 
greater. Even at high O2, the rate of NO breakdown is still remarkably stable 
at NO concentrations considered to be within, and indeed above, the 
physiological range ( 0 - 1 0 0  nM). The finding that the rate of consumption is 
increased at both high O2 and high NO may be of physiological relevance, 
however, as at high O2, the rate of NO synthesis will be greater, and 
increased breakdown could conceivably serve to prevent NO levels rising to 
toxic levels. As discussed previously, though, it is unclear whether NO levels 
are ever likely to rise to pathologically relevant concentrations.
The rate of NO consumption is reasonably independent of O2 at 
physiological NO concentrations which, as observed above, does not allow 
NO consumption to compensate for the O2 dependence of synthesis. Jack 
Lancaster’s group have considered an additional factor affecting tissue O2 
and NO in their model of NO and O2 diffusion from a blood vessel into tissue 
(Thomas et al., 2001). If NO rises to levels sufficient to inhibit mitochondrial 
respiration, NO can inhibit O2 consumption by the tissue and therefore 
extend the O2 gradient such that tissue distant from a blood vessel becomes 
more oxygenated. Thomas et al. also observed consumption of NO (by 
hepatocytes) that was linearly related to the O2 concentration, which 
indicates that NO and O2 may both regulate each other’s consumption in 
liver, in a manner that may serve to extend both the NO and O2 gradients 
away from the source at a blood vessel (from the endothelium or RBC 
respectively). It is less clear how this extension of O2 concentration might 
work following neuronal NO synthesis, where NO reaches only around 4 nM 
(see Chapter 1) and, as such, has a minimal effect on respiration (10 % 
inhibition according to calculations in Thomas et al., 2001). It may serve to 
partially normalise NO signals, however, as if NO is able to reach levels at 
which respiration can be inhibited, O2 levels in surrounding tissue will
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increase. By reducing O2 concentration gradients across the brain, nNOS 
activity will be less dependent on physical location with respect to blood 
vessels and may be more regulated by signalling pathways. If nNOS activity 
is not so dependent on proximity to a blood vessel, then NO consumption 
does not need to linearly depend on O2 to produce equivalent NO signals 
across the brain. It should be noted, however, that this equilibration of O2 
across the brain by NO would only be effective were adjacent sources of NO 
in the tissue concurrently active, so the possibility that this is a physiological 
mechanism for normalising NO signals relies not only on NO being able to 
reach sufficient concentrations to inhibit respiration, but also on the pattern of 
NO synthesis. Clearly, several aspects of NO signalling require further 
explanation, not least the properties of NO consumption. This can hopefully 
be achieved by an understanding of the processes underlying its triphasic 
nature and their relative importance in the intact brain.
NO consumption processes in other tissues have also been shown to be 
dependent on O2, though studies vary in the way in which rates of 
consumption change with O2. The consumption process observed in CaCo- 
2 cells demonstrated Michaelis-Menten type kinetics that varied between a 
Km for O2 of 17 pM at 1 pM NO and 4 pM at 0.05 pM NO (Gardner et al., 
2001). Aortas were found to consume NO in a biphasic manner, the rate of 
which initially decreased linearly with decreasing O2 but then increased once 
more in anaerobic conditions (Liu et al., 2004). As discussed above, isolated 
hepatocytes also consume NO by a first order process (with respect to NO) 
that is linearly dependent on 0 2 , though anaerobic O2 levels were not studied 
(Thomas et al., 2001). Consumption of NO in biological membranes via 
accelerated autoxidation is second order with respect to NO, but first order 
(linear) with respect to O2 (Liu et al., 1998). As discussed above, the 
triphasic nature of the response in cultured glia is suggestive of a 
combination of different ongoing processes, to which the above processes 
may contribute. The further characterisation and identification of the 
mechanisms underlying the observed biological NO consumption is required 
to understand the kinetics and its relevance for physiological NO signalling.
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5.4.3 Modelling 02-dependent NO consumption in slices
By adapting the diffusion and inactivation model used in Chapter 3, the 
relative importance of the different phases of NO consumption (at different 
O2 levels) can be assessed and the relevance of the cell kinetics to the intact 
slice situation determined. Using published rates of O2 consumption by brain 
slices, the slice was compartmentalised based on the O2 concentration, and 
the rate of breakdown adjusted correspondingly. Adjustments to the rate at 
high, medium or low O2 then allowed the relative importance of these 
components to be assessed. Changing the maximal rate of inactivation at 
mid-range O2 or the rate constant for inactivation at high O2 had most effect 
on the predicted NO-cGMP profiles, consistent with the relative fraction of 
the slice exposed to these O2 levels (high O2 > intermediate O2 > low O2 > air
O2). Manipulating any of these rates, alone or in combination, produced 
predicted curves that were markedly dissimilar from the experimental data. 
Firstly, the experimental data fell well to the right of the predicted curve 
directly extrapolated from the kinetics of the cells, indicating that 
consumption is more avid in slices (per mg protein) than in cells. Secondly, 
even when consumption rates in the model were varied, the predicted curves 
rose much more shallowly with increased bathing NO than did the data. The 
parameters for O2 consumption in the slice were derived from experiments 
on adult rat and cat, however (Ganfield et al., 1970; McGoron et al., 1997), 
while the slices in these studies were from 8 day-old rat. As O2 consumption 
by brain is known to markedly increase between 10 and 20 post-natal days 
(Kreisman et al., 1989; Tyler & van Harreveld, 1942), the effect of decreasing 
O2 consumption, and therefore the O2 gradient across the slice, was 
investigated. The inhibition of respiration and thus O2 consumption by high 
bathing concentrations of NO will also serve to decrease the steepness of 
the O2 gradient. The effect of decreasing O2 consumption was to generate a 
high O2 concentration across the whole slice, such that inactivation was 
predicted to be first order with respect to NO throughout the tissue. The 
predicted NO-cGMP curves thus generated were very shallow, however, 
indicating that inactivation of NO in the slices is not as predicted from the 
cells’ data and also is not first order with respect to NO. Increasing O2
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consumption by the slice, did generate a better fit to the data when the rate 
constant at high O2 and the Vmax at intermediate O2 were multiplied by 30 (K 
= 87 s*1; Vmax = 123 pM/s). As there is no theoretical justification for 
increasing O2 consumption in the model, and for these manipulations of the 
kinetic parameters, no real conclusions from this fit can be made. It seems, 
therefore, that the altered model, taking into account the triphasic O2 
dependence of the cellular NO consumption process, does not well describe 
inactivation by slices. This suggests that aspects of the cellular inactivation 
characteristics are not relevant for the intact slice situation. This is not 
entirely surprising as the slice contains many more cell types than does the 
glial culture. Different levels of components with differing 0 2 -dependences 
would change the relative kinetics of breakdown in slices and the manner in 
which these kinetics change with O2 as compared to glial cells. For example, 
relatively high levels of a less 0 2 -dependent process in neurons as opposed 
to glia would alter the kinetic profile in slices compared to the glial cultures. 
Clearly, as mentioned above, further characterisation of the different 
processes underlying inactivation in cells is required to dissect out the 
relevant mechanisms for physiological NO breakdown in the intact brain.
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6.1 Introduction
Brain tissue is able to consume NO by a process that is independent of 
ongoing lipid peroxidation. In slices, this process does not to involve 
contaminant RBC, extracellular or intracellular 0 2 “ or autoxidation. The 
kinetics in cells demonstrated marked triphasic O2 dependence that did not 
extrapolate well to the inactivation process observed in slices. The triphasic 
nature of the O2 dependence is suggestive of a multi-component process, 
the nature of which must be determined to understand the relative 
importance of the observations in cells to the situation in both slices and the 
intact brain.
Aside from the findings subsequently shown to be due to lipid peroxidation, 
no one has previously reported inactivation of NO by brain tissue. Several 
papers have, however, shown NO consumption by other tissues, as 
discussed in Chapter 1. As the lipid peroxidation-dependent inactivation 
process in brain was insensitive to inhibitors of these mechanisms (Griffiths 
et al., 2002), these candidates were initially ruled out as underlying neural 
consumption of NO. Lipid peroxidatio^-independent NO consumption by 
brain may well share properties with one or more of these previously 
reported processes, however, making it necessary to revisit this literature in 
the search for the NO inactivation mechanism(s) in brain.
The main proteins already identified as being able to inactivate NO are the 
globins, (Hb and Mb, and possibly the recently identified Nb and cytoglobin), 
15- and 12/15-LOX, PGHS-1 and possibly other peroxidases and CcO. 
Recent work has demonstrated 0 2 -dependent aortic NO consumption that 
was sensitive to inhibition by cyanide and was fully mimicked by purified CcO 
(Liu et al., 2004), further evidence for the ability of CcO to consume NO. 
Additionally, a cyanide-sensitive and DPI-sensitive process suggestive of a 
flavin- and haem-containing protein metabolises NO to N0 3 - in certain cell 
lines, especially CaCo-2 cells. Since this work was begun, further work on 
this consumption process has been published (Hallstrom et al., 2004). The
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consumption activity is lost on cell permeabilisation, is fully recoverable by 
NADPH, but not NADH (20 % of activity remains with NADH) and differential 
centrifugation reveals that it is highly expressed in microsomes derived from 
endoplasmic reticulum. Additionally, it is inhibited by cytochrome c(lll) and 
anti-cytochrome P450 oxidoreductase (CYPOR) immunoglobulins 
suggesting that CYPOR is involved in NO consumption by CaCo-2 
microsomes. The authors suggest a process by which electrons are 
transferred through CYPOR to an as yet unknown haem-containing enzyme 
which metabolises NO. On the basis of inhibitor screens, this is likely to be a 
member of the cytochrome P450 family. A similar process has been 
reported in primary cultures of endothelial cells (Schmidt & Mayer, 2004). As 
in CaCo-2 cells, this process is lost on cell lysis but recovered by addition of 
NADPH and this activity localises to the membranes, in keeping with an 
endoplasmic reticular location. It is inhibited by haem poisons and the 
flavoenzyme inhibitor DPI and forms NO3' as the oxidation product of NO. 
Unlike in CaCo-2 cells, however, the consumption can also be recovered by 
addition of NADH to homogenates, and the haem and flavin inhibitors do not 
wholly obliterate NO metabolism. There are considerable similarities 
between the processes observed in endothelial and CaCo-2 cells, but they 
are by no means identical and could reflect the existence of an additional 
process in the endothelial cell lysates.
A further enzyme that is also able to consume NO has also been recently 
identified. Dihydrolipoamide dehydrogenase (DLDH) is a flavoenzyme that 
has been shown to oxidise NO to NO3' in an NADH but not NADPH- 
dependent manner (Igamberdiev et al., 2004). This activity is not inhibited by 
NaCN or DPI, which does not inhibit flavoenzymes like DLDH that transfer 
two electrons during catalysis (O'Donnell et al., 1994) but was inhibited by N- 
ethylmaleimide. DLDH is present in the brain but physiologically catalyses 
the reduction of NAD+ rather than the oxidation of NADH (Klivenyi et al., 
2004), so it is unclear whether this process will be of physiological relevance.
There are therefore multiple potential processes by which NO could be 
consumed by brain. To begin the process of identification of the
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mechanism(s) behind brain NO consumption, I attempted to draw parallels 
between previously described processes and the one observed in brain cells 
and homogenate by using pharmacological agents that affected the above 
mechanisms to try to determine the type of enzyme(s) involved (e.g. 
haem/flavin-containing), the cofactors required for its activity, its subcellular 
location and the product formed from NO metabolism. By comparison of our 
results to those achieved in other tissues, I hoped to discover the likely 
identity of the consumption process and then to determine its relevance to 
intact tissue.
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6.2 Materials and Methods
6.2.1 Tissue Preparation
Platelets and white blood cells (WBC) were prepared from adult Sprague- 
Dawley rat blood. Whole blood was collected into acid citrate dextrose 
solution (12.5%) and centrifuged at 300 g for 10 min at 20 °C. The 
supernatant of platelet-rich plasma was removed and the centrifugation 
repeated to eliminate RBC and WBC. At this stage WBC were aspirated 
from the top of the cell pellet and suspended in platelet buffer (PB; see 
below). The supernatant of platelet-rich plasma was then centrifuged for 10 
min at 2000 g at 20 °C and the platelet pellet resuspended into PB containing 
137 mM NaCI, 0.5 mM MgCI2, 0.55 mM NaH2P 04l 2.7 mM KCI, 25 mM 
Hepes and 5.6 mM glucose, pH 7.45 at 37 °C. Both platelets and WBC were 
suspended in a small volume, protein determined and then each was diluted 
to the appropriate concentration (usually 1 mg/ml). WBC were counted using 
a haemocytometer to determine the relationship between WBC count and 
protein concentration (1 mg/ml protein corresponds to 48 million WBC/ ml).
Lysates of mixed glia, platelets and WBC were prepared from the intact 
suspensions (see above and chapter 4) by freezing to -20°C, thawing and 
brief sonication. Lysis was verified visually under a light microscope.
Whole brain homogenate was prepared as described earlier. Membrane and 
cytosolic fractions from homogenates were prepared by centrifugation at 100 
000 g for 1 hour. The cytosolic supernatant was retained and membranes 
were resuspended by sonication into first incubation buffer (IB) or later Tris 
(both pH 7.45 at 37 °C).
Cerebellar slices were prepared as described in Chapter 3.2.
Cerebellar blocks were prepared by chopping 8-day old Sprague-Dawley rat 
cerebella in sagittal and parasagittal planes at 400 pm intervals with a
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Mcllwain tissue chopper. Blocks were washed into aCSF containing 1 mM 
kynurenic acid and 100 pM L-NA or IB, resuspended using a Pasteur pipette 
and allowed to recover at 37 °C in a shaking water bath for 1 hour. The 
blocks in aCSF, l-NA and kynurenic acid were then transferred to aCSF 
containing L-NA but no kynurenic acid. Immediately prior to experiments, 1.1 
ml of buffer plus tissue blocks were placed in the NO probe chamber, stirred 
vigorously to ensure that the blocks were held in suspension, and 100 pi of 
the suspension removed, sonicated and the protein concentration 
determined.
Synaptosome lysates were prepared by Sujay Mukherjee. Briefly, adult rat 
forebrains were homogenised into 0.25 M sucrose with 8 strokes of a Potter- 
Elvehjem homogeniser (Braun Melsungen, Melsungen, Germany). 
Homogenates were then centrifuged at 1000 g for 10 min and the pellet 
discarded. This supernatant was spun for a further 15 min at 46 000 g and 
the resulting supernatant discarded. The synaptosome pellet was 
resuspended in IB using 8 strokes with the Potter homogeniser. 
Synaptosomes were lysed by freezing to -20 °C, thawing and sonicating. 
The protein concentration was determined by the bicinchoninic acid method. 
Synaptosome membranes were then prepared by centrifugation of the 
lysates at 100 000 g for 1 hour. Membrane pellets were reconstituted in Tris 
buffer (pH 7.45 at 37 °C) to the appropriate concentration.
When studying cerebellar blocks, whole brain homogenate and membrane 
pellets, experiments were carried out, not only in the presence of 1000 U/ml 
SOD and 100 pM DTPA (as previously) but also 100 pM Trolox, to block any 
potential lipid peroxidation. All other experiments, except those on intact 
slices, were carried out in the presence of 100 pM DTPA and 1000 U/ml 
SOD.
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6.2.2 Determination of NOx breakdown products
Glial suspensions at different cell concentrations were prepared as described 
previously (Chapter 4). For most conditions, 0.6 ml of the suspensions were 
maintained at 37 °C in a vigorously-shaking water bath and exposed to 
repeated additions of 250 nM PROLI/NO or an equivalent volume of 100 pM 
NaOH (final concentration). 1 ml of both buffer and 15 x 106 cells/ml were 
monitored during the same stimulation on the electrochemical probes. 
Timing of the repeated PROLI/NO additions was such that the NO level in 
buffer (and therefore at all cell concentrations) remained below 0.6 pM, 
minimising any contribution of autoxidation to breakdown. After the period of 
stimulation, cells were sonicated to break down the membranes and 
centrifuged at 100 000 g for 1 hour to pellet the membrane fraction. The 
cytosolic supernatant was collected and analysed for NOx content by 
chemiluminescence.
NO2' content was determined by injection of 10 -  100 pi of sample into a 
reaction vessel containing 6 ml of 1.5 % w/v sodium iodide in glacial acetic 
acid. This reduces any NCV to NO, which is removed from the reaction 
chamber under reduced pressure in a stream of N2. To measure total NOx 
(NO2' and N 03 ), the chamber was heated to 95 °C and samples were 
injected into 0.8 -  0.9 % vanadium (III) choride in 1 N HCI. This environment 
is sufficiently reducing that N 03‘ is reduced to NO which, as for N02-, is 
removed from the chamber in a stream of N2, this time passing through a 
cooled condenser to remove any water vapour. The NO in both cases is 
then mixed with ozone and the chemiluminescent product detected with a 
photomultiplier. Concentrations were determined by comparison with 
responses generated from N02- and N 03‘ standards, prepared in IB, 
containing DTPA, SOD and NaOH at the same concentrations as in the 
experimental conditions.
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6.2.3 Hb-lysate preparation and Hb concentration determination
Haemoglobin-rich lysate (Hb-lysate) was prepared from RBC as described 
previously (Liu et al., 1998a). Blood from 8-day old Sprague-Dawley rats 
was washed into PBS (pH 7.4). RBC were pelleted by centrifugation at 2300 
g for 10 min at 4 °C and washed three times by resuspension in PBS and 
recentrifugation. After the washes, the RBC pellet was incubated for 30 min 
in a five-fold volume excess of hypotonic phosphate buffer (5 mM, pH 8) to 
lyse the cells. The Hb concentration of the lysate was estimated by 
comparison of the absorbance peak at 410 nm with that of Hb standards.
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6.3 Results
6.3.1 Cell types vary in their ability to inactivate NO
The ubiquity of the biological NO inactivation in different tissues was 
investigated using preparations of white blood cells (WBC) and platelets 
isolated from adult rat blood. The profile of NO accumulation following 
application of 100 pM DETA/NO is identical in buffer to that in suspensions of 
either WBC or platelets at 1 mg/ml (Fig. 6.1a & b). Even when the platelet 
concentration is doubled to 2 mg/ml no inactivation of NO is apparent. As 
observed previously, however, suspensions of cultured glia demonstrate 
considerable inactivation compared to platelets, WBC and buffer. This 
difference is not simply due to an effect of platelet buffer (PB) as incubating 
glia in PB rather than cell incubation buffer (IB) has no effect on the 
inactivation of NO (Fig. 6.1c). Biological NO consumption is therefore not 
ubiquitous but is restricted to certain tissues, including brain.
6.3.2 Catalytically active NOS is not required for inactivation of NO
Glial cells may express any of the three isoforms of NOS (Murphy, 2000). 
Active NOS in the glial suspensions may affect results in two ways. Firstly, 
endogenous NO production in addition to NO release from applied donor 
may serve to partially saturate an inactivation mechanism, such that on 
addition of the donor, a greater increase in the NO level is observed. 
Alternatively, as the haem domain of NOS, particularly nNOS, is able to form 
a ferrous haem-NO complex which can readily react with O2 to form N0 3 -, 
(Alderton et al., 2001; Stuehr et al., 2004) it is conceivable that NO 
inactivation in glial cells could be NOS-mediated. Inhibition of NOS catalytic 
activity with the broad-spectrum inhibitor L- nitroarginine (L-NA) had no 
significant effect on inactivation of DETA/NO-derived NO by glial 
suspensions, however (Fig. 6.2a & b; Student’s t-test; t = 0.92; d.f. = 11; p =
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0.37). Any endogenous NO release does not therefore interfere with the 
rate of NO breakdown by mixed glia in response to 250 pM DETA/NO.
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Fig. 6.1: Lipid peroxidation-independent NO inactivation is dependent on cell-type.
(a) NO accumulation in response to 100 pM DETA/NO in buffer (black symbols), glia (red 
symbols), WBC (blue symbols) and platelets (green symbols).
(b) Summary data of plateau NO reached from the experiment shown in (a), also including 
data from platelets at 2 mg/ml.
(c) NO accumulation following 100 pM DETA/NO addition to cell (red symbols) and platelet 
(black symbols) incubation buffers and glia suspended in each of these buffers.
All data represent mean ± S.E.M., n = 3.
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Neither is catalytic activity of NOS required for inactivation to occur. 
Antagonism of the L-arginine binding site, with L-NA, may not prevent 
electron transfer from NADPH to the haem, however, so it is possible that 
formation of a Fe2+-NO complex would still be possible in the presence of L- 
NA and that this could still mediate NO breakdown.
0.4
0.2 -a—  Buffer 
Cells
Cells + L-NA
0.0
0 2 4 6 8
Time (min)
0.75
n.s.
0.25
0.00
Fig 6.2 : Inactivation of NO in a cerebellar mixed glial suspension is not affected by NOS 
inhibition.
(a) Representative traces of NO accumulation to 250 pM DETA/NO in the presence and 
absence of 100 pM L-nitroarginine (l-NA).
(b) Summary data for the experiment in (a). (Data represent mean ± SEM, n = 6 -  7)
6.3.3 NO inactivation is partially cyanide sensitive
As discussed above, recent publications have reported the existence of 
cyanide- sensitive NO breakdown mechanisms in cultured human CaCo-2 
cells (Gardner et al., 2001; Hallstrom et al., 2004) cultured porcine 
endothelial cells (Schmidt & Mayer, 2004), and in rat aortas (by CcO; (Liu et 
al., 2004). Pre-incubation for 15 min with 100 pM sodium cyanide (NaCN)
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partially inhibits inactivation of DETA/NO-derived NO in mixed cerebellar glia 
(Fig. 6.3a & b; One way ANOVA with Tukey post hoc tests; cells alone are 
significantly different from cells + NaCN, p < 0.01; cells + NaCN are 
significantly different from buffer ± NaCN, p < 0.001. A one way ANOVA was 
used to demonstrate the partial nature of the inhibition. A two way univariate 
ANOVA was also conducted and demonstrated significant effects of NaCN 
and tissue; for results see table 6.1).
Effect F d.f. P
NaCN 6.74 1,12 0.023*
Tissue 157.2 1, 12 < 0.001*
NaCN * Tissue 11.0 1, 12 0.006*
Table 6.1: Results of a univariate ANOVA on data from figure 6.3b (* denotes significance at 
the 0.05 level).
NaCN has a significant effect on NO accumulation as does tissue type (buffer or cells). 
NaCN affects cells more than buffer as there is a significant interaction between the tissue 
type and NaCN treatment.
Effect F d.f. p
Within subjects effects 
NaCN 20.2 1, 10 0.001*
NaCN * tissue 24.0 1, 10 0.001*
NaCN * myx. 1.17 1, 10 0.305
NaCN * myx. * tissue 0 1, 10 0.994
Between subjects 
effects
Tissue 126.8 1, 10 <0.001*
Myx. 0.665 1, 10 0.434
Tissue * myx. 0.345 1,10 0.570
Table 6.2: Results of repeated measures ANOVA on data from figure 6.3d (* denotes 
significance at the 0.05 level).
Tissue (buffer or cells) and treatment with NaCN significantly affect NO accumulation, while 
treatment with myxothiazol does not. NaCN affects NO levels in cells but not buffer, as 
evidenced by the significant interaction between tissue and NaCN treatment.
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A similar effect of NaCN is seen immediately on addition of 100 |jM NaCN to 
the NO plateau formed after equilibration of 100 pM DETA/NO with cells 
alone and is not occluded by incubation with 3 pM of the complex lll-inhibitor 
myxothiazol, (Fig. 6.3c & d; for statistics see Table 6.2). In cultured 
hippocampal slices, toxicity of 3 pM myxothiazol, via respiratory inhibition, is 
equivalent to that produced by supramaximal NaCN (Keynes et al., 2004), 
indicating that the NaCN inhibition of NO inactivation observed here is not 
merely due to respiratory compromise of the cells, but due to a more specific 
antagonism, probably at a ferric haem, and as such is similar to the 
inactivation previously described in other tissues.
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Fig. 6.3: NO inactivation is partially inhibited by 100 pM NaCN.
(a) NO accumulation on addtion of 100 pM DETA/NO to buffer (black symbols) and a 
suspension of mixed glia (red symbols) in the presence (open symbols) and absence (filled 
symbols) or 100 pM NaCN (data represent mean ± SEM, n = 4).
(b) Summary of (a), showing NO plateau reached.
(c) Representative NO traces following addition of 100 pM DETA/NO to buffer (black 
symbols), cells (red symbols) and cells + 3 pM myxothiazol (blue symbols). 100 pM NaCN 
is added where indicated.
(d) Summary data from (c). IB + myxothiazol also includes the inhibitor of glucose-6- 
phosphate dehydrogenase, dehydroepiandrosterone (DHEA) which depletes NADPH 
(Schafer & Buettner, 2001) as part of an experiment detailed below (data represent mean ± 
SEM, n = 3 -4 ) .
No more than the partial inhibition of NO inactivation observed with 100 pM 
NaCN is possible. While increasing the concentration of NaCN past 100 pM 
risks interfering with the functioning of the NO electrodes, decreasing the 
concentration to 3 pM does not affect the degree of inhibition (Fig. 6.4a), 
indicating that 100 pM is easily supramaximal. In this respect the NO 
inactivation observed in mixed glia differs from that in CaCo-2 cells 
(Hallstrom et al., 2004), where only ~10% of the NO inactivation activity
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remains after treatment with 25 |jM NaCN. This study used a bolus addition 
of 2 pM NO, while in our study, NO in buffer reached only 350 nM. Schmidt 
and Mayer (2004) reported a degree of NaCN inhibition intermediate 
between that seen here and reported by Hallstrom et al (2004) and, in their 
study, buffer NO reached 0.8 pM. All these NO concentrations are greater 
than those expected physiologically, due to the technical difficulties of 
directly measuring lower NO levels. It is possible, therefore, that the degree 
of NaCN inhibition and physiological relevance of a NaCN-sensitive 
mechanism is different at different NO concentrations. To test this 
hypothesis, sequential additions of DETA/NO were added to buffer and 
mixed glial suspensions with and without NaCN to generate concentrations 
between 50 and 500 nM NO (Fig. 6.4b). As in Chapter 5, the rate of NO 
release from DETA/NO can be calculated according to equation 5.3 and a 
plot of rate vs. [NO] constructed (Fig. 6.4c). Subtracting the buffer data 
reveals the relationship between NO concentration and the rate of biological 
breakdown in the presence and absence of NaCN (Fig. 6.4d). The 
divergence of Michaelis-Menten fits of these plots demonstrates that there is 
a greater effect of NaCN on the rate of biological NO breakdown at high NO 
concentrations. While this goes some way to explain why other studies 
using high NO levels may have found a greater degree of inhibition of NO 
inactivation with NaCN, here NO inactivation remains incompletely inhibitable 
by NaCN at high NO levels. The NO inactivation observed in mixed glial 
suspensions does, therefore, seem somewhat different to that reported in 
CaCo-2 cells and more similar to that in endothelial cells. Like NaCN, the 
flavoprotein inhibitor diphenyleneiodonium chloride (DPI; 50 pM) dramatically 
inhibits NO inactivation in CaCo-2 cells and partially inhibits it in endothelial 
cells. In mixed glial suspensions too, 50 pM DPI inhibits inactivation to a 
similar extent to NaCN (R. Keynes, personal communication). It seems, 
then, that a flavin- and haem-dependent protein may be responsible for 
some, but not all, of the inactivation observed in mixed glial suspensions.
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Fig. 6.4: Inhibition of NO inactivation by NaCN is maximal but incomplete at 3 pM NaCN 
and predominates at higher NO concentrations.
(a) The plateau NO reached, following addition of 100 pM DETA/NO, expressed as a 
fraction of buffer. Significantly more NO accumulates in mixed glial suspensions incubated 
with 3 and 100 pM NaCN than in control cells (One way ANOVA with Tukey post hoc tests; * 
= p < 0.05, n = 4-10).  Maximal inhibition of inactivation with NaCN is therefore achieved 
with 3 pM NaCN.
(b) NO accumulation to sequential additions of DETA/NO, with (red symbols) and without 
(blue symbols) 100 pM NaCN. Black symbols show accumulation in buffer alone. Data 
represent mean ± SEM, n = 4.
(c) Data in (b), where the NO at each DETA/NO concentration is plotted against the 
corresponding rate of NO breakdown (calculated according to equation 5.3).
(d) Data from (b) after subtraction of the rate of NO breakdown in buffer alone, yielding the 
rate of biological breakdown in the presence and absence of cyanide. Data was fitted with 
the Michaelis-Menten equation. Control cells, Vmax = 0.16 pM/min, Km = 0.242 pM; plus 
cyanide, Vmax = 0.06 pM/min, Km = 0.121 pM.
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6.3.4 The primary breakdown product of biological NO inactivation is 
nitrite
In the previous reports of a NaCN-sensitive NO inactivation mechanism, the 
product of NO breakdown was found to be NO3' (Gardner et al., 2001; 
Schmidt & Mayer, 2004). The NO oxidation products were also studied in 
mixed cerebellar glia. The NONOate donor PROLI/NO has a half-life in 
aqueous solution of only 1.8 s, such that application of PROLI/NO essentially 
delivers a bolus of NO.
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Fig. 6.5 : Products of NO consumption by mixed glial suspensions.
(a) Representative traces of NO accumulation following sequential additions of 250 nM 
PROLI/NO to buffer or a mixed glial suspension at a concentration 15 x 106 cells/ml.
(b) Accumulation of nitrite (NO2O following sequential additions of 250 nM PROLI/NO to 0 -  
15 x 106 cells/ml (solid black symbols) or unstimulated cells (red symbols). The difference 
between stimulated and unstimulated conditions is shown by open symbols. The dashed 
blue line denotes the final concentration of NO added and thus maximum possible 
stimulation-induced N 0 2\  Data represent mean ± SEM, n = 3.
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Repeated applications of 250 nM PROLI/NO were delivered to buffer and 
mixed glial suspensions at different cell concentrations (Fig. 6.5a). This 
method of delivery ensured three things:
i) that the contribution of autoxidation to NOx product-formation was 
minimised as the NO level was predominantly kept below 0.5 pM NO;
ii) that NO release ceased immediately after the last PROLI/NO 
injection, so no confounding NO release occurs during the detection of 
products, as would occur were DETA/NO used;
iii) that a sufficient amount of N O  was delivered to allow detection of 
N O x  products via chemiluminescence with its limit of detection of low 
micromolar levels.
Detection of total NOx proved hugely variable, presumably due to high levels 
of contaminant NO3" in solutions and possibly also due to interfering effects 
of SOD (Schmidt & Mayer, 2004). NO2' detection was reliable, however (Fig. 
6.5b) and indicated that as cell concentration increased, the levels of NO2' 
increased, to approach the maximum that would be present were all added 
NO converted to NCV. This indicates that, contrary to published findings in 
other cell types, the major product of NO breakdown in mixed glial 
suspensions is NO2'.
6.3.5 The ability to inactivate NO is lost on cell lysis but recoverable 
with NAD(P)H
Another feature of the NO inactivation observed in CaCo-2 and endothelial 
cells is the loss of consumption activity on cell lysis. The NO inactivation 
activity in mixed glia was also largely lost on lysis by freeze-thawing the 
suspension of cells to -20°C followed by sonication (Fig. 6.6). In the previous 
reports, inactivation by lysates is recoverable by addition of 100 pM NADPH 
and partially recoverable by 100 pM NADH. Consistent with these findings, 
addition of 100 pM NADPH and, to a lesser extent 100 pM NADH, 
supramaximally increased the ability of mixed glial cell lysate to inactivate
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NO (Fig. 6.7a&b). Subsequent addition of 100 |jM  NaCN to NADPH-treated 
lysate inhibited NO inactivation to approximately the same degree as seen in 
intact cells (Fig. 6.7c&d). Statistical analysis to identify which specific 
conditions were different (One way ANOVA with Tukey post hoc tests) 
revealed that lysate alone and all buffer conditions are not significantly 
different (p > 0.05), while all treated lysate conditions (NADPH ± NaCN) are 
insignificantly different from each other and both cells conditions. The small 
sample sizes and number of comparisons, and hence decrease in p value 
required to reach significance increases the chances of declaring a 
difference non-significant when in fact it is. Student’s t test is more likely to 
generate a significant result, but using this test, cells and lysate + NADPH 
are still not significantly different (f = 1.27, d.f. = 7, p = 0.24) and neither are 
cells + NaCN and lysate + NADPH + NaCN (f = 0.065, d.f.- 7, p = 0.95). In 
short, it seems that 100 pM NADPH is sufficient to recover all NO- 
inactivating activity from glial cell lysate and this recovered activity is NaCN- 
sensitive to the same extent as are intact cells.
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Fig 6.6 : NO inactivation activity is largely lost on cell lysis. Data represent mean ± SEM, n 
= 3 - 4 .
While the degree of recovery with NADPH is consistent with recovery of the 
same mechanism for NO inactivation that is lost on cell lysis, it is merely 
correlative evidence and it is wholly possible that instead, addition of surplus
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NADPH could engage an alternative mechanism that is then able to 
inactivate NO. To try to eliminate this possibility, cells were incubated for 1 
hr at 37°C in the presence of dehydroepiandrosterone (DHEA), an inhibitor of 
glucose-6-phosphate dehydrogenase, which depletes intracellular NADPH 
(Fig. 6.8a; Gordon et al., 1995; Schafer & Buettner, 2001). A repeated 
measures ANOVA finds that, while, unsurprisingly, there is a significant 
effect of NaCN treatment (F  = 18.02; d.f.- 1,10; p = 0.002) which interacts 
with tissue type (cells vs. buffer), and a significant effect of tissue type (F = 
126.2; d.f. = 1,10; p < 0.001), there is no effect of incubation with DHEA (F = 
2.086; d.f. = 1,10; p = 0.179). Unfortunately, this negative result does not 
allow us to conclude that intracellular NADPH depletion has no effect on NO 
inactivation and that another mechanism is being artificially engaged on lysis 
and NADPH application. Depletion of NADPH by DHEA treatment typically 
only reduces intracellular levels by less than half (Gupte et al., 1999; Tian et 
al., 1998), so if the intracellular NADPH levels are well above maximal for 
NO inactivation anyway, depletion would have no effect on the activity. The 
Km for NADPH of the NaCN-sensitive mechanisms previously reported is 
between 0.8 and 10 pM (Hallstrom et al., 2004; Schmidt & Mayer, 2004), so 
intracellular levels of 4 -  50 pM may be sufficient to support maximum 
activity, concentrations that are well within the potential range of intracellular 
NADPH concentrations (Hancock eta!., 1989).
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Fig. 6.7 : NO inactivation in mixed glial lysate can be recovered with 100 |jM NAD(P)H and 
is partially inhibited by NaCN.
(a) Representative trace following addition of 100 pM DETA/NO then 2 x 100 pM NADPH 
(black symbols) or 100 pM NADH (blue symbols) to mixed glial lysate at 1 mg/ml.
(b) Summary data of plateau NO reached on addition of 100 pM DETA/NO then 100 pM 
NADPH (light grey bars) or 100 pM NADH (dark grey bar) to buffer or lysate.
(c) Representative trace following sequential additions of 100 pM DETA/NO, 100 pM 
NADPH and 100 pM NaCN to lysate at 1 mg/ml.
(d) Summary data from (b), for comparison, also showing the effect of addition of 100 pM 
NaCN to a mixed glial suspension at 3 million/ml.
All data represent mean ± SEM, n = 3 -  5.
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Fig. 6.8: Recovery of inactivation activity with NADPH appears to be a specific effect.
(a) Intracellular depletion of NADPH by preincubation for 1 hour with 100 pM DHEA does 
not, affect NO inactivation in intact mixed glial suspensions. (Treated buffer traces also 
contain 3 pM myxothiazol, as this experiment was conducted alongside that in Fig. 6.3d.)
(b) NADPH (100 pM) and subsequent NaCN (100 pM) treatment does not increase NO 
inactivation in 1 mg/ml lysates of platelets or WBC, which when intact do not demonstrate 
NO inactivation.
Data represent mean ± SEM, n = 3 - 4 .
Whether NADPH is simply engaging a very general, artefactual inactivation 
process when added to lysates can be studied by comparing the effect on 
NO inactivation of adding it to lysates of cell types that do not inactivate NO 
when intact. If these lysates show enhanced breakdown of NO on addition 
of NADPH, then we can be confident that the NADPH-mediated effect is 
different from that observed in intact cells. This was tested by studying the 
effect of addition of 100 pM NADPH and 100 pM NaCN to lysates of platelets
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and WBC, both at 1 mg/ml (Fig. 6.8b). There was no significant effect of 
treatment with NADPH or NaCN (F = 1.798; d.f. = 2,18; p = 0.194), though 
there was a small, but significant, difference between the tissue types (buffer, 
platelets and WBC) in terms of overall NO plateau height (F = 4.874; d.f. = 
2,9; p = 0.037). A Tukey post hoc test revealed that this was due to a small 
but significant difference between buffer and platelets. Platelets and WBC do 
not, therefore, inactivate NO when intact, nor is their ability to inactivate NO 
enhanced on addition of NADPH. Though once more correlative, this 
evidence lends further support to the hypothesis that NADPH-recoverable 
inactivation activity is in some way specific, rather than a general artefact.
6.3.6 NADPH-recoverable NO inactivation localises to the membrane 
fraction of cell lysates and whole brain homogenate
The previous reports of NADPH-dependent NO metabolism found the activity 
to be present in the membrane, rather than cytosolic, subcellular fraction. 
Centrifugation of mixed glial lysates at 100 000 g for 1 hour generated a 
membrane pellet that, on suspension to the same original volume, exhibited 
the same NADPH-dependent and NaCN-sensitive NO inactivation activity as 
whole lysate and resuspended lysate (supernatant and pellet recombined) 
while there was no demonstrable activity in the cytosolic supernatant (Fig. 
6.9a&b). These effects were of statistical significance as evidenced by a 
significant effect of tissue preparation (i.e. buffer, lysate, pellet etc.; F = 22.4; 
d.f. = 4, 15; p < 0.001) in a repeated measures ANOVA. Tukey post hoc 
tests revealed that buffer and supernatant were not significantly different 
from each other, but were different from the membrane pellet, resuspended 
lysate and control lysate. The treatment (i.e. DETA/NO, NADPH, NaCN) 
unsurprisingly significantly affected the plateau NO (F = 92.8, d.f. = 1, 15, p < 
0.001) and there was a significant interaction between the effects of tissue 
and treatment (F = 7.89, d.f = 4 , 15, p = 0.001), as NADPH and NaCN 
treatment affected NO levels in lysate, resuspended lysate and the 
membrane pellet, but not in supernatant or buffer. NADPH-dependent NO 
inactivation is therefore localised to the membranes of glial lysates, as it is in 
preparations from endothelial and CaCo-2 cells.
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Fig. 6.9 : NADPH-sensitive NO inactivation localises to membranes.
(a) Representative traces of NO accumulation following sequential applications of 100 pM 
DETA/NO, 100 pM NADPH and 100 pM NaCN to buffer (black symbols), glial lysate (red 
symbols) and, following centrifugation at 100 000 g for 1 hour, resuspended lysate (green 
symbols), the membrane pellet (blue symbols) and the cytosolic supernatant (maroon 
symbols).
(b) Summary data from experiments like those shown in (a). Data represent mean ± SEM, n 
= 4.
This finding creates the possibility that NO inactivation can be studied in 
whole brain homogenate, where previously contaminant Hb was found to 
confound interpretation of results (Chapter 4.3.4). Hb localises to the 
cytosolic fraction (Fig. 4.7c) so will partition differently from the NADPH-
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recoverable activity. Whole brain homogenate at 1 mg/ml demonstrated a 
similar pattern of NADPH- and NaCN-sensitive NO metabolism as that seen 
in mixed glial lysates, though homogenate alone was more able to break 
down NO, presumably due to contaminant Hb (Fig.6.10a&b). Centrifugation 
at 100 000 g for 1 hour also created a similar pattern of results to those in 
glial lysates, with any differences easily explainable by contaminant Hb (Fig. 
6.10b). Relative levels of contaminant Hb were monitored by measuring the 
duration of the clamp at zero NO following DETA/NO application (Fig. 6.10c). 
Detectable Hb (~2 min clamp) was present in the control homogenate, 
resuspended homogenate and supernatant fractions, and none was 
apparent in the membrane pellet. Correspondingly, the inactivation of NO 
by resuspended homogenate and supernatant on DETA/NO addition is 
greater than that in pellet, due to the presence of Hb, but it is the membrane 
pellet, rather than the supernatant, that responds to addition of NADPH. In 
all tissue conditions, there is an effect of NaCN, as the breakdown of NO by 
Hb is also reduced by NaCN, probably by antagonism of NO-haem binding 
by CN'.
6.3.7 NADPH-dependent NO inactivation is not affected by buffer and is 
not due to O2' production
The cells are routinely maintained in IB, a Tris based buffer (25 mM Tris), 
with ionic concentrations and glucose approximating a physiological 
extracellular solution (see General Solutions, Chapter 2.2). As lysed glia 
were prepared by simply freeze-thawing and sonicating the cell suspension, 
lysates also contained this buffer. The ability to pellet and resuspend the 
active fraction of lysates and homogenate allows us to investigate whether 
the ions and glucose present in IB are important for NO inactivation. As 
seen in Chapter 5, for example, the breakdown of glucose via glucose 
oxidase generates species that can scavenge NO. If a similar species can 
be generated by the tissue and buffer glucose, this may account for NO 
inactivation. Alternatively, the breakdown process may require ionic 
components as cofactors. Resuspending the membrane pellet in 25 mM Tris 
alone (at pH 7.45), however, has no effect on the response to treatment with
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DETA/NO, NADPH and NaCN (Fig. 6.11a). There is a significant effect of 
tissue type, due to the differences between pellet and buffer alone (Repeated 
measures ANOVA, F = 59.7; d.f. =2, 15; p < 0.001) but there is no significant 
difference between pellet resuspended in IB or 25 mM Tris, while both are 
significantly different from buffer (Tukey post hoc tests).
NADPH
NaCN
DETA/NO
100
0 5 1510 20
Tim e (min)
I 1 DETA/NO. I uci n/i U
t H  I 1 NADPH
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i t i l l
Fig. 6.10: Membranes from whole brain homogenate also demonstrate NADPH-recoverable 
NO inactivation.
(a) Representative trace or NO accumulation in 1 mg/mi whole brain homogenate following 
application of 100 pM DETA/NO, 2 x 100 pM NADPH and 100 pM NaCN.
(b) Summary data from experiments as shown in (a).
(c) Duration of clamp at zero NO after application of DETA/NO (indicative of Hb
contamination). All data represent mean ± SEM, n = 3.
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a
Fig. 6.11: NO inactivation in homogenate pellet is not affected by buffer or additional SOD.
(a) Plateau NO reached on addition of 100 pM DETA/NO (white bars) then 100 pM NADPH 
(light grey bars) and 100 pM NaCN (dark grey bars), when the membrane pellet is 
resuspended in either IB or 25 mM Tris. There is no effect of changing the buffer.
(b) The NO level reached following 100 pM DETA/NO (white bars) then 100 pM NADPH 
(grey bars) is also not affected by doubling the SOD concentration to 2000 U/ml.
Data represents mean ± SEM, n = 3 - 4.
Another possible contributor to NO breakdown in many systems is reaction 
with O2 to form ONOO'. While the presence of SOD should eliminate 0 2"  
and thus any NO scavenging, on addition of NADPH, 02“  production may 
increase. NADPH oxidase is a membrane-bound protein complex that 
catalyses the production of 02“  by transferring electrons from NADPH to O2 
(Babior, 2004; Shatwell & Segal, 1996) and is expressed in the brain
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(Serrano et a/., 2003). It is possible NADPH oxidase is active in the 
membrane pellet such that on addition of NADPH it could generate O2" and 
hence contribute to NO inactivation. Phagocytes highly express NADPH 
oxidase and are presumably present in the WBC preparation which does not 
respond to NADPH, making an involvement of NADPH oxidase in NO 
inactivation unlikely. Increasing the SOD concentration to 2000 U/ml easily 
addresses this issue, however, as more of any surplus 0 2 “ will be scavenged 
and NO inactivation correspondingly reduced. Doubling the level of SOD in 
this way had no effect on the response to NADPH (Fig. 6.11b). There was 
still a significant effect of treatment with NADPH (Repeated measures 
ANOVA; F = 7.75; d.f. = 1,8; p = 0.024) and a significant difference between 
buffer and membrane pellet (F = 6.03; d.f. = 1,8; p = 0.040), but no difference 
between the two SOD concentrations (F = 0.046; d.f. = 1,8; p = 0.835). 
Increased 0 2 “ production does not, therefore, contribute to NADPH- 
dependent NO inactivation.
6.3.8 NO inactivation in cerebellar slices is insensitive to NaCN and 
DPI.
In dispersed preparations, it seems that, like previous reports, NO 
inactivation is localised to membranes and is predominantly NADPH- 
dependent, but at odds with some of these reports, it is only partially 
sensitive to flavoprotein and haemoprotein inhibitors. Unlike other findings, 
the predominant product of NO metabolism in mixed glial cells appears to be 
NO2' rather than NO3'. It is critical, especially given these contradictory 
findings, to determine whether NO inactivation in intact tissue shares these 
properties. Using the same strategy as in Chapters 3 and 4, cGMP was 
used as an indicator of NO levels, and hence NO inactivation, in cerebellar 
slices, following stimulation with a sub-ECso concentration of NO (generated 
from pre-equilibrated 10 pM Sper/NO) and maximal stimulation (100 pm 
DEA/NO). Slices were pre-incubated for 15 min with 100 pM NaCN or 50 
pM DPI before stimulation with NO. Though the GC (NO) receptor contains
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a haem moiety, its activity is unaffected by 100 pM KCN (Ignarro et al., 
1986b)
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Fig 6.12: In intact tissue and at high protein concentrations, inactivation of NO is less 
sensitive to inhibition by NaCN.
(a) cGMP accumulation in unstimulated cerebellar slices (white bars) and slices incubated 
with pre-equilibrated 10 pM Sper/NO (light grey bars) and 100 pM DEA/NO (dark grey) and 
subjected to 15 min preincubation with 100 pM NaCN or 50 pM DPI or 100 pM Trolox 
present throughout preparation and use of slices. Data represent mean ± SEM, n = 4 -  8.
(b) Plateau NO reached on stimulation of blocks of cerebellum with 100 pM NO (solid 
symbols) followed by 100 pM NaCN (open symbols).
(c) Plateau NO reached in membrane pellets of whole brain homogenate, on sequential 
application of 100 pM DETA/NO (black symbols), 100 pM NADPH (red symbols) and 100 
pM NaCN (blue symbols). Data represent mean ± SEM, n = 4.
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1986b) and it does not contain flavin domains, so should be unaffected by 
DPI. cGMP synthesis should therefore be unaffected by NaCN and DPI, 
so any change in cGMP-levels should be due to changes in NO. I 
also investigated the effect of maintaining slices in 100 |jM Trolox from the 
very beginning of their preparation, to minimise any oxidative stress 
associated with the process of cutting and incubating the slices (which could 
conceivably affect NO inactivation). There was no significant effect of 
treatment with potential inhibitors on cGMP levels (Fig. 6.12a; Univariate 
ANOVA; F  = 1.010; d.f. = 5,52; p = 0.421) and the effect of NO stimulation 
was, naturally, significant (F = 359.57; d.f. = 2, 52; p < 0.001). The 
interaction between treatment and NO stimulation was also insignificant (F = 
1.158; d.f. = 10,52; p = 0.340). Thus treatments did not differently affect 
cGMP accumulation to different levels of NO. When the different NO 
stimulation conditions were separated and a one-way ANOVA conducted on 
each, there was no significant effect of inhibitor treatment in either control or 
DEA/NO-stimulated groups. In the Sper/NO-treated group, however, there 
was a significant effect of inhibitor treatment (F = 6.207; d.f.= 5, 22; p = 
0.001). Tukey post hoc tests revealed that this was due to the Trolox-treated 
slices generating significantly less cGMP than any other condition. In short, 
there was no evidence of NaCN- or DPI-sensitivity of NO inactivation by 
cerebellar slices. Incubation with Trolox from the start of slice preparation, 
however, increased NO inactivation (decreasing NO and cGMP levels). 
Exposure to oxidative stress and free radicals during slice-cutting and 
incubation may serve to damage the ability of slices to inactivate NO.
6.3.9 A NaCN and NADPH-independent mechanism may be important 
at high protein concentrations
The absence of any NaCN- and DPI-sensitivity of cerebellar slice inactivation 
clearly raises questions as to the physiological relevance of any such 
mechanism in dispersed preparations. It is important to understand, 
therefore, why such differences between dispersed and intact preparations 
exist. One obvious difference between the two is the way in which
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inactivation is being measured: by direct measurement of NO in cells and 
homogenates and by indirect measurement via cGMP levels in the case of 
slices. To investigate whether the method of measurement could be 
distorting the results, cerebellar tissue blocks were suspended in buffer by 
fast stirring, stimulated with DETA/NO, and the NO profile in the suspension 
was measured using the electrochemical probe. This represents a half-way 
house between truly dispersed preparations and the intact tissue; the 
preparation is not homogenous -  the probe detects merely the bathing NO 
that is itself affected by the presence of sinks, in the form of the tissue 
blocks, across which there is a gradient of NO. Additionally, the apparent 
speed of inactivation will be slowed due to the encapsulation of sinks into 
discrete blocks as the probability is decreased of a given NO molecule 
encountering a sink, compared to when sinks are present throughout the 
solution. In this way, the situation is analogous to the slow breakdown of NO 
by Hb encapsulated in RBC compared to that by free Hb in solution (Liu et 
a/., 1998a; Liu et al., 2002). In summary, this method cannot be used to 
generate data about the precise kinetics of inactivation, but is potentially 
useful for characterisation purposes.
Blocks were suspended in either IB, in which the glial suspensions are 
maintained, or aCSF, gassing with 95 % O215 % C02, in which the slices are 
incubated. Different amounts of blocks were added to the probe, and while 
stirring and in suspension, a sample was removed for homogenisation and 
protein determination. Due to this retrospective determination of protein, the 
ranges of protein concentrations for the two buffers only partially overlap (Fig 
6.12b). Despite this problem, four things are apparent from the NO levels 
present at different protein concentrations:
i) The NO plateaux and hence inactivation activity is similar at 
low protein concentrations (1 mg/ml) to that seen in cells. As 
a given rate of activity will appear slower in the blocks than in 
dispersed cells, as discussed above, this is consistent with a 
faster rate of inactivation in blocks per mg protein than seen 
in cells.
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ii) NaCN-sensitivity of inactivation is similar at low protein
concentrations to that seen in cell suspensions.
iii) As block concentration increases, the inactivation activity
increases but the NaCN-sensitivity decreases, such that 
there is no apparent effect of NaCN at the highest 
concentrations studied (~10 mg/ml)
iv) The behaviour of blocks suspended in IB and gassing aCSF
is similar. As the O2 levels in gassing aCSF are high
compared to those in air-equilibrated IB, this suggests that
the 0 2 -dependence of NO inactivation in tissue blocks may
be less than observed in glial suspensions.
The results in blocks are therefore consistent with both those in dispersed
cells and slices and suggest that a NaCN-insensitive mechanism of NO
inactivation is important at the higher protein concentrations found in intact 
tissue. As discussed above, however, the lack of homogeneity of the block 
suspension makes quantifying the changes in inactivation activity 
problematic. The effect of NaCN (and NADPH) on NO inactivation was 
therefore studied in membrane pellets from different concentrations of whole 
brain homogenate (Fig. 6.12c). Consistent with the data from tissue blocks, 
as the protein concentrations increased, the NaCN-insensitive NO 
inactivation activity became much greater. A NaCN-sensitive fraction was 
present at 10 mg/ml protein, however, which was not present in the blocks. 
Unfortunately, however, though no Hb contamination of the membrane pellet 
was seen at low protein concentrations, some Hb is present, as at high 
concentrations (above 3 mg/ml), there was a distinctive clamp at zero NO 
after DETA/NO (Fig. 6.13a). Addition of DETA/NO to lysed RBC (Hb lysate) 
at a concentration sufficient to give a similar clamp duration (72 nM Hb) 
reveals that this contaminant Hb inactivates NO sufficiently strongly to 
reduce the plateau height after DETA/NO addition (Fig. 6.13b), though not 
sufficiently to account for all the NADPH-independent inactivation seen in 
pellet from 5 mg/ml homogenate. It was not sensitive to NADPH addition, 
but was NaCN-sensitive. In summary, contaminant Hb in the membrane 
pellet artificially enhances the apparent NADPH-independent inactivation, but
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also the NaCN-sensitive fraction. Figure 6.12c is therefore consistent with 
an inactivation mechanism wherein a NaCN-sensitive component becomes 
less important at high protein concentrations, but this must be studied in a 
Hb-free preparation.
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Fig. 6.13: Hb-contamination of membrane pellets confounds interpretation of results.
(a) Clamp at zero NO after DETA/NO addition to Hb-lysate (HbLys) at 7 nM Hb and 
membrane pellets from different homogenate protein concentrations.
(b) Plateau NO reached in buffer, Hb-lysate at 72 nM Hb and membrane pellet from 5 mg/ml 
homogenate.
Data represent mean ±SEM, n -  3 - 4 .
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6.3.10 NO inactivation in synaptosomal membranes
To minimise any Hb contamination, forebrain synaptosomes were prepared 
from adult rat and lysed by freezing to -20°C and sonication. The membrane 
fraction was then collected by centrifugation for 1 hr at 100 000 g. Intact 
synaptosomes inactivate NO in a similar way to glial suspensions (S. 
Mukherjee, personal communication) but have minimal Hb contamination, as 
they are washed during preparation (see Chapter 6.2; Methods). This, 
combined with the removal of the cytosolic supernatant, should minimise 
contaminant Hb. Indeed, unlike membranes from 10 mg protein/ml of 
homogenate, membranes from 10 mg protein/ml of synaptosome lysate did 
not demonstrate any “clamp” at zero NO following addition of 100 pM 
DETA/NO (Fig. 6.14a), indicating there is not significant Hb contamination in 
synaptosomal membranes. The NO levels achieved following addition of 
DETA/NO, NADPH and NaCN to membranes from different protein 
concentrations are very similar to those observed in homogenate 
membranes (Fig 6.14b&c). A repeated measures ANOVA indicates that the 
small difference between the preparations approaches significance (F = 
4.07; d.f. = 1, 31, p = 0.052). From examination of the plot of both 
preparations (Fig. 6.14c), it is apparent that the NO level reached is the 
same after DETA/NO addition but differs slightly after NADPH and NaCN 
treatment. This is likely due to the different ages of the preparations; the 
homogenate membranes were freshly prepared while, prior to membrane 
fractionation, the synaptosome lysates had been stored at -20°C for a 
number of months prior to use. As the pattern of NO level achieved is 
conserved between the two preparations, however, synaptosome 
membranes were considered sufficiently similar to those previously studied. 
Like observed for tissue blocks and homogenate membranes, then, 
synaptosome membranes also demonstrate an increasingly dominant 
NADPH and NaCN-independent NO inactivation at high protein 
concentrations.
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Previous reports have suggested that the NaCN- and NADPH-sensitivity of 
NO inactivation indicates the involvement of a protein or protein complex that 
contains both haem and flavin-binding domains (Hallstrom et al., 2004; 
Schmidt & Mayer, 2004). This assumes convergence of the haem- and 
flavin-dependent components onto a single mechanism for NO breakdown. 
Addition of 100 pM NaCN to synaptosome membranes inhibited inactivation 
of NO even before addition of NADPH, however (Fig. 6.14d inset and main 
figure). Furthermore, following such inhibition by NaCN, 100 pM NADPH 
was still able to boost NO inactivation in the same manner as occurred prior 
to NaCN addition. As 100 pM NaCN is well-maximal (even allowing for the 
increased protein concentrations), NADPH and NaCN cannot be affecting 
the same mechanism.
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Fig. 6.14: NO inactivation in synaptosomal membranes is similar to that in whole brain 
membranes and demonstrates independent NaCN and NADPH sensitivity.
(a) NO profile on addition of 100 pM DETA/NO to membrane pellets from 10 mg protein/ml 
whole brain homogenate (solid symbols) or synaptosomes (open symbols). Data represents 
mean ± SEM, n = 3.
(b) NO levels attained following addition of 100 pM DETA/NO (black symbols), 100 pM 
NADPH (red symbols) and then 100 pM NaCN (blue symbols) to membranes from 
synaptosomes at 3 mg protein/ml. Data represent mean ± SEM, n=  3. Inset: representative 
NO profile.
(c) NO levels from (b; synaptosomal membranes; circles) and Fig. 6.12c (homogenate 
membranes; squares) after addition of DETA/NO, NADPH and NaCN (coded as above).
(d) NO levels reached following addition of DETA/NO followed by NaCN then NADPH to 
membranes from synaptosomes at 3 mg protein/ml. Data represents mean ± SEM, n = 3 -  
8, colour-coded as in (b) & (c). Inset: representative NO profile.
(e) Data from (b) and (d) plotted on the same axes. Closed symbols represent the NO level 
after DETA/NO addition, open symbols the NO after NaCN addition and half-filled symbols 
the NO after NADPH addition. Black symbols denote addition of NaCN then NADPH, blue 
symbols, vice versa.
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Plotting figures 6.14b and d on the same axes illustrates that, irrespective of 
the order of NaCN and NADPH delivery, the final NO concentration is 
identical to that following addition of DETA/NO alone (Fig. 6.14e). A 
univariate ANOVA for the effects of treatment (DETA/NO, NADPH 1st or 2nd, 
NaCN 1st or 2nd) and protein concentration, with Tukey post hoc tests 
emphasises this: the only significant differences between the treatments are 
found when DETA/NO and NADPH or DETA/NO and NaCN are present. All 
other conditions are the same.
These studies in synaptosome membranes therefore suggest that there are 
three components (at least!) underlying observed biological NO breakdown: 
one is sensitive to inhibition by NaCN, suggestive of involvement of a 
haemoprotein; one is increased by NADPH, indicative of a reductive process 
involving a flavoprotein and another is independent of both of these 
processes but seems increasingly important at higher protein concentrations. 
Such a situation can explain the lack of an inhibitory effect of NaCN or DPI 
on NO inactivation in slices. In intact tissue, the third of these processes 
may dominate and any partial inhibition of either mechanism will be masked 
by the functioning of the other two.
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6.4 Discussion
These studies aimed to address the nature and identity of the lipid 
peroxidation-independent inactivation of NO in brain tissue. The 
consumption process is not a general property of cells, but has restricted 
tissue distribution, as evidenced by the lack of NO consumption by rat 
platelets and white blood cells in contrast to an equal concentration of 
cerebellar glia. A physiological rat platelet count is 500 -  1000 x 103 
platelets/pl (Wolfensohn & Lloyd, 1998), corresponding to a platelet protein 
concentration of 1.05 -  2.1 mg/ml blood (Eigenthaler et al., 1992). The 
platelet protein concentrations used here therefore corresponded to those 
found physiologically. Similarly, WBC were used here at 1 mg/ml protein, 
which corresponds to 48 million cells/ml. The rat WBC count is 6 -  17 x 103 
cells/pl (Wolfensohn & Lloyd, 1998) or 6 -  17 million cells/ml. The WBC 
concentrations used here were 3 - 8  fold more concentrated than found 
physiologically. Neither WBC nor platelets will therefore consume NO in 
vivo. Glia, on the other hand, demonstrate substantial NO inactivation at 1 
mg/ml, but are physiologically 100-fold more concentrated at a tissue protein 
concentration of 100 mg/ml (Mcllwain, 1963) and therefore, in situ, must 
demonstrate vastly more NO inactivation than WBC or platelets. This is 
physiologically sensible, because as components of blood, platelets and 
white blood cells are surrounded by high concentrations of Hb-filled red 
blood cells, which avidly consume NO, making further inactivation processes 
redundant. Brain is densely vascularised, but cells may still be up to 25 pm 
from a blood vessel (Boero et al., 1999), such that, as discussed previously, 
inactivation of NO by brain tissue itself may be of importance to the control of 
NO signals.
The consumption process was found to be independent of catalytically-active 
NOS, but was partially sensitive to NaCN. Cyanide is a haem poison that 
predominantly inhibits enzymes containing ferric haem, the ferrous haem- 
cyanide complex being very unstable (Milani et a/., 2004). The incomplete 
inhibition by cyanide therefore suggests that part of glial NO consumption is
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due to a haem protein that must exist in, or cycle through, the ferric state. 
Several other NO breakdown pathways have demonstrated cyanide 
inhibition and the results here are consistent with a contribution to glial NO 
breakdown of either CcO or the flavo/haemoproteins involved in NO 
consumption in CaCo-2 and endothelial cells. It must be noted, however, that 
many other proteins (including metHb) are also cyanide-sensitive and cannot 
be ruled out.
Full inhibition of consumption by cyanide was not possible, even with high 
concentrations. Testing a range of NO concentrations revealed that the 
cyanide-sensitive fraction of NO consumption is larger at high NO 
concentrations, but a cyanide-insensitive portion remained even at the higher 
NO levels. Unlike in CaCo-2 cells, then, in which NaCN almost fully inhibited 
NO consumption (Hallstrom et al., 2004), an additional, cyanide-independent 
NO breakdown process is present in glial suspensions. Such residual 
activity also remains in endothelial cells after incubation with cyanide 
(Schmidt & Mayer, 2004). The glial NO consumption was sensitive to the 
flavoprotein inhibitor DPI to a similar extent to that seen with cyanide (R. 
Keynes, personal communication). This is consistent with a role for a flavin 
and haem containing protein(s) underlying part of glial NO breakdown, as 
reported in CaCo-2 cells and endothelial cells, but with the presence of an 
additional consumption pathway.
Fig. 6.15: NO consumption by a cyanide- and DPI-sensitive process and an additional 
mechanism
NO + Q,
Electrons
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The product of NO breakdown in both CaCo-2 cells and homogenates of 
endothelial cells was NO3', suggesting a dioxygenase function of the 
consumption mechanism. Here, however, increasing cell concentration and 
therefore increasing biological inactivation produced an increase in the levels 
of NO2' produced in glial cells after addition of NO, indicating that NO2' rather 
than NO3' is the major product of NO breakdown in glia. The lack of 
complete recovery of NO as N02- in buffer and at low cell concentrations is 
unexpected, as it suggests that a small amount of N0 3 - is formed in these 
conditions. The product of NO breakdown by autoxidation is NO2', which is 
presumably the route of NO breakdown in the absence of cells, so in buffer it 
would be expected that all NO would be recovered as NO2'. Possibly either 
SOD or contaminant iron (albeit chelated with DTPA) is able to mediate 
some oxidation of NO2' to NO3' as SOD mimetics and iron proteins have 
previously been shown to mediate this reaction (Ignarro et al., 1993; Sharpe 
et al., 2002). That the primary breakdown product of biological NO 
breakdown in glia is NO2' not NO3' is clearly at odds with findings in CaCo-2 
cells and endothelial cells. This would suggest that the NaCN and DPI- 
sensitive process in glia is different to that observed in the other 
preparations, or possibly that the component that is insensitive to these 
inhibitors produces NO2' and becomes increasingly dominant at higher cell 
concentrations. An alternative cyanide sensitive NO consumption pathway 
could be CcO, which produces NO2' (Torres et al., 2000), though the lack of 
flavin domains means that DPI should not inhibit its activity. DPI can also 
interact with haems, however (Doussiere et al., 1999). If the effect of DPI 
was not, as expected, to inhibit flavin domains, but to interfere with a haem 
protein, then the involvement of CcO cannot be excluded (though the lack of 
inactivation by platelets would argue against this -  see below).
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Fig. 6.16: NO consumption by a NaCN and DPI sensitive process that may produce N 0 2‘ or 
N 0 3' and a N 0 2' -producing additional mechanism.
Lysis of glial suspensions causes a dramatic decrease in NO consumption, 
indicative of the presence of soluble cofactors for breakdown activity that are 
diluted away on cell lysis. Activity could be wholly recovered by addition of 
NADPH, as in CaCo-2 and endothelial cells. As also observed in endothelial 
cells, but not CaCo-2 cells, NADH could also recover activity, but to a lesser 
extent. This is supportive evidence for the involvement of a flavoprotein in 
NO consumption, as flavoproteins often use NAD(P)H as electron donors to 
their bound flavins. The partial effectiveness of NADH would suggest that 
both pyridine nucleotides can bind and donate electrons to this mechanism, 
but it is perhaps unsurprising that NADPH is more effective. The intracellular 
NADPH: NADP+ ratios are high, so NADPH can well act as a reducing agent. 
Conversely NADH: NAD+ ratios are kept low to provide the NAD+ required to 
accept electrons during catabolism. NADPH is therefore the more likely 
physiological reducing agent and binding would be best optimised for 
NADPH over NADH. That the NADPH-recovered activity engages the same 
mechanism as observed in intact cells has not been demonstrated, but is 
supported by the lack of an effect in platelet and WBC lysates, suggesting 
that a very general cellular process is not being hijacked.
The NADPH-recovered consumption activity in glial lysates was only partially 
cyanide sensitive, to that same extent as in intact glia. This is further support
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for the idea that the NADPH-generated consumption is the same as the 
activity in intact cells, engaging the same haemoprotein. Also, however, it 
indicates that the other cyanide-independent process also relies on NADPH.
All of the NADPH-dependent activity, both cyanide sensitive and insensitive, 
localised to the pellet following centrifugation at 100 000 g for 1 hour. No 
activity was left in the cytosolic supernatant. This spin pellets all cellular 
membranes (Mcllwain, 1963) so suggests that all of the NADPH activity 
requires a membrane-bound factor, or the membranes themselves. Many 
other NO consumption processes are also localised to membranes. For 
example, the mechanisms in CaCo-2 cells and endothelial cells are found in 
microsomal membranes; CcO localises to mitochondrial membranes and 
accelerated autoxidation occurs in the hydrophobic environment of biological 
membranes.
NAD(P)H NAD(P)NO, CN-
NO + Ofe
NAD(P)H li-
NO + ODPI?NAD(P)
Fig. 6.17: NO consumption occurs in membranes, by NAD(P)H dependent processes.
The membrane localisation of the NO consumption process in glia raised the 
possibility of using other preparations (membranes from synaptosomes and 
whole brain homogenate) that were not possible previously due to the effects 
of contaminant Hb. As Hb is cytosolic, it localises to the supernatant fraction 
of the centrifugation described above, leaving the membranes Hb-free (at 
least at 1 mg/ml protein). The advantages of using different preparations are 
two-fold. Firstly, the tissue yield from the synaptosome and whole brain
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preparations is much greater than from the glial cell cultures. After a week in 
culture, 7 day old cerebella from 16 rats eventually yielded 48 ml of glia at 1 
mg protein/ml. Whole brain homogenate from the forebrains of the same 
animals yielded well over 10 times this amount, with no delay required due to 
culturing. Similarly, a single adult forebrain yielded around 50 ml of 
synaptosomes at 1 mg/ml, again without the need for culturing. Use of these 
preparations therefore allowed NO consumption to be studied in greater 
tissue concentrations. Secondly, synaptosomes and whole brain 
homogenate better represent the composition of brain, containing, as they 
do, tissue from neurons as well as glia.
Firstly I used membrane fractions from whole brain homogenate and 
demonstrated that very similar NADPH- and cyanide-sensitive NO 
consumption was present to that seen in membranes from cultured glia. In 
this preparation, contributions to NO breakdown from two potential 
confounding artefacts were ruled out. There was no difference between the 
use of cell incubation buffer and Tris alone in terms of the membranes’ ability 
to consume NO, signifying both that the activity is not an artefact of reaction 
with, for example, metabolites of glucose, nor is it dependent on any ions 
commonly found in extracellular solutions. Additionally, no change in activity 
was observed after doubling the concentration of SOD, ruling out reaction 
with O2* ' , which may be generated by an artefactual stimulation of NADPH 
oxidase by the added NADPH.
When higher tissue concentrations (membranes from > 3 mg protein/ml 
homogenate) began to be used, it became apparent that a degree of Hb 
contamination was still present in the membrane pellets from whole brain 
homogenate. Membranes from forebrain synaptosomes undergo an 
additional wash during their preparation (see Chapter 6.2), which should 
decrease the amount of Hb preeent, Indeed, membranes from 
synaptosomes at up to 10 mg protein/ml showed no apparent Hb 
contamination, as determined by the absence of a lag in the time taken NO 
to rise after DETA/NO addition, that would have been indicative of the rapid 
reaction of NO with oxyHb. Synaptosome membranes demonstrated the
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same pattern of NO inactivation as seen in membranes from whole brain 
homogenate. It should be noted that in homogenate and synaptosome 
membranes, the whole of the NADPH-sensitive NO consumption was 
inhibited by cyanide, unlike the partial sensitivity seen in intact and lysed glia. 
In this respect the activity of these membranes is the same as seen in intact 
synaptosomes, where the cyanide sensitivity was greater than seen in intact 
glia (S. Mukherjee, personal communication).
The need to increase tissue concentrations emerged following the finding 
that cyanide and DPI were unable to increase cGMP accumulation and 
therefore could not inhibit the avid inactivation of NO seen in cerebellar 
slices. This result severely questions the relevance of the cyanide- and DPI- 
sensitive process observed in the dispersed preparations. Use of tissue 
blocks allowed direct detection of NO in the presence of relatively intact brain 
tissue and confirmed that, at high tissue concentrations, there was no effect 
of cyanide on NO inactivation. There was also no apparent difference in 
inactivation when blocks were air-equilibrated or gassed with O2, suggesting 
the absence of the drastic 0 2 -dependence seen in glial cells, where the 
breakdown is faster when gassed with O2. When the concentration of 
synaptosome membranes was increased to a tenth of that in intact tissue 
(using membranes from 1 0  mg protein/ml synaptosomes), the cyanide 
sensitivity of NO breakdown was decreased relative to membranes from 1 
mg protein/ml synaptosomes. As the tissue concentration increased, 
however, the cyanide-insensitive component of inactivation, which appeared 
very small in membranes from synaptosomes at 1 mg protein/ml, 
dramatically increased. Indeed, this appeared the dominant component in 
the breakdown of NO in membranes at a concentration a tenth of that in 
brain. Extrapolating to the intact situation, therefore, it seems that this 
component will predominate, explaining the cyanide insensitivity of 
inactivation in intact tissue.
So far, the data suggest the existence in brain tissue of a membrane-bound 
NADPH- and cyanide-sensitive process, presumably involving haem and 
flavin binding proteins, but also another membrane-bound process
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independent of this mechanism that becomes increasingly important at high 
tissue concentrations. The situation becomes yet more complicated, 
however, with the finding that cyanide itself can inhibit the inactivation of NO 
by membranes, before addition of NADPH, and that preincubation with 
cyanide does not prevent an increase in NO consumption by addition of 
NADPH. It appears that rather than affecting the same process, as 
previously assumed, the effects of cyanide and NADPH are independent, 
indicating that there may be three components to NO breakdown in brain 
membranes: a cyanide-sensitive component, which may be a haemoprotein, 
an NADPH-dependent component and a process independent of both of the 
above. This may explain one observation: that the cyanide sensitivity of 
intact glia and of glial membranes is less than in synaptosome membranes, 
though the NADPH sensitivity is similar. If the two processes are 
independent then neuronal tissue (found in synaptosomes) may more richly 
express the cyanide sensitive component than do glia, while the NADPH- 
dependent component is present in both preparations to the same amount.
NAD(P)H NAD(P)
CI\T
NONO + O
NO + O.
DPI?DPI?
N0 + 0 2
Fig. 6.18: NO consumption in brain membranes by three processes.
Several questions arise from the finding that the cyanide and NADPH 
sensitive components are independent. The current state of knowledge 
about the different NO inactivation processes is illustrated in figure 6.18. It is 
not now clear where DPI is acting and therefore which, if any, of the 
components is a flavoprotein. DPI could, for example, act on flavin domains 
on the haem-containing cyanide sensitive component, or in a similar manner
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in the NADPH-dependent component. Alternatively, it could affect the haem 
moiety as does cyanide, such that none of the processes involve flavins. 
This question can be addressed by studying occlusion of the effects of DPI 
and cyanide or NADPH, to see at which (if either) of these processes DPI 
acts.
While, assuming the same product profile as in intact glia, the major product 
of NO breakdown is NO2', it is no longer clear which of these processes will 
produce this NCV. At high concentrations of tissue, NO2' is the only product 
of NO breakdown and the NADPH- and cyanide-independent component 
seems to predominate. This would suggest that the product of NO 
breakdown by this process is NCV, leaving the possibility that either or both 
of the other two components could produce NO3'. The products of NO 
breakdown in membranes in the presence and absence of NADPH and 
NaCN would produce valuable data to address this question. If these are 
found to be different, it becomes of interest to determine the product of NO 
breakdown by tissue slices, to try and address the question of which of the 
above processes is most relevant to the intact situation.
The properties of NO breakdown characterised in this chapter do not match 
well with any of the candidates suggested in the literature. The studies in 
CaCo-2 cells suggest that cytochrome P450 oxidoreductase and an 
additional haem protein, possibly a cytochrome P450, underlie NO 
degradation in these cells. This process is unlikely to be predominant in 
brain as it was wholly cyanide sensitive and required NADPH but not NADH 
as a cofactor (Hallstrom et al., 2004). Here, the cyanide and NADPH 
sensitivities are independent and NADH is also effective as a cofactor. The 
brain membrane consumption is more similar to that seen in endothelial 
cells, where NADPH and NADH could rescue activity and where NaCN and 
DPI incompletely inhibited consumption. Here, too, the assumption was 
made that the NADPH and NaCN sensitivity were facets of the same 
process. It is entirely possible that, like in these studies, they are in fact 
independent, as the effects of inhibitors on activity in endothelial membranes 
were only ever studied in the presence of NADPH. Identification of the
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endothelial pathway has not yet been successful, however. Inactivation of 
NO by DLDH was NaCN and DPI-insensitive, but required NADH not 
NADPH as a cofactor, ruling it out as a component of brain membrane 
inactivation. CcO remains a possible candidate for the cyanide-sensitive 
process, though it should also be present in platelets and WBC which do not 
demonstrate NO inactivation. Additionally, PGHS-1 is unlikely to be involved 
as the inhibitor, indomethacin, had no effect on NO breakdown by intact glia 
(R. Keynes, personal communication). Lipoxygenases have not been 
definitively ruled out as candidates, but are unlikely as they mediate NO 
consumption via NO binding to LOO' radicals, which are scavenged by the 
antioxidant Trolox, a treatment that does not affect breakdown in glia and is 
present to prevent lipid peroxidation in the brain membrane preparations.
Accelerated autoxidation occurs in biomembranes (Liu et al., 1998b) and 
generates N02- (Ford et al., 1993) and, though it cannot account for the 
inactivation of NO by cerebellar slices (Chapter 4), it may contribute to 
breakdown in dispersed preparations. Using the predicted increase in 
autoxidation rates from Liu et a/.’s study, the NO generated at different tissue 
concentrations was predicted using the model for autoxidation generated in 
Chapter 3, assuming the relative increase in autoxidation would be the same 
with the atypical autoxidation kinetics seen in our system (Fig. 6.19). 
Comparing this to experimental data in the presence of cyanide, but no 
NADPH, allows comparison between accelerated autoxidation and the 
situation where NO breakdown is governed by only the NADPH and cyanide- 
insensitive component. This demonstrates that accelerated autoxidation 
could contribute to the NADPH- and cyanide-insensitive component of NO 
inactivation by membranes but, as it stands, cannot fully account for all of the 
activity of this component. Variations in O2 and NO solubility in brain and the 
soybean lipids used in the aforementioned study may account for some of 
the difference. Experimental investigation of this possibility is required to 
clarify this issue, for example by studying breakdown by commercially 
available brain lipids or by characterising the kinetics of breakdown by the 
NADPH and cyanide insensitive component. If, in lipids, the consumption 
reaction follows 1st to 2nd order kinetics with respect to NO, autoxidation may
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be responsible, but if the reaction is Michaelis-Menten in character, another 
explanation is required.
Fig. 6.19: Comparison of [NO] reached following DETA/NO addition (100 pM) at different 
tissue concentrations in the presence of NaCN (100 pM; open circles) or predicted were NO 
inactivated by accelerated autoxidation (solid squares; normalised to buffer alone).
Superficially it seems strange that accelerated autoxidation can, theoretically 
at least, have a substantial effect on the NO profile seen on application of 
DETA/NO, but have no effect on the predicted concentration-response 
curves to cGMP (Fig. 4.5)3. The reason for this is that both normal and 
accelerated autoxidation are so slow at the low NO concentrations that 
encompass the sensitivity range for the GC(NO) receptor (0 -  20 nM) that 
diffusion into the slice predominates and no NO gradient exists across the 
slice (Fig. 6.20a), so the stimulation of the GC(NO) receptor is wholly 
determined by the bathing concentration of NO. At higher bathing 
concentrations of NO, however, accelerated autoxidation is predicted to 
significantly affect the gradient of NO across the slice. For example, using 
the standard autoxidation equation, at a bathing concentration of 1 pM NO, 
the breakdown of NO via accelerated autoxidation at the edge of the slice is
32.5 nM/s. At 1 nM NO, however, the rate of accelerated autoxidation is only
3 Modelling of autoxidation in slices uses the standard autoxidation as published (e.g. 
Schmidt et al, 1997) as it is assumed that the atypical autoxidation kinetics are a feature of 
the experimental NO probe setup and not therefore applicable to the situation in submerged 
tissue.
O-L-ZA-ht-r 
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Tissue protein cone (mg/ml)
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32.5 fM/s. The concentration has only changed by 3 orders of magnitude, 
but the rate of decay has decreased by 6 orders of magnitude, due to the 
second order dependence of autoxidation on NO concentration. According 
to Fick’s first law of diffusion, the rate of transfer of NO into the slice (flux) per 
unit area of tissue is proportional (i.e. linearly related) to the concentration 
gradient. Decreasing the bathing concentration by 3 orders of magnitude 
therefore decreases the flux of NO into the tissue by the same proportion. 
As the bathing NO falls, the relative contribution of NO diffusion into the slice 
therefore becomes predominant over the effect of breakdown via 
autoxidation.
a  0.010-  
zL
0 . 0 0 0  - I  T .  T  - -- -- -- -- -- -- -- -- -- -- -- -- --
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Position in slice (pm)
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Fig. 6.20: Predicted profiles across a brain slice after incubation with steady-state bathing 
NO of 1 and 10 nM (a) and 10 and 100 pM (N.B. at 1 nM external NO, normal and 
accelerated autoxidation profiles superimpose.) (b), when NO is broken down by either 
normal autoxidation (black lines; k = 13.6 x  106 M 2s'1) or 13-fold accelerated by the 
increased concentration of NO and 0 2 in hydrophobic membranes (red lines).
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The fact that autoxidation kinetics can, theoretically, dramatically affect the 
profile of NO accumulation in dispersed cells in response to DETA/NO but 
not in slices exposed to constant external NO exposes the difficulty of 
extrapolating from measurements in dispersed preparations to intact tissue. 
The use of these easily-manipulatable and directly-measurable preparations 
is important in the process of purification and identification of the different 
components, but their physiological relevance can only really be assessed by 
consideration of the intact situation. The importance of each will be affected 
by their levels and locations in tissue and the rates at which each can act in 
the physiological situation. For example, it could be the case that the 
NADPH component, not the NADPH- and cyanide-independent process 
could be more important in vivo, if it has further cofactor requirements that 
are present in intact tissue, but have been removed in the membrane 
preparations. Similarly, while the cyanide-sensitive component appears 
unimportant for controlling the gross diffusion of NO into a brain slice, it may 
become relevant if it is expressed in the vicinity of an endogenous NO 
source.
In short, while the existence of NO inactivation in brain has now been well- 
established, the identity of the different components of NO inactivation in 
brain still remains a mystery and must be a priority for further research. 
Strategies for the future include determining whether the various components 
are proteins, and if so, their purification. As discussed above, the importance 
of non-protein processes such as accelerated autoxidation must also be 
experimentally quantified. Finally, the relevance of the different processes 
for inactivation in cerebellar slices and for endogenous NO signalling must 
still be determined.
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7.1 Summary of experimental findings___________________
These studies have investigated the nature of inactivation of NO by brain 
tissue. The pathways by which endogenous NO signals are terminated are 
as yet unknown and the properties of such processes may have implications 
for physiological NO signals and for its role in pathophysiology. Prior to this 
work, NO consumption by dispersed brain preparations had been observed 
but the mechanism by which this process occurred was unknown (Griffiths et 
al., 2002; Griffiths & Garthwaite, 2001). In Chapter 3 a more intact 
preparation, cerebellar slices, was shown to also avidly inactivate NO and 
the kinetics of this process was quantified, using a model of diffusion and 
inactivation of NO based in part on kinetic data from the dispersed 
preparations. This suggested that, with a Km of 67 nM (as measured in 
dispersed cells and homogenate), the maximal rate of NO inactivation by the 
slices was at least 1 pM/s. Such kinetics is predicted to shape NO signals 
when several sources are concurrently active.
Meanwhile, the NO consumption by dispersed preparations was shown to be 
caused by ongoing lipid peroxidation and hence reaction of NO with lipid 
peroxyl radicals (Keynes et al., 2005) a process of significance to 
pathophysiological, but not physiological, signalling. In Chapter 4, however, 
it was demonstrated that the avid inactivation of NO by cerebellar slices is 
independent of ongoing lipid peroxidation and, as such, must be mediated by 
a different mechanism. A lipid peroxidation-independent NO consumption 
process was also apparent in dispersed cerebellar cells in the presence of 
lipid peroxidation inhibitors and when cells were maintained in an air 
equilibrated environment. A similar phenomenon was also observed in 
suspensions of cultured cerebellar glia, which were used for further study 
due to the absence of contaminant red blood cells.
Kinetic characterisation of glial NO consumption revealed a distinct triphasic 
dependence on 0 2 , the reaction changing from being apparently first order 
with respect to NO at high O2, to following saturating Michaelis-Menten
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kinetics at intermediate levels and being absent at low O2. The rates of NO 
breakdown at any given NO concentration are only likely to be affected by O2 
levels at supraphysiological levels of NO as, below 100 nM, the rate does not 
much change between 40 and 300 pM O2. The triphasic nature of the 0 2 - 
dependence suggested that multiple components contribute to glial NO 
consumption. Modelling NO penetration and cGMP accumulation in slices 
with these kinetic parameters did not well fit the experimental data, however, 
suggesting a different relative contribution of these factors to inactivation in 
intact tissue compared to glial cells.
Further characterisation of glial NO breakdown aimed to dissect the 
properties of the different processes involved with an aim to identify them 
and assess their relative relevance for both inactivation by slices and in 
whole brain. Glial consumption was partially inhibited by cyanide, was lost 
on cell lysis and was recovered with NAD(P)H addition. NO consumption 
localised to glial membranes and was similar in membranes of whole brain 
and synaptosomes. At least three separate components of inactivation could 
be distinguished: an NADPH-sensitive process, a cyanide-sensitive process 
and an additional mechanism(s) that became substantially increased at 
higher tissue concentrations and may partially be accounted for by 
accelerated autoxidation.
7.2 Artefacts or physiology? Implications and justifications
As discussed in Chapter 6, it is clearly important to identify the underlying 
mechanisms causing NO inactivation in brain membranes, cells and slices. 
The nature of the mechanisms will be of importance in assessing their 
physiological relevance. We have seen that at least some components of 
the breakdown are highly dependent on the ambient O2 levels and also that 
the kinetics of the process appear somewhat different in cells and slices, 
being substantially faster in slices than cells. The properties of the different 
components under physiological conditions will necessarily determine their
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role in modulating endogenous NO signals and it remains a possibility that 
the processes observed in vitro will be proved to be artefactual and 
insignificant at, for example, physiological NO and O2. If this is indeed the 
case, it is still of vast importance to fully understand these phenomena. The 
presence of the consumption of NO by slices is likely to be modulating the 
NO levels in numerous published studies into the role of NO in brain. If slice 
consumption is artefactually high, then the sensitivity of processes such as 
synaptic plasticity for NO could have been severely underestimated, or the 
spatiotemporal resolution overestimated (Jacoby etal., 2001; Lev-Ram et al., 
1995). Equally, the NO concentrations reached in brain following 
endogenous stimulation could be much higher than the low nanomolar levels 
measured in slices (Shibuki & Kimura, 1997; Wakatsuki et al., 1998). 
Inactivation by dispersed cells is substantially less than intact tissue due to 
decreased tissue concentration and possibly lower intrinsic inactivation 
activity (per mg protein; see below). The effects of exogenous NO on single 
cells could therefore also be overestimated as dispersed cells are less able 
to protect themselves from high NO.
While it is important to be aware of the potential for artefactually high NO 
consumption in in vitro preparations, these studies do suggest that, 
physiologically, brain tissue is likely to be able to consume NO. The 
dramatic O2 dependence initially suggested that NO consumption may only 
occur at supraphysiological O2 levels. In Chapter 5, however, it was 
demonstrated that glia consume NO at O2 concentrations that incorporate 
much of the physiological range in brain. Indeed, at physiological NO levels, 
the rate of breakdown was not highly dependent on the O2 concentration, 
which only affected inactivation rates at over 100 nM NO. Addtionally, 
inactivation by slices (see below) and tissue blocks does not seem consistent 
with highly O2 dependent processes, suggesting intact tissue may express 
relatively high levels of more 02-independent processes. NO consumption is 
therefore likely to be functioning at normoxic levels as well as the hyperoxic 
conditions typical in vitro.
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Many other potential artefacts have also been excluded. The specificity of 
NO breakdown for brain rather than platelet or WBC tissue suggests it is not 
a very general artefact of the experimental setup or of biological tissue. 
Reaction with both intra- and extracellular 02*’ has been excluded by the use 
of SOD and MnTBAP. Lipid peroxidation, which can occur in vitro in 
dispersed brain cells and which avidly consumes NO (Keynes et al., 2005) 
has been excluded from the mechanisms studied here by the use of 
inhibitors. Indeed, inactivation in slices may be increased by the long term 
application of the antioxidant and lipid peroxidation inhibitor Trolox (Fig. 
6.12a), suggesting that oxidative stress associated with in vitro hyperoxia 
and slice preparation inhibits rather than causes the consumption processes 
in slices. Consumption by brain may therefore be even more active in vivo, 
where oxidative stresses will be minimal. Finally, contaminant Hb and RBC 
have been excluded as contributing to the various preparations’ behaviour. It 
is likely, then, that the NO consumption processes characterised here are 
physiologically relevant.
7.3 Kinetics of NO consumption by brain tissue
While the exclusion of the potential artefacts described above suggests that 
NO is consumed physiologically by brain tissue, the rate at which this occurs 
will determine the impact of NO consumption on physiological and 
pathophysiological concentrations of NO. As discussed above, the kinetics 
of cerebellar slice NO consumption were originally determined based on 
parameters from cells and homogenate and these were subsequently found 
to be irrelevant to the mechanism in slices. The kinetics of lipid peroxidation- 
independent NO inactivation in cells was subsequently determined but did 
not fit well with the apparent kinetics in slices.
Some predictions of slice inactivation kinetics can be made, however by 
studying how the NO-cGMP curves predicted from certain inactivation 
reactions differ from those experimentally determined in slices. In Chapter 5,
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for example, we saw that a first-order inactivation reaction produced very 
shallow predicted NO-cGMP curves, markedly unlike those experimentally 
measured (Fig. 5.10c). Similarly, high values of Km (>100 nM) that best-fitted 
data in cells again produced shallow predicted NO-cGMP curves (Figs. 5.9 & 
5.10). This suggests that slice inactivation kinetics are not half-maximal at 
high nanomolar NO levels and are also not linearly dependent on the NO 
concentration. Indeed, the best fit of the experimental data occurred when 
the Km was rather small (67 nM; Fig 3.11c) 4 For this reason, I briefly 
revisited the model of diffusion and inactivation used in chapters 3 and 5 and 
investigated the effect of altering the Km for inactivation on the NO-cGMP 
curves predicted, when the Vmax was 2 pM/s (deemed to be the best fit of the 
data when Km was 67 nM; Fig. 3.11c). Decreasing the Km right-shifted and 
steepened the predicted NO-cGMP curves until the lines converged at a Km 
of 1 nM, such that further decreasing the Km had no effect on the predicted 
curve (Fig. 7.1a). The experimental data is well-fitted by inactivation kinetics 
with a Vmax of 2 pM/s and a Km of 1 or 10 nM (as these two lines are very 
close to each other). Altering the Vmax for inactivation with a Km of 1 nM 
demonstrates that a maximal rate of 1 or 2 pM/s best fits the data with this 
lower Km (Fig. 7.1b). In short, the experimental data in cerebellar slices is 
best fitted by a model of NO diffusion and inactivation whereby the Vmax for 
inactivation is between 1 and 2 pM/s and the Km is between 1 and 10 nM.
In comparison, adjusting to intact tissue concentrations, air-equilibrated 
cultured glial cells inactivate NO with a Vmax for of 1 pM/s and a Km of 373 nM 
(Fig. 5.7b&c). At lower O2 concentrations, the Vmax falls to 270 nM and the 
Km to 89 nM. The reason for the difference in kinetics between cells and 
slices is not yet clear. Firstly, the 0 2 -dependence of NO inactivation by 
slices is not known. The lack of a difference in consumption by tissue blocks 
in air-equilibrated IB and aCSF gassed with 95 % O2 (Fig. 6.12b) suggests 
such 0 2 -dependence is minimal, as does the poor fit to experimental data of 
models assuming decreased NO consumption in the 0 2 -deprived slice core
4 A good fit of the experimental data was also achieved when 0 2-consumption by the slice 
was assumed to be 10-fold accelerated and only the Vmax for inactivation at intermediate 0 2 
concentrations was varied. This was deemed to be too artificial a situation for any 
meaningful conclusions to be derived (see Chapter 5.4).
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(Figs. 5.9 & 5.10). Identification of the mechanism of NO consumption 
relevant to slices is required to verify this, but if true, adds more credence to 
the single Michaelis-Menten fit above as a valid description of slice kinetics 
(as opposed to a more complicated, 0 2 -dependent model).
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Fig. 7.1 : Predicted NO-cGMP curves following incubation of cerebellar slices with constant 
concentrations of bathing NO. Dotted lines represent the curves predicted after adjusting for 
the effects of donor release from within the slice.
a) Vmax = 2 pM/s; Km = (left to right) 100,10,1 and 0.1 nM.
b) Km = 1 nM; Vmax = (left to right) 1, 2, 4 and 8 pM/s
The deduced maximal inactivation rates are also somewhat slower in cells 
than slices and the Km values considerably higher. There are number of 
possible reasons for these discrepancies. It could be the case that the major 
component of inactivation in slices (with a high Vmax and low Km) is simply 
lost on dispersion of the tissue. Alternatively, the activity of a common 
mechanism could simply be increased in maximal rate and potency in slices
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compared to cells. This could be due to the presence of different cell types 
(e.g. neurons) in slices compared to glia; a requirement for interactions 
between cells for optimal inactivation activity; cell damage accrued when 
suspending the cells (e.g. on trypsinisation), for example leading to a change 
in cofactor availability, or modulation of a mechanism in slices that cannot 
occur in cells (e.g. phosphorylation changes leading to changes in potency). 
The reason awaits identification and full characterisation of the different 
components of inactivation. This must necessarily progress from studies in 
dispersed cells and glia, where parameters affecting inactivation can be fully 
dissected and controlled. I would argue, however, that while such studies 
are critical for this identification and characterisation, the best indication of 
the physiological functioning of NO consumption can be gleaned from the 
most intact preparation: cerebellar slices.
7.4 The impact of NO consumption on physiological NO 
signalling
In Chapter 3, a number of simple models of physiological NO signalling were 
used to assess the likely impact of NO consumption by brain tissue on 
physiological NO signals. Here, the newly-derived parameters were used in 
these same models. The first model assumed homogenous distribution of 
NO sources and sinks and simultaneous activation and deactivation of NO 
synthesis and modelled the temporal profile of NO accumulation and decay 
according to equations 3.8 and 3.9 (Fig. 7.2). In Chapter 3 a Km for 
inactivation of 67 nM and a Vmax of 1 pM/s were used. The higher Vmax and 
lower Km values used here (Vmax = 2 pM/s; Km = 1 - 1 0nM) result in more avid 
inactivation of NO. Comparing figure 7.2 with figure 3.12a, higher rates of 
NO synthesis are required to generate physiological concentrations of NO (0 
-10 nM). With a Km of 10 nM, but not 1 nM, inactivation is able to convert 
rates of NO synthesis to constant concentrations, as seen in Chapter 3, but 
the half-life of the NO decay on cessation of synthesis is much shorter, being 
less than 10 ms when the Km is 10 nM and 4 ms when the Km is 1nM. When
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the time course of NO synthesis is modulated according to the profile of a 
typical Ca2+ transient (Eqs. 3.10 and 3.11), the temporal NO profile (Fig. 7.3) 
is more tightly linked to that of the activation and deactivation of NOS than in 
Chapter 3 (Fig. 3.12), such that the peak NO occurs at the same time as 
peak NOS activity when the Km is 1 nM, and only 10 ms later when it is 10 
nM. Examining the predicted spatial NO profile following synthesis from 
a single synaptic bouton or a collection of 20 sources (Eq. 3.12) reveals that,
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Fig. 7.2 : Predicted temporal profiles of endogenous NO signals, when sources
homogenously distributed throughout tissue are immediately synchronously activated and 
deactivated. Vmax for inactivation is 2 pM/s. Km is 1 nM (black lines: a, c & d) or 10 nM (red 
lines, b, c & d).
a) & b) Profiles following a pulse of NO synthesis (50 or 100 ms) at the rates labelled (in 
pM/s).
c) At a NO synthesis rate of 2 pM/s, NO does not reach a plateau and during a longer 
stimulation (here 1 s) but continues to accumulate.
d) Time course of NO decay following cessation of NO synthesis after NO has reached 50, 
100 and 200 nM NO.
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like previously, inactivation has very little influence on the NO profile 
following synthesis from a single bouton, but when a collection of sources 
are active, NO is strongly affected by inactivation. With synthesis at the 
maximum rate expected in tissue (1.6 pM/s) NO levels rise to 45 nM without 
inactivation, but only reach 5 nM with an inactivation Km of 10 nM, and 0.65 
nM when the Km is 1 nM. As in Chapter 3, inactivation also limits the spatial 
spread of the NO signal, constraining it to the area of tissue that is 
contributing to NO synthesis. With both values of Km, the NO concentration 
falls to half-maximal at 19 pm from the centre, while the sources occupy an 
area of tissue with a radius of 20 pm.
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Fig. 7.3 : Predicted temporal profiles of endogenous NO signals when NO synthesis is 
homogenously distributed and activated and deactivated parallel to the time course of Ca2+ 
spikes in a spine (see Chapter 3).
a) Temporal profile of NO synthesis, calculated according to equation 3.11, where the 
maximum rate of NO synthesis is 0.5, 1,1.5 and 2 pM/s.
b) & c) Predicted NO profiles generated by the NO profiles in (a), with Vmax for inactivation of 
2 pM/s and Km of 1 nM (b) or 10 nM (c).
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Fig. 7.4 : Predicted spatial NO profiles following endogenous NO synthesis from discrete 0.5 
pm synaptic boutons, with no inactivation (blue line), or inactivation with a Vmax of 2 pM/s 
and a Km of either 1 nM (black line) or 10 nM (red line).
a) Main panel: Spatial profile of NO when it is synthesised by one bouton, at a rate of 16 
nM/s.
b) Main panel: Spatial profile of NO reached when synthesised by 20 boutons, at a rate of 16 
nM/s.
Insets: Peak NO achieved with NO synthesis at 8, 16, 800 and 1600 nM/s with a single 
source (a) or 20 sources concurrently active (b).
In summary, as seen in Chapter 3, inactivation with kinetics as derived from 
slices predominantly affects NO signals from several sources, rather than a 
single site, in which case diffusion is the major factor governing the NO 
profile. The increased avidity of inactivation compared to that modelled in 
Chapter 3 means that much higher rates of NO synthesis are required to 
generate physiologically-relevant concentrations of NO. The dynamics of the 
NO signal are, however, more tightly linked to the underlying kinetics of 
synthesis, such that the decay of NO is predicted to have a very short half- 
life of less than 10 ms, at physiological NO concentrations. This suggests 
that the limiting factor in the temporal resolution of NO signals is the kinetics 
of NO synthesis, in turn determined by the Ca2+ transient, and not of NO 
breakdown or diffusion. NO signals can therefore be of sufficient temporal 
resolution to account for the very specific temporal coincidence requirements 
observed in, for example, cerebellar LTD (Lev-Ram et al., 1997).
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Spatially, as seen in Chapter 3, NO produced from a single synaptic bouton 
is barely influenced by tissue inactivation. A single source produces only a 
very low concentration of NO (low picomolar levels), however, even at 
maximum synthesis rates, so it is unlikely that NO produced from only one 
bouton would be able to have a physiological effect. Synthesis from a single 
bouton is unlikely, however, as there is likely to be a number of concurrently 
active sites, for example along the same cerebellar parallel fibre, or in 
adjacent fibres. When several sources are active, inactivation dramatically 
shapes the NO signal, reducing the peak NO and constraining the spread of 
NO to actively synthesising tissue. The linearity of the relationship between 
peak NO produced and the rate of NO synthesis indicates that, as in the 
model of homogenously distributed synthesis, inactivation is able to scale a 
rate of synthesis to a given concentration of NO, which will produce a 
specific degree of downstream activation of the GC(NO) receptor. The 
inactivation kinetics therefore seems well-suited to shape NO signals for 
meaningful activation of the GC(NO) receptor, when several sources are 
active. This is inconsistent with a purely synapse-specific role for NO but, as 
discussed in Chapter 3, is compatible with an involvement for NO in synaptic 
plasticity at the level of groups of neurons and synapses.
Each of these models demonstrates that there is a substantial difference in 
the degree of inactivation when the Km for inactivation is 1 nM compared to 
10 nM. This is unsurprising as inactivation will proceed at its maximal rate 
for more of the time with the lower Km. It is unclear from the slice data 
whether the Km is closer to 1 or 10 nM, but the modelling here would suggest 
that it would be physiologically more useful to be around 10 nM. There is a 
trade-off between having fast inactivation and sharper NO signals, and 
“wasting” NO which is produced but never reaches its biological target. A Km 
of 10 nM would preserve the advantages of temporally and spatially 
constraining NO signals to the time course and sites of its synthesis, but 
reduces the rates of synthesis required to produce sufficiently high NO levels 
to produce a physiological effect.
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Inactivation of NO by slices therefore seems likely to play an important role in 
shaping physiological NO signals, but is so avid that high synthesis rates 
seem to be required for NO to accumulate to sufficient levels to have a 
physiological effect. Endogenous NO synthesis rates are not known, but the 
maximal NO synthesis rates in cerebellum is 50 nmol/min/g tissue (Salter et 
al., 1995b), corresponding to 800 nM/s. Here I assumed that half the volume 
of the tissue was able to produce NO and the maximum synthesis rate was 
therefore 1600 nM/s. If less of the tissue produces NO, then the maximum 
rate will be correspondingly higher. The synthesis rates required to raise NO 
to low nanomolar levels are, therefore, within the biologically plausible range. 
It remains to be seen, however, whether such rates can occur in conditions 
of limited substrate availability and lower O2. Experimental determination of 
endogenous synthesis rates is required to improve these predictions as to 
the nature of physiological NO signals and is also critical for determining the 
potential for NO accumulation to potentially toxic levels. These models 
predict that even at high synthesis rates (e.g. 1.5 pM/s) NO levels are held at 
low concentrations such that even long periods of stimulation will not lead to 
accumulation of toxic NO concentrations (Fig. 7.2). If the rate of synthesis is 
higher (e.g. 2 pM/s) then inactivation is unable to hold NO at a steady state 
and it can gradually accumulate, such that prolonged stimulation could 
conceivably eventually produce damaging concentrations of NO (Fig. 7.2c). 
Conversely, if inactivation was compromised in any way, the high synthesis 
rates could lead to a more rapid accumulation of NO and pathophysiology 
could then ensue.
All the models used here assume a homogenous distribution of NO 
inactivation throughout the tissue. This is a necessary simplification given 
the current lack of identification of the process(es) involved, but limits the 
power of the models somewhat. Identification and localisation of these 
mechanisms would allow their relative contributions to physiological NO 
signals to be predicted. It is possible that different processes may be more 
relevant to endogenous release than to exposure to relatively high 
exogenous NO concentrations, due to different cellular and sub-cellular 
locations. The cyanide-sensitive process, for example, while it does not
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seem to affect NO accumulation in a slice following exogenous NO 
application, may be more effective if located in close proximity to an 
endogenous NO source. Measurement of endogenous NO signals and the 
manner in which they can be affected is obviously the ideal manner in which 
this could be addressed, but without the technical capability to achieve this, 
knowledge of the kinetics and distribution of inactivation pathways would 
allow predictions to be made as to their relative importance compared to 
each other, diffusion and inactivation by circulating blood.
7.5 Conclusions
Inactivation of NO by cerebellar slices is rapid and is predicted to shape 
physiological NO signals produced by groups of neurons. Studies in 
dispersed brain preparations indicate that a number of different processes 
can consume NO brain tissue. Further information as to the identity, kinetic 
properties and distribution of these mechanisms and rates of endogenous 
NO synthesis is required to further probe the role of inactivation in 
physiological and pathophysiological NO signalling.
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